JACKSON LABORATORY
Cite this
Plain text JACKSON LABORATORY. furp.org, nonprofit organization profile, tax years 2009–2024. https://furp.org/org/jackson-laboratory-010211513. Retrieved 2026-10-29.
APA furp.org. (n.d.). JACKSON LABORATORY [Nonprofit organization profile; tax years 2009–2024]. Retrieved October 29, 2026, from https://furp.org/org/jackson-laboratory-010211513
MLA “JACKSON LABORATORY.” furp.org, tax years 2009–2024, https://furp.org/org/jackson-laboratory-010211513. Accessed 29 Oct. 2026.
Retrieved 2026-10-29; covers tax years 2009–2024. Data: furp.org, CC BY 4.0.
2024 · Form 990 · revenue $652.5M · expenses $617.0M · assets $1.56B
- EIN
- 01-0211513
- Address
- 600 MAIN ST, BAR HARBOR, ME 04609-1522
- Website
- WWW.JAX.ORG
- NTEE code
- H920
- Exempt type
- 501(c)(3): charitable, religious, educational, scientific or literary (corporation)
- Ruling date
- May 1950 (when the IRS recognized its exemption)
- IRS status
- Exempt (unconditional) (IRS Business Master File) IRS data ↗
- Tax-deductible donations
- Yes: listed in IRS Publication 78 (public charity) Pub 78 ↗
- Foundation status
- Public charity supported by the public (170(b)(1)(a)(vi))
- Cross-check
- ProPublica Nonprofit Explorer
Mission
THE PURPOSES OF THE LABORATORY ARE SCIENTIFIC, MEDICAL, CHARITABLE, AND EDUCATIONAL. OUR MISSION IS TO DISCOVER PRECISE GENOMIC SOLUTIONS FOR DISEASE AND EMPOWER THE BIOMEDICAL COMMUNITY.
Each tax year counts once: when a return was amended, only the latest return for that period is used below (superseded returns stay listed, greyed, under Finances).
People paid by the organization
59 people paid across every filing: current people first, then by total pay from this organization. Organizations counts every nonprofit each person appears on.
| Name | Latest title | Years | Latest year pay | Total pay from here | Organizations |
|---|---|---|---|---|---|
| Edison T Liu Md | Former President & CEO | 2012-2024 | $461,986 | $13,775,207 | 5 |
| S CATHERINE Longley | EXECUTIVE VICE PRESIDENT & COO (UNTIL 03/24) | 2016-2024 | $568,581 | $7,106,433 | 2 |
| Lon Cardon PHD FMEDSCI | PRESIDENT & CEO | 2021-2024 | $2,746,750 | $6,432,393 | 1 |
| Charles Lee MD | SCIENTIFIC DIRECTOR, JAX GM | 2013-2024 | $583,302 | $4,980,734 | 1 |
| Nadia A Rosenthal | SCIENTIFIC DIRECTOR | 2016-2024 | $590,177 | $4,705,465 | 1 |
| Jens Rueter | CHIEF MEDICAL OFFICER | 2017-2024 | $612,962 | $4,112,562 | 1 |
| Douglas W Abbott | SR VICE PRESIDENT & CFO | 2018-2024 | $963,417 | $3,901,374 | 1 |
| Daniel Hoag | GENERAL COUSEL & SECRETARY | 2021-2024 | $689,023 | $2,255,593 | 1 |
| Mitchell Kennedy | EXECUTIVE VP & PRESIDENT, JMCRS | 2023-2024 | $1,385,901 | $2,176,641 | 1 |
| Andy Greene | SR VICE PRESIDENT FOR RESEARCH | 2023-2024 | $728,486 | $1,306,872 | 1 |
| Emily Schorer | SR VP, CHIEF OF STAFF & CHIEF PEOPLE OFFICER | 2021-2024 | $684,754 | $1,168,264 | 1 |
| Brian Bannerman | VICE PRESIDENT, JMCRS FINANCE | 2023-2024 | $536,584 | $1,094,941 | 1 |
| James Keck | SR DIRECTOR, INNOVATION AND PRODUCT DEVELOPMENT | 2023-2024 | $523,170 | $1,070,698 | 1 |
| Mary Dickinson | EXECUTIVE VP & CHIEF SCIENTIFIC OFFICER | 2024 | $836,899 | $836,899 | 1 |
| Gina Rodriguez | SR VP OF ADVANCEMENT AND EXTERNAL RELATIONS | 2024 | $661,161 | $661,161 | 1 |
| Paul Flicek | CHIEF DATA SCIENCE OFFICER | 2024 | $517,529 | $517,529 | 1 |
| Charles Hewett PhD (former) | Trustee (End 08/24/23) | 2009-2023 | $0 | $9,141,579 | 2 |
| Aurobindo Nair (former) | EXECUTIVE VP & PRESIDENT JMCRS | 2009-2021 | $1,576,794 | $8,544,388 | 1 |
| Kenneth H Fasman (former) | SENIOR VICE PRESIDENT RESEARCH | 2016-2021 | $721,015 | $3,411,975 | 1 |
| Jacques F Banchereau Phd (former) | PROFESSOR | 2014-2020 | $457,908 | $3,069,854 | 1 |
| Robert E Braun (former) | FACULTY MEMBER | 2009-2017 | $392,211 | $3,019,194 | 1 |
| Kathy Vandegrift (former) | ASSOC. GM, SITE DIR. & PROD | 2009-2019 | $434,798 | $2,900,630 | 1 |
| Brian R Leslie (former) | GENERAL COUNSEL | 2013-2017 | $486,719 | $2,352,369 | 1 |
| Barbara-Jean Bormann-Kennedy (former) | VP SCI TRANSLATION/ALLIANCES | 2018-2022 | $510,115 | $1,880,837 | 1 |
| Michael Hyde (former) | VP EXTERNAL AFFAIRS | 2009-2014 | $388,734 | $1,841,027 | 1 |
| Edison T Liu Md Until 1121 (former) | PRESIDENT & CEO | 2021 | $1,791,641 | $1,791,641 | 1 |
| David Grass (former) | VP, JMCRS MICE & SERVICE OPS (UNTIL 10/23) | 2020-2023 | $788,081 | $1,789,991 | 1 |
| John Ryan (former) | FORMER GENERAL COUNSEL & SECRETARY | 2018-2021 | $158,999 | $1,661,995 | 1 |
| Kristen B Rozansky (former) | VICE PRESIDENT, DEV & COMMUN | 2013-2016 | $525,554 | $1,611,554 | 1 |
| Gregory Leet (former) | VICE PRESIDENT FOR ADVANCEMENT | 2017-2019 | $511,171 | $1,375,482 | 1 |
| Charles Miller (former) | VP, JMCRS ASIA PACIFIC MARKET | 2021-2022 | $644,501 | $1,354,542 | 1 |
| Linda A Jensen Ms (former) | CHIEF FINANCIAL OFFICER | 2012-2014 | $400,140 | $1,159,179 | 1 |
| Linda A Jensen (former) | CHIEF FINANCIAL OFFICER | 2009-2015 | $420,395 | $1,088,414 | 1 |
| Richard P Woychik Phd (former) | PRESIDENT & CEO | 2009-2010 | $541,735 | $1,081,535 | 1 |
| Aurobindo Nair Until 922 (former) | EXECUTIVE VP & PRESIDENT JMCRS | 2022 | $1,070,589 | $1,070,589 | 1 |
| Janan T Eppig Phd (former) | PROFESSOR | 2009-2013 | $280,781 | $1,046,836 | 1 |
| Michael Waters (former) | SR DIR OPPORTUNITY DEVELOPMENT | 2009-2013 | $285,435 | $1,030,434 | 1 |
| Leah Rae B Donahue Phd (former) | DIR GENETIC RESOURCE SCIENCE | 2012-2014 | $195,046 | $751,225 | 1 |
| Gary A Churchill Phd (former) | PROFESSOR | 2009-2012 | $261,438 | $734,357 | 1 |
| Yijun Ruan Phd (former) | DIRECTOR, JAX GM | 2013-2014 | $300,368 | $670,256 | 1 |
| Kenneth Fasman Until 1022 (former) | SENIOR VICE PRESIDENT RESEARCH | 2022 | $662,854 | $662,854 | 1 |
| MaryEllen Joseph (former) | VP, JMCRS Global Sales, Marketing, & Customer Support (UNTIL 10/23) | 2023 | $640,688 | $640,688 | 1 |
| Linda Waterman Dvm (former) | SR DIR LAB ANIMAL HEALTH | 2012-2013 | $271,474 | $533,480 | 1 |
| Kathy Vandegrift Until 1121 (former) | ASSOC. GM, SITE DIR & PROD | 2021 | $532,003 | $532,003 | 1 |
| Barbara-Jean Bormann-K (former) | VP SCI TRANSLATION/ALLIANCES | 2019 | $460,888 | $460,888 | 1 |
| Charles Lee Phd Facmg (former) | SCIENTIFIC DIRECTOR, JAX GM | 2016 | $439,197 | $439,197 | 1 |
| Andrew Greene (former) | PROF&DIRECT MASS SPEC PROTEIN | 2020 | $430,537 | $430,537 | 1 |
| George M Weinstock (former) | DIRECTOR, MICROBIAL GENOMICS | 2016 | $412,092 | $412,092 | 1 |
| Etzard Stolte Phd (former) | CHIEF INFOMRATION OFFICER | 2014 | $395,164 | $395,164 | 1 |
| Mike E Hyde (former) | VP EXTERNAL AFFAIRS & STRATE | 2015 | $392,941 | $392,941 | 1 |
| Joanne Ruh (former) | CHIEF INFORMATION OFFICER | 2012 | $346,738 | $346,738 | 1 |
| John Fitzpatrick (former) | SENIOR DIRECTOR, FACILITIES | 2014 | $339,869 | $339,869 | 1 |
| Jana Robinson (former) | ASSISTANT SECRETARY | 2009-2013 | $96,569 | $314,087 | 1 |
| Jay Vetelino (former) | ASSISTANT TREASURER | 2013-2014 | $150,408 | $298,037 | 1 |
| Ronald Sucy (former) | ASSISTANT TREASURER | 2009-2010 | $140,606 | $272,631 | 1 |
| Joseph Vetelino (former) | ASSISTANT TREASURER | 2010-2012 | $139,723 | $265,159 | 1 |
| Susan D Airhart (former) | SR. DIR STRATEGIC OPPORTUNITY | 2010 | $247,693 | $247,693 | 1 |
| Leah Rae Donahue Phd (former) | DIR GENETIC RESOURCE SCIENCE | 2010 | $230,813 | $230,813 | 1 |
| Kenneth Paigen Phd (former) | PROFESSOR | 2010 | $211,804 | $211,804 | 1 |
Officers and directors, no compensation reported
76 people listed on the returns with $0 (or no amount) in every compensation column: current people first. Hours are as filed on the latest return each person appears on.
| Name | Latest title | Years | Hrs/wk (latest) | Compensation | Organizations |
|---|---|---|---|---|---|
| Dinakar Singh | TRUSTEE | 2022-2024 | 2 | $0 reported | 4 |
| Bertrand Garcia-Moreno | TRUSTEE | 2021-2024 | 2 | $0 reported | 2 |
| Timothy D Dattels | BOARD CHAIR | 2015-2024 | 5 | $0 reported | 1 |
| Carla E Brodley Phd | VICE CHAIR | 2020-2024 | 2 | $0 reported | 1 |
| Eric Horvitz Md Phd | TRUSTEE (START 02/24) | 2023-2024 | 2 | $0 reported | 1 |
| Ernestine Fu | TRUSTEE (START 08/24) | 2024 | 2 | $0 reported | 1 |
| Frank Moss Phd | TRUSTEE | 2018-2024 | 2 | $0 reported | 1 |
| Geoffrey W Smith Jd | TRUSTEE | 2017-2024 | 2 | $0 reported | 1 |
| George G Montgomery | TRUSTEE | 2018-2024 | 2 | $0 reported | 1 |
| Janet Rossant Phd | TRUSTEE | 2014-2024 | 2 | $0 reported | 1 |
| Jeffrey M Friedman Md Phd | TRUSTEE | 2016-2024 | 2 | $0 reported | 1 |
| Jenny E Rooke Phd | TRUSTEE | 2018-2024 | 2 | $0 reported | 1 |
| John A Gibbons Jr | TRUSTEE (UNTIL 08/24) | 2017-2024 | 2 | $0 reported | 2 |
| John Lowry | TRUSTEE | 2021-2024 | 2 | $0 reported | 1 |
| Joshua Broder | TRUSTEE | 2021-2024 | 2 | $0 reported | 1 |
| Julie H Daum | TRUSTEE | 2017-2024 | 2 | $0 reported | 1 |
| Mary Kate Wold Jd | TRUSTEE | 2018-2024 | 2 | $0 reported | 1 |
| Melissa C Guzy | TRUSTEE | 2020-2024 | 2 | $0 reported | 1 |
| Nancy J Cox Phd | TRUSTEE | 2022-2024 | 2 | $0 reported | 1 |
| Neal B Milch Jd | VICE CHAIR | 2012-2024 | 2 | $0 reported | 1 |
| Otis W Brawley Md | TRUSTEE | 2016-2024 | 2 | $0 reported | 1 |
| Robert King Phd | TRUSTEE (START 02/24) | 2024 | 2 | $0 reported | 1 |
| Sandra Waite Jd | TRUSTEE | 2021-2024 | 2 | $0 reported | 1 |
| Steven B Fink Jd | TRUSTEE | 2017-2024 | 2 | $0 reported | 1 |
| Stewart J Hen | TRUSTEE (START 08/24) | 2009-2024 | 2 | $0 reported | 2 |
| Thomas C Barry | TRUSTEE | 2015-2024 | 2 | $0 reported | 1 |
| Adaora Adimora MD MPH (former) | Trustee (End 08/24/23) | 2020-2023 | 2 | $0 reported | 1 |
| David Roux (former) | Trustee (End 08/24/23) | 2012-2023 | 2 | $0 reported | 2 |
| Dennis Paustenbach PhD (former) | Trustee | 2013-2023 | 2 | $0 reported | 1 |
| Joan Steitz PhD (former) | Trustee (End 08/24/23) | 2014-2023 | 2 | $0 reported | 2 |
| Jean Hoffman Until 1222 (former) | TRUSTEE | 2022 | 2 | $0 reported | 1 |
| John Schimenti Phd Until 822 (former) | TRUSTEE | 2022 | 2 | $0 reported | 1 |
| John C Schimenti Phd (former) | TRUSTEE | 2020-2021 | 2 | $0 reported | 1 |
| Kathleen A Corbet Until 821 (former) | TRUSTEE | 2021 | 2 | $0 reported | 1 |
| Jean Hoffman (former) | TRUSTEE | 2018-2021 | 2 | $0 reported | 1 |
| Anthony B Evnin (former) | TRUSTEE (UNTIL 12/20) | 2009-2020 | 1 | $0 reported | 5 |
| Kathleen A Corbet (former) | TRUSTEE | 2009-2020 | 1 | $0 reported | 1 |
| Kathy Bloomgarden (former) | TRUSTEE (UNTIL 7/20) | 2019-2020 | 1 | $0 reported | 1 |
| Mark Blumenkranz (former) | TRUSTEE (UNTIL 1/20) | 2017-2020 | 1 | $0 reported | 1 |
| Louis J D'Ambrosio (former) | TRUSTEE (UNTIL 8/20) | 2009-2020 | 1 | $0 reported | 1 |
| Mark S Blumenkranz M (former) | TRUSTEE | 2019 | 1 | $0 reported | 1 |
| David Elliman Until 8 (former) | TRUSTEE | 2019 | 1 | $0 reported | 1 |
| Jeffrey M Friedman M (former) | TRUSTEE | 2019 | 1 | $0 reported | 1 |
| Paul Godley Md Phdd (former) | TRUSTEE | 2019 | 1 | $0 reported | 1 |
| Richard Lannamann Unt (former) | TRUSTEE | 2019 | 1 | $0 reported | 1 |
| DAVID R CABOT until 818 (former) | TRUSTEE | 2018 | 1 | $0 reported | 1 |
| David D Elliman (former) | TRUSTEE | 2009-2018 | 1 | $0 reported | 1 |
| PETER F GERRITY until 818 (former) | TRUSTEE | 2018 | 1 | $0 reported | 1 |
| Paul Godley Md Phd Deceased (former) | TRUSTEE | 2018 | 1 | $0 reported | 1 |
| Richard S Lannamann (former) | TRUSTEE | 2009-2018 | 1 | $0 reported | 1 |
| BRIAN F WRUBLE until 1218 (former) | TRUSTEE | 2018 | 1 | $0 reported | 1 |
| Charles M Rice (former) | TRUSTEE (UNTIL 08/2017) | 2012-2017 | 1 | $0 reported | 2 |
| David R Cabot (former) | TRUSTEE | 2009-2017 | 1 | $0 reported | 1 |
| James J Gallogly (former) | TRUSTEE (UNTIL 06/2017) | 2009-2017 | 1 | $0 reported | 1 |
| Peter F Gerrity (former) | TRUSTEE | 2009-2017 | 1 | $0 reported | 1 |
| Paul A Godley Md Phd (former) | TRUSTEE | 2016-2017 | 1 | $0 reported | 1 |
| Leo A Holt (former) | TRUSTEE (UNTIL 08/2017) | 2009-2017 | 1 | $0 reported | 1 |
| Sam R Little (former) | TRUSTEE (UNTIL 08/2017) | 2009-2017 | 1 | $0 reported | 1 |
| Edward Rubin Md Phd (former) | TRUSTEE (UNTIL 04/2017) | 2013-2017 | 1 | $0 reported | 1 |
| Brian F Wruble (former) | TRUSTEE | 2009-2017 | 1 | $0 reported | 1 |
| Weslie R Janeway (former) | TRUSTEE | 2009-2016 | 1 | $0 reported | 3 |
| John Gibbons (former) | TRUSTEE | 2016 | 1 | $0 reported | 1 |
| Richard S Gurin (former) | TRUSTEE | 2009-2016 | 1 | $0 reported | 1 |
| David Baltimore Phd (former) | TRUSTEE | 2009-2014 | 1 | $0 reported | 1 |
| David Valle Md (former) | TRUSTEE | 2010-2014 | 1 | $0 reported | 1 |
| Thomas S Volpe (former) | TRUSTEE | 2013-2014 | 1 | $0 reported | 1 |
| Tom Maniatis Phd (former) | TRUSTEE | 2009-2013 | 1 | $0 reported | 2 |
| Jeffrey Dunn (former) | TRUSTEE | 2012-2013 | 1 | $0 reported | 1 |
| Ross E Dworman (former) | TRUSTEE | 2009-2012 | 1 | $0 reported | 1 |
| Tom S Volpe (former) | TRUSTEE | 2009-2012 | 1 | $0 reported | 1 |
| Edward L Samek (former) | TREASURER | 2009-2012 | 1 | $0 reported | 1 |
| William S Harwood Esq (former) | TRUSTEE | 2009-2012 | 1 | $0 reported | 1 |
| Shirley M Tilghman Phd (former) | TRUSTEE | 2009-2012 | 1 | $0 reported | 1 |
| Robert C Beck (former) | TRUSTEE | 2009-2010 | 1 | $0 reported | 1 |
| Terry R Magnuson Phd (former) | TRUSTEE | 2009-2010 | 1 | $0 reported | 1 |
| Marie J Langlois (former) | TRUSTEE | 2009 | 1 | $0 reported | 1 |
People by year
2024 · 42 people listed · 16 paid, $13.1M · 3,203 employees · 26 volunteers
| Name | Title | Hrs/wk | From org | From related | Other | Total | Orgs |
|---|---|---|---|---|---|---|---|
| Lon Cardon PHD FMEDSCI | PRESIDENT & CEO | 40 | $2,515,944 | $0 | $230,806 | $2,746,750 | 1 |
| Mitchell Kennedy | EXECUTIVE VP & PRESIDENT, JMCRS | 40 | $1,260,592 | $0 | $125,309 | $1,385,901 | 1 |
| Douglas W Abbott | SR VICE PRESIDENT & CFO | 40 | $843,368 | $0 | $120,049 | $963,417 | 1 |
| Mary Dickinson | EXECUTIVE VP & CHIEF SCIENTIFIC OFFICER | 40 | $762,057 | $0 | $74,842 | $836,899 | 1 |
| Andy Greene | SR VICE PRESIDENT FOR RESEARCH | 40 | $637,481 | $0 | $91,005 | $728,486 | 1 |
| Daniel Hoag | GENERAL COUSEL & SECRETARY | 40 | $586,313 | $0 | $102,710 | $689,023 | 1 |
| EMILY SCHORER | SR VP, CHIEF OF STAFF & CHIEF PEOPLE OFFICER | 40 | $590,474 | $0 | $94,280 | $684,754 | 1 |
| Gina Rodriguez | SR VP OF ADVANCEMENT AND EXTERNAL RELATIONS | 40 | $557,507 | $0 | $103,654 | $661,161 | 1 |
| Jens Rueter | CHIEF MEDICAL OFFICER | 40 | $542,168 | $0 | $70,794 | $612,962 | 1 |
| Nadia A Rosenthal | SCIENTIFIC DIRECTOR | 40 | $554,548 | $0 | $35,629 | $590,177 | 1 |
| Charles Lee MD | SCIENTIFIC DIRECTOR, JAX GM | 40 | $515,295 | $0 | $68,007 | $583,302 | 1 |
| S CATHERINE Longley | EXECUTIVE VICE PRESIDENT & COO (UNTIL 03/24) | 40 | $532,237 | $0 | $36,344 | $568,581 | 2 |
| Brian Bannerman | VICE PRESIDENT, JMCRS FINANCE | 40 | $470,676 | $0 | $65,908 | $536,584 | 1 |
| James Keck | SR DIRECTOR, INNOVATION AND PRODUCT DEVELOPMENT | 40 | $466,052 | $0 | $57,118 | $523,170 | 1 |
| PAUL FLICEK | CHIEF DATA SCIENCE OFFICER | 40 | $461,867 | $0 | $55,662 | $517,529 | 1 |
| Edison T Liu | Former President & CEO | 40 | $401,349 | $0 | $60,637 | $461,986 | 5 |
| TIMOTHY D DATTELS | BOARD CHAIR | 5 | $0 | $0 | $0 | $0 | 1 |
| BERTRAND GARCIA-MORENO PHD | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 2 |
| CARLA E BRODLEY PHD | VICE CHAIR | 2 | $0 | $0 | $0 | $0 | 1 |
| DINAKAR SINGH | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 4 |
| ERIC HORVITZ MD PHD | TRUSTEE (START 02/24) | 2 | $0 | $0 | $0 | $0 | 1 |
| ERNESTINE FU | TRUSTEE (START 08/24) | 2 | $0 | $0 | $0 | $0 | 1 |
| FRANK MOSS PHD | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 1 |
| GEOFFREY W SMITH JD | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 1 |
| GEORGE G MONTGOMERY | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 1 |
| JANET ROSSANT PHD | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 1 |
| JEFFREY M FRIEDMAN MD PHD | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 1 |
| JENNY E ROOKE PHD | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 1 |
| JOHN A GIBBONS JR | TRUSTEE (UNTIL 08/24) | 2 | $0 | $0 | $0 | $0 | 2 |
| JOHN LOWRY | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 1 |
| Joshua Broder | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 1 |
| JULIE H DAUM | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 1 |
| MARY KATE WOLD JD | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 1 |
| MELISSA C GUZY | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 1 |
| NANCY J COX PHD | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 1 |
| NEAL B MILCH JD | VICE CHAIR | 2 | $0 | $0 | $0 | $0 | 1 |
| OTIS W BRAWLEY MD | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 1 |
| ROBERT KING PHD | TRUSTEE (START 02/24) | 2 | $0 | $0 | $0 | $0 | 1 |
| SANDRA WAITE JD | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 1 |
| STEVEN B FINK JD | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 1 |
| STEWART HEN | TRUSTEE (START 08/24) | 2 | $0 | $0 | $0 | $0 | 2 |
| THOMAS C BARRY | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 1 |
2023 · 42 people listed · 14 paid, $11.0M · 3,303 employees · 29 volunteers
| Name | Title | Hrs/wk | From org | From related | Other | Total | Orgs |
|---|---|---|---|---|---|---|---|
| Lon Cardon PHD FMEDSCI | President & CEO | 40 | $1,872,421 | $0 | $235,857 | $2,108,278 | 1 |
| S Catherine Longley | Executive Vice President & COO | 40 | $1,302,770 | $0 | $116,356 | $1,419,126 | 2 |
| Mitchell Kennedy | Executive VP & President, JMCRS | 40 | $724,685 | $0 | $66,055 | $790,740 | 1 |
| David Grass | VP, JMCRS MICE & SERVICE OPS (UNTIL 10/23) | 40 | $732,495 | $0 | $55,586 | $788,081 | 1 |
| Douglas Abbott | Senior Vice President and CFO | 40 | $543,036 | $0 | $114,066 | $657,102 | 1 |
| Daniel Hoag | General Counsel & Secretary | 40 | $547,000 | $0 | $95,001 | $642,001 | 1 |
| MaryEllen Joseph | VP, JMCRS Global Sales, Marketing, & Customer Support (UNTIL 10/23) | 40 | $606,130 | $0 | $34,558 | $640,688 | 1 |
| Charles Lee MD | SCIENTIFIC DIRECTOR, JAX GM | 40 | $542,872 | $0 | $66,916 | $609,788 | 1 |
| Nadia A Rosenthal | SCIENTIFIC DIRECTOR | 40 | $545,282 | $0 | $33,291 | $578,573 | 1 |
| Andy Greene | Senior Vice President for Research | 40 | $488,812 | $0 | $89,574 | $578,386 | 1 |
| Jens Rueter | Chief Medical Officer | 40 | $508,930 | $0 | $64,977 | $573,907 | 1 |
| Brian Bannerman | Vice President, JMCRS Finance | 40 | $497,494 | $0 | $60,863 | $558,357 | 1 |
| James Keck | Senior Director, Innovation and Product Development | 40 | $496,833 | $0 | $50,695 | $547,528 | 1 |
| Edison T Liu MD | FORMER PRESIDENT & CEO | 40 | $443,759 | $0 | $54,854 | $498,613 | 5 |
| TIMOTHY D DATTELS | BOARD CHAIR | 5 | $0 | $0 | $0 | $0 | 1 |
| Adaora Adimora MD MPH | Trustee (End 08/24/23) | 2 | $0 | $0 | $0 | $0 | 1 |
| BERTRAND GARCIA-MORENO PHD | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 2 |
| CARLA E BRODLEY PHD | VICE CHAIR | 2 | $0 | $0 | $0 | $0 | 1 |
| Charles Hewett PhD | Trustee (End 08/24/23) | 2 | $0 | $0 | $0 | $0 | 2 |
| David Roux | Trustee (End 08/24/23) | 2 | $0 | $0 | $0 | $0 | 2 |
| Dennis Paustenbach PhD | Trustee | 2 | $0 | $0 | $0 | $0 | 1 |
| DINAKAR SINGH | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 4 |
| Eric Horvitz MD PhD | Trustee (Start 12/18/23) | 2 | $0 | $0 | $0 | $0 | 1 |
| FRANK MOSS PHD | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 1 |
| GEOFFREY W SMITH JD | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 1 |
| GEORGE G MONTGOMERY | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 1 |
| JANET ROSSANT PHD | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 1 |
| JEFFREY M FRIEDMAN MD PHD | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 1 |
| JENNY E ROOKE PHD | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 1 |
| Joan Steitz PhD | Trustee (End 08/24/23) | 2 | $0 | $0 | $0 | $0 | 2 |
| JOHN A GIBBONS JR | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 2 |
| JOHN LOWRY | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 1 |
| Joshua Broder | Trustee | 2 | $0 | $0 | $0 | $0 | 1 |
| JULIE H DAUM | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 1 |
| MARY KATE WOLD JD | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 1 |
| MELISSA C GUZY | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 1 |
| NANCY J COX PHD | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 1 |
| NEAL B MILCH JD | VICE CHAIR | 2 | $0 | $0 | $0 | $0 | 1 |
| OTIS W BRAWLEY MD | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 1 |
| SANDRA WAITE JD | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 1 |
| STEVEN B FINK JD | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 1 |
| THOMAS C BARRY | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 1 |
2022 · 42 people listed · 13 paid, $10.2M · 3,166 employees · 27 volunteers
| Name | Title | Hrs/wk | From org | From related | Other | Total | Orgs |
|---|---|---|---|---|---|---|---|
| LON CARDON PHD FMEDSCI | PRESIDENT & CEO | 40 | $1,299,235 | $0 | $197,226 | $1,496,461 | 1 |
| EDISON T LIU MD | FORMER PRESIDENT & CEO | 40 | $1,336,777 | $0 | $52,110 | $1,388,887 | 5 |
| AUROBINDO NAIR UNTIL 922 | EXECUTIVE VP & PRESIDENT JMCRS | 40 | $1,019,881 | $0 | $50,708 | $1,070,589 | 1 |
| S CATHERINE LONGLEY | EXECUTIVE VICE PRESIDENT & COO | 40 | $938,613 | $0 | $114,261 | $1,052,874 | 2 |
| KENNETH FASMAN UNTIL 1022 | SENIOR VICE PRESIDENT RESEARCH | 40 | $605,025 | $0 | $57,829 | $662,854 | 1 |
| CHARLES MILLER | VP, JMCRS ASIA PACIFIC MARKET | 40 | $488,329 | $90,000 | $66,172 | $644,501 | 1 |
| DOUGLAS ABBOTT | SR VICE PRESIDENT & CFO | 40 | $507,735 | $0 | $111,435 | $619,170 | 1 |
| NADIA A ROSENTHAL | SCIENTIFIC DIRECTOR | 40 | $537,543 | $0 | $30,952 | $568,495 | 1 |
| DANIEL HOAG | GENERAL COUNSEL & SECRETARY | 40 | $506,599 | $0 | $59,808 | $566,407 | 1 |
| JENS RUETER | MEDICAL DIRECTOR | 40 | $495,496 | $0 | $61,919 | $557,415 | 1 |
| CHARLES LEE MD | SCIENTIFIC DIRECTOR, JAX GM | 40 | $494,739 | $0 | $61,185 | $555,924 | 1 |
| DAVID GRASS | VP, JMCRS MICE & SERVICES OPS | 40 | $477,771 | $0 | $61,164 | $538,935 | 1 |
| BARBARA-JEAN BORMANN-KENNEDY | VP SCI TRANSLATION/ALLIANCES | 40 | $479,169 | $0 | $30,946 | $510,115 | 1 |
| DAVID J ROUX | CHAIR EMERITUS | 2 | $0 | $0 | $0 | $0 | 2 |
| THOMAS C BARRY | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 1 |
| OTIS W BRAWLEY MD | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 1 |
| TIMOTHY D DATTELS | BOARD CHAIR | 5 | $0 | $0 | $0 | $0 | 1 |
| JULIE H DAUM | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 1 |
| STEVEN B FINK JD | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 1 |
| JEFFREY M FRIEDMAN MD PHD | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 1 |
| JEAN HOFFMAN UNTIL 1222 | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 1 |
| JOHN A GIBBONS JR | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 2 |
| NEAL B MILCH JD | VICE CHAIR | 2 | $0 | $0 | $0 | $0 | 1 |
| GEORGE G MONTGOMERY | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 1 |
| FRANK MOSS PHD | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 1 |
| DENNIS J PAUSTENBACH PHD | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 1 |
| JENNY E ROOKE PHD | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 1 |
| JOSHUA BRODER | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 1 |
| MARY KATE WOLD JD | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 1 |
| GEOFFREY W SMITH JD | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 1 |
| JOAN A STEITZ PHD | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 2 |
| CHARLES E HEWETT PHD | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 2 |
| BERTRAND GARCIA-MORENO PHD | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 2 |
| ADAORA A ADIMORA MD MPH | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 1 |
| CARLA E BRODLEY PHD | VICE CHAIR | 2 | $0 | $0 | $0 | $0 | 1 |
| JOHN LOWRY | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 1 |
| MELISSA C GUZY | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 1 |
| JOHN SCHIMENTI PHD UNTIL 822 | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 1 |
| SANDRA WAITE JD | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 1 |
| NANCY J COX PHD | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 1 |
| JANET ROSSANT PHD | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 1 |
| DINAKAR SINGH | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 4 |
2021 · 42 people listed · 15 paid, $10.0M · 2,983 employees · 26 volunteers
| Name | Title | Hrs/wk | From org | From related | Other | Total | Orgs |
|---|---|---|---|---|---|---|---|
| EDISON T LIU MD UNTIL 1121 | PRESIDENT & CEO | 40 | $1,488,347 | $0 | $303,294 | $1,791,641 | 1 |
| AUROBINDO NAIR | EXECUTIVE VP & PRESIDENT JMCRS | 40 | $1,479,984 | $0 | $96,810 | $1,576,794 | 1 |
| S CATHERINE LONGLEY | EXECUTIVE VICE PRESIDENT & COO | 40 | $866,847 | $0 | $111,515 | $978,362 | 2 |
| KENNETH H FASMAN | SENIOR VICE PRESIDENT RESEARCH | 40 | $593,048 | $0 | $127,967 | $721,015 | 1 |
| CHARLES MILLER | CEO, THE JACKSON LABORATORY ANITECH BIOTECH LTD | 40 | $548,909 | $90,000 | $71,132 | $710,041 | 1 |
| DOUGLAS ABBOTT | CHIEF FINANCIAL OFFICER | 40 | $488,440 | $0 | $87,749 | $576,189 | 1 |
| NADIA A ROSENTHAL | SCIENTIFIC DIRECTOR | 40 | $515,344 | $0 | $30,359 | $545,703 | 1 |
| KATHY VANDEGRIFT UNTIL 1121 | ASSOC. GM, SITE DIR & PROD | 40 | $477,438 | $0 | $54,565 | $532,003 | 1 |
| JENS RUETER | MEDICAL DIRECTOR | 40 | $462,148 | $0 | $58,841 | $520,989 | 1 |
| CHARLES LEE MD | SCIENTIFIC DIRECTOR, JAX GM | 40 | $431,762 | $0 | $60,483 | $492,245 | 1 |
| BARBARA-JEAN BORMANN-KENNEDY | VP SCI TRANSLATION/ALLIANCES | 40 | $460,327 | $0 | $30,247 | $490,574 | 1 |
| EMILY SCHORER | CHIEF HUMAN RESOURCES OFFICER | 40 | $453,314 | $0 | $30,196 | $483,510 | 1 |
| DANIEL HOAG | GENERAL COUNSEL & SECRETARY | 40 | $340,224 | $0 | $17,938 | $358,162 | 1 |
| JOHN RYAN | FORMER GENERAL COUNSEL & SECRETARY | 0 | $157,599 | $0 | $1,400 | $158,999 | 1 |
| LON CARDON PHD FMEDSCI | PRESIDENT & CEO | 40 | $71,385 | $0 | $9,519 | $80,904 | 1 |
| BERTRAND GARCIA-MORENO PHD | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 2 |
| CARLA E BRODLEY PHD | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 1 |
| JOHN LOWRY | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 1 |
| MELISSA C GUZY | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 1 |
| JOHN C SCHIMENTI PHD | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 1 |
| SANDRA WAITE JD | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 1 |
| ADAORA A ADIMORA MD MPH | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 1 |
| CHARLES E HEWETT PHD | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 2 |
| GEOFFREY W SMITH JD | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 1 |
| DAVID J ROUX | BOARD CHAIR | 5 | $0 | $0 | $0 | $0 | 2 |
| THOMAS C BARRY | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 1 |
| OTIS W BRAWLEY MD | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 1 |
| KATHLEEN A CORBET UNTIL 821 | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 1 |
| TIMOTHY D DATTELS | VICE BOARD CHAIR | 2 | $0 | $0 | $0 | $0 | 1 |
| JULIE H DAUM | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 1 |
| STEVEN B FINK JD | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 1 |
| JOAN A STEITZ PHD | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 2 |
| JEFFREY M FRIEDMAN MD PHD | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 1 |
| JOHN A GIBBONS JR | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 2 |
| NEAL B MILCH JD | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 1 |
| GEORGE G MONTGOMERY | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 1 |
| FRANK MOSS PHD | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 1 |
| DENNIS J PAUSTENBACH PHD | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 1 |
| JENNY E ROOKE PHD | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 1 |
| JOSHUA BRODER | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 1 |
| MARY KATE WOLD JD | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 1 |
| JEAN HOFFMAN | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 1 |
2020 · 41 people listed · 13 paid, $8.6M · 2,904 employees · 29 volunteers
| Name | Title | Hrs/wk | From org | From related | Other | Total | Orgs |
|---|---|---|---|---|---|---|---|
| EDISON T LIU MD | PRESIDENT & CEO | 40 | $1,175,290 | $0 | $414,195 | $1,589,485 | 5 |
| AUROBINDO NAIR | EXECUTIVE VP & PRESIDENT JMCRS | 40 | $1,032,625 | $0 | $99,132 | $1,131,757 | 1 |
| S CATHERINE LONGLEY | EXECUTIVE VICE PRESIDENT & COO | 40 | $736,006 | $0 | $111,129 | $847,135 | 2 |
| KENNETH H FASMAN | SENIOR VICE PRESIDENT RESEARCH | 40 | $557,232 | $0 | $68,447 | $625,679 | 1 |
| JOHN RYAN | GENERAL COUNSEL | 40 | $492,732 | $0 | $66,981 | $559,713 | 1 |
| DOUGLAS ABBOTT | CHIEF FINANCIAL OFFICER | 40 | $444,063 | $0 | $87,017 | $531,080 | 1 |
| NADIA A ROSENTHAL | SCIENTIFIC DIRECTOR | 40 | $493,262 | $0 | $29,634 | $522,896 | 1 |
| JENS RUETER | MEDICAL DIRECTOR | 40 | $433,458 | $0 | $57,866 | $491,324 | 1 |
| CHARLES LEE MD | SCIENTIFIC DIRECTOR, JAX GM | 40 | $420,787 | $0 | $61,308 | $482,095 | 1 |
| BARBARA-JEAN BORMANN-KENNEDY | VP SCI TRANSLATION/ALLIANCES | 40 | $448,372 | $0 | $29,602 | $477,974 | 1 |
| DAVID GRASS | GEN MANAGER PROD MICE & SERV | 40 | $404,135 | $0 | $58,840 | $462,975 | 1 |
| JACQUES F BANCHEREAU PHD | PROFESSOR | 40 | $415,925 | $0 | $41,983 | $457,908 | 1 |
| ANDREW GREENE | PROF&DIRECT MASS SPEC PROTEIN | 40 | $390,537 | $0 | $40,000 | $430,537 | 1 |
| DAVID J ROUX | CHAIR OF THE BOARD | 5 | $0 | $0 | $0 | $0 | 2 |
| THOMAS C BARRY | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| OTIS W BRAWLEY MD | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| KATHLEEN A CORBET | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| TIMOTHY D DATTELS | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| JULIE H DAUM | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| ANTHONY B EVNIN PHD | TRUSTEE (UNTIL 12/20) | 1 | $0 | $0 | $0 | $0 | 5 |
| STEVEN B FINK JD | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| JEFFREY M FRIEDMAN MD PHD | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| JEAN HOFFMAN | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| JOHN A GIBBONS JR | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 2 |
| NEAL B MILCH JD | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| GEORGE G MONTGOMERY | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| FRANK MOSS PHD | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| DENNIS J PAUSTENBACH PHD | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| JENNY ROOKE PHD | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| JANET ROSSANT PHD | TRUSTEE (UNTIL 8/20) | 1 | $0 | $0 | $0 | $0 | 1 |
| MARY KATE WOLD JD | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| GEOFFREY W SMITH JD | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| JOAN A STEITZ PHD | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 2 |
| CHARLES E HEWETT PHD | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 2 |
| KATHY BLOOMGARDEN | TRUSTEE (UNTIL 7/20) | 1 | $0 | $0 | $0 | $0 | 1 |
| ADAORA ADIMORA MD MPH | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| CARLA E BRODLEY PHD | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| MARK BLUMENKRANZ | TRUSTEE (UNTIL 1/20) | 1 | $0 | $0 | $0 | $0 | 1 |
| LOUIS J D'AMBROSIO | TRUSTEE (UNTIL 8/20) | 1 | $0 | $0 | $0 | $0 | 1 |
| MELISSA C GUZY | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| JOHN C SCHIMENTI PHD | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
2019 · 40 people listed · 13 paid, $8.2M · 3,150 employees · 27 volunteers
| Name | Title | Hrs/wk | From org | From related | Other | Total | Orgs |
|---|---|---|---|---|---|---|---|
| EDISON T LIU MD | PRESIDENT & CEO | 40 | $1,375,547 | $0 | $154,807 | $1,530,354 | 5 |
| AUROBINDO NAIR | EXECUTIVE VP & PRESIDENT JMCRS | 40 | $966,644 | $0 | $93,722 | $1,060,366 | 1 |
| S CATHERINE LONGLEY | EXECUTIVE VICE PRESIDENT & COO | 40 | $700,595 | $0 | $109,619 | $810,214 | 2 |
| KENNETH H FASMAN | SENIOR VICE PRESIDENT RESEARCH | 40 | $487,127 | $0 | $57,318 | $544,445 | 1 |
| JOHN RYAN | GENERAL COUNSEL | 40 | $477,002 | $0 | $57,990 | $534,992 | 1 |
| GREGORY LEET | VICE PRESIDENT FOR ADVANCEMENT | 40 | $484,226 | $0 | $26,945 | $511,171 | 1 |
| NADIA A ROSENTHAL | SCIENTIFIC DIRECTOR | 40 | $465,921 | $0 | $16,681 | $482,602 | 1 |
| JENS RUETER | MEDICAL DIRECTOR | 40 | $420,144 | $0 | $55,702 | $475,846 | 1 |
| BARBARA-JEAN BORMANN-K | VP SCI TRANSLATION/ALLIANCES | 40 | $431,808 | $0 | $29,080 | $460,888 | 1 |
| CHARLES LEE MD | SCIENTIFIC DIRECTOR, JAX GM | 40 | $400,878 | $0 | $56,759 | $457,637 | 1 |
| JACQUES F BANCHEREAU | PROFESSOR | 40 | $404,064 | $0 | $41,118 | $445,182 | 1 |
| KATHY VANDEGRIFT | ASSOC. GM, SITE DIR. & PROD | 40 | $385,683 | $0 | $49,115 | $434,798 | 1 |
| DOUGLAS ABBOTT | CHIEF FINANCIAL OFFICER | 40 | $371,500 | $0 | $55,456 | $426,956 | 1 |
| DAVID J ROUX | CHAIR OF THE BOARD | 5 | $0 | $0 | $0 | $0 | 2 |
| THOMAS C BARRY | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| MARK S BLUMENKRANZ M | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| OTIS W BRAWLEY MD | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| KATHLEEN A CORBET | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| LOUIS J D'AMBROSIO | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| TIMOTHY D DATTELS | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| JULIE H DAUM | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| DAVID ELLIMAN UNTIL 8 | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| ANTHONY B EVNIN PHD | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 5 |
| STEVEN B FINK JD | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| JEFFREY M FRIEDMAN M | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| JEAN HOFFMAN | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| JOHN A GIBBONS JR | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 2 |
| PAUL GODLEY MD PHDD | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| RICHARD LANNAMANN UNT | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| NEAL B MILCH JD | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| GEORGE G MONTGOMERY | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| FRANK MOSS PHD | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| DENNIS J PAUSTENBACH | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| JENNY ROOKE PHD | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| JANET ROSSANT PHD | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| MARY KATE WOLD | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| GEOFFREY W SMITH JD | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| JOAN A STEITZ PHD | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 2 |
| CHARLES E HEWETT PHD | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 2 |
| KATHY BLOOMGARDEN PHD | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
2018 · 41 people listed · 13 paid, $7.1M · 2,557 employees · 27 volunteers
| Name | Title | Hrs/wk | From org | From related | Other | Total | Orgs |
|---|---|---|---|---|---|---|---|
| EDISON T LIU MD | PRESIDENT & CEO | 40 | $1,123,868 | $0 | $155,001 | $1,278,869 | 5 |
| AUROBINDO NAIR | EXECUTIVE VP & PRESIDENT JMCRS | 40 | $752,541 | $0 | $93,656 | $846,197 | 1 |
| S CATHERINE LONGLEY | EXECUTIVE VICE PRESIDENT & COO | 40 | $574,039 | $0 | $109,963 | $684,002 | 2 |
| CHARLES E HEWETT PHD | EXECUTIVE VICE PRESIDENT | 20 | $525,707 | $0 | $44,583 | $570,290 | 2 |
| KENNETH H FASMAN | SENIOR VICE PRESIDENT RESEARCH | 40 | $451,616 | $0 | $57,512 | $509,128 | 1 |
| NADIA A ROSENTHAL | SCIENTIFIC DIRECTOR | 40 | $452,963 | $0 | $28,418 | $481,381 | 1 |
| JENS RUETER | MEDICAL DIRECTOR | 40 | $410,755 | $0 | $55,433 | $466,188 | 1 |
| GREGORY LEET | VICE PRESIDENT FOR ADVANCEMENT | 40 | $425,246 | $0 | $38,534 | $463,780 | 1 |
| JACQUES F BANCHEREAU PHD | PROFESSOR | 40 | $395,685 | $0 | $38,953 | $434,638 | 1 |
| JOHN RYAN | GENERAL COUNSEL | 40 | $373,898 | $0 | $34,393 | $408,291 | 1 |
| BARBARA-JEAN BORMANN-KENNEDY | VP SCI TRANSLATION/ALLIANCES | 40 | $373,774 | $0 | $28,400 | $402,174 | 1 |
| CHARLES LEE MD | SCIENTIFIC DIRECTOR, JAX GM | 40 | $345,058 | $0 | $56,925 | $401,983 | 1 |
| DOUGLAS ABBOTT | CHIEF FINANCIAL OFFICER | 40 | $122,085 | $0 | $5,375 | $127,460 | 1 |
| THOMAS C BARRY | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| MARK S BLUMENKRANZ MD | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| OTIS W BRAWLEY MD | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| DAVID R CABOT until 818 | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| KATHLEEN A CORBET | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| LOUIS J D'AMBROSIO | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| TIMOTHY D DATTELS | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| JULIE H DAUM | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| DAVID D ELLIMAN | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| ANTHONY B EVNIN PHD | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 5 |
| STEVEN B FINK JD | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| JEFFREY M FRIEDMAN MD PHD | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| JEAN HOFFMAN | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| PETER F GERRITY until 818 | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| JOHN A GIBBONS JR | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 2 |
| PAUL GODLEY MD PHD DECEASED | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| RICHARD S LANNAMANN | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| NEAL B MILCH JD | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| GEORGE G MONTGOMERY | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| FRANK MOSS PHD | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| DENNIS J PAUSTENBACH PHD | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| JENNY ROOKE PHD | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| JANET ROSSANT PHD | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| MARY KATE WOLD | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| GEOFFREY W SMITH JD | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| JOAN A STEITZ PHD | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 2 |
| BRIAN F WRUBLE until 1218 | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| DAVID J ROUX | CHAIR OF THE BOARD | 5 | $0 | $0 | $0 | $0 | 2 |
2017 · 40 people listed · 12 paid, $7.9M · 2,401 employees · 39 volunteers
| Name | Title | Hrs/wk | From org | From related | Other | Total | Orgs |
|---|---|---|---|---|---|---|---|
| EDISON T LIU MD | PRESIDENT & CEO | 40 | $1,502,989 | $0 | $153,298 | $1,656,287 | 5 |
| CHARLES E HEWETT PHD | EXECUTIVE VICE PRESIDENT & COO | 40 | $1,454,120 | $0 | $122,928 | $1,577,048 | 2 |
| AUROBINDO NAIR | PRES JAX MICE CLINIC/RESEARCH | 40 | $592,254 | $0 | $92,351 | $684,605 | 1 |
| S CATHERINE LONGLEY | VP & CHIEF FINANCIAL OFFICER | 40 | $455,622 | $0 | $90,051 | $545,673 | 2 |
| KENNETH H FASMAN | VICE PRESIDENT FOR RESEARCH | 40 | $434,989 | $0 | $55,709 | $490,698 | 1 |
| BRIAN R LESLIE | GENERAL COUNSEL | 40 | $441,004 | $0 | $45,715 | $486,719 | 1 |
| NADIA A ROSENTHAL | SCIENTIFIC DIRECTOR | 40 | $436,005 | $0 | $27,812 | $463,817 | 1 |
| JACQUES F BANCHEREAU PHD | PROFESSOR | 40 | $382,146 | $0 | $38,034 | $420,180 | 1 |
| JENS RUETER | MEDICAL DIRECTOR | 40 | $361,103 | $0 | $52,828 | $413,931 | 1 |
| GREGORY LEET | VICE PRESIDENT FOR ADVANCEMENT | 40 | $363,793 | $0 | $36,738 | $400,531 | 1 |
| ROBERT E BRAUN | FACULTY MEMBER | 40 | $363,854 | $0 | $28,357 | $392,211 | 1 |
| CHARLES LEE MD | SCIENTIFIC DIRECTOR, JAX GM | 40 | $337,926 | $0 | $53,838 | $391,764 | 1 |
| THOMAS C BARRY | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| MARK S BLUMENKRANZ MD | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| OTIS W BRAWLEY MD | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| DAVID R CABOT | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| KATHLEEN A CORBET | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| LOUIS J D'AMBROSIO | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| TIMOTHY D DATTELS | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| JULIE H DAUM | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| DAVID D ELLIMAN | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| ANTHONY B EVNIN PHD | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 5 |
| STEVEN B FINK JD | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| JEFFREY M FRIEDMAN PHD | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| JAMES J GALLOGLY | TRUSTEE (UNTIL 06/2017) | 1 | $0 | $0 | $0 | $0 | 1 |
| PETER F GERRITY | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| JOHN A GIBBONS JR | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 2 |
| PAUL A GODLEY MD PHD | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| LEO A HOLT | TRUSTEE (UNTIL 08/2017) | 1 | $0 | $0 | $0 | $0 | 1 |
| RICHARD S LANNAMANN | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| SAM R LITTLE | TRUSTEE (UNTIL 08/2017) | 1 | $0 | $0 | $0 | $0 | 1 |
| NEAL B MILCH JD | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| DENNIS J PAUSTENBACH PHD | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| CHARLES M RICE PHD | TRUSTEE (UNTIL 08/2017) | 1 | $0 | $0 | $0 | $0 | 2 |
| JANET ROSSANT PHD | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| EDWARD RUBIN MD PHD | TRUSTEE (UNTIL 04/2017) | 1 | $0 | $0 | $0 | $0 | 1 |
| GEOFFREY W SMITH JD | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| JOAN A STEITZ PHD | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 2 |
| BRIAN F WRUBLE | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| DAVID J ROUX | CHAIR OF THE BOARD | 5 | $0 | $0 | $0 | $0 | 2 |
2016 · 39 people listed · 13 paid, $7.5M · 2,114 employees · 35 volunteers
| Name | Title | Hrs/wk | From org | From related | Other | Total | Orgs |
|---|---|---|---|---|---|---|---|
| EDISON T LIU MD | PRESIDENT & CEO | 40 | $1,039,273 | $0 | $327,798 | $1,367,071 | 5 |
| CHARLES E HEWETT PHD | EXECUTIVE VICE PRESIDENT & COO | 40 | $672,159 | $0 | $220,928 | $893,087 | 2 |
| AUROBINDO NAIR | GENERAL MANAGER, JMCRS | 40 | $532,147 | $0 | $193,551 | $725,698 | 1 |
| BRIAN R LESLIE | GENERAL COUNSEL | 40 | $455,945 | $0 | $132,429 | $588,374 | 1 |
| KRISTEN B ROZANSKY | VICE PRESIDENT, DEV & COMMUN | 40 | $488,601 | $0 | $36,953 | $525,554 | 1 |
| KENNETH H FASMAN | VICE PRESIDENT FOR RESEARCH | 40 | $404,606 | $0 | $116,404 | $521,010 | 1 |
| NADIA A ROSENTHAL | SCIENTIFIC DIRECTOR, JAX GM | 40 | $415,736 | $0 | $56,085 | $471,821 | 1 |
| JACQUES F BANCHEREAU PHD | PROFESSOR | 40 | $393,074 | $0 | $71,534 | $464,608 | 1 |
| KATHY L VANDEGRIFT | ASSOCIATE GM FINANCE & OP | 40 | $357,257 | $0 | $103,144 | $460,401 | 1 |
| CHARLES LEE PHD FACMG | SCIENTIFIC DIRECTOR, JAX GM | 40 | $333,425 | $0 | $105,772 | $439,197 | 1 |
| ROBERT E BRAUN PHD | VICE PRESIDENT RESEARCH | 40 | $385,194 | $0 | $31,106 | $416,300 | 1 |
| GEORGE M WEINSTOCK | DIRECTOR, MICROBIAL GENOMICS | 40 | $355,722 | $0 | $56,370 | $412,092 | 1 |
| S CATHERINE LONGLEY | CHIEF FINANCIAL OFFICER | 40 | $152,590 | $0 | $47,876 | $200,466 | 2 |
| OTIS W BRAWLEY MD | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| KATHLEEN A CORBET | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| LOUIS J D'AMBROSIO | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| TIMOTHY D DATTELS | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| DAVID D ELLIMAN | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| ANTHONY B EVNIN PHD | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 5 |
| JEFFREY M FRIEDMAN MD PHD | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| JAMES J GALLOGLY | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| JOHN GIBBONS | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| PAUL A GODLEY MD PHD | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| RICHARD S GURIN | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| LEO A HOLT | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| WESLIE JANEWAY | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 3 |
| RICHARD S LANNAMANN | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| SAM R LITTLE | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| NEAL B MILCH JD | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| DENNIS PAUSTENBACH PHD | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| CHARLES M RICE PHD | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 2 |
| JANET ROSSANT PHD | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| EDWARD RUBIN MD PHD | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| JOAN A STEITZ PHD | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 2 |
| BRIAN F WRUBLE | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| THOMAS C BARRY | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| DAVID R CABOT | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| PETER F GERRITY | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| DAVID J ROUX | CHAIR OF THE BOARD | 1 | $0 | $0 | $0 | $0 | 2 |
2015 · 33 people listed · 11 paid, $7.3M · 2,080 employees · 30 volunteers
| Name | Title | Hrs/wk | From org | From related | Other | Total | Orgs |
|---|---|---|---|---|---|---|---|
| CHARLES E HEWETT PHD | EXECUTIVE VICE PRESIDENT & COO | 40 | $2,019,342 | $0 | $169,955 | $2,189,297 | 2 |
| EDISON T LIU MD | PRESIDENT & CEO | 40 | $1,025,277 | $0 | $127,798 | $1,153,075 | 5 |
| AUROBINDO NAIR | GENERAL MANAGER, JMCRS | 40 | $523,799 | $0 | $94,130 | $617,929 | 1 |
| BRIAN R LESLIE | GENERAL COUNSEL | 40 | $441,578 | $0 | $45,215 | $486,793 | 1 |
| JACQUES F BANCHEREAU PHD | PROFESSOR | 40 | $388,142 | $0 | $37,034 | $425,176 | 1 |
| KRISTEN B ROZANSKY | VICE PRESIDENT, DEV & COMMUN | 40 | $369,342 | $0 | $51,188 | $420,530 | 1 |
| LINDA A JENSEN | CHIEF FINANCIAL OFFICER | 40 | $375,015 | $0 | $45,380 | $420,395 | 1 |
| ROBERT E BRAUN PHD | VICE PRESIDENT RESEARCH | 40 | $380,054 | $0 | $28,902 | $408,956 | 1 |
| CHARLES LEE MD | SCIENTIFIC DIRECTOR, JAX GM | 40 | $348,739 | $0 | $55,824 | $404,563 | 1 |
| MIKE E HYDE | VP EXTERNAL AFFAIRS & STRATE | 40 | $339,601 | $0 | $53,340 | $392,941 | 1 |
| KATHY L VANDEGRIFT | ASSOCIATE GM FINANCE & OP | 40 | $337,495 | $0 | $48,096 | $385,591 | 1 |
| JAMES J GALLOGLY | TREASURER | 1 | $0 | $0 | $0 | $0 | 1 |
| PETER F GERRITY | SECRETARY | 1 | $0 | $0 | $0 | $0 | 1 |
| WESLIE R JANEWAY | VICE CHAIR OF THE BOARD | 1 | $0 | $0 | $0 | $0 | 3 |
| DAVID J ROUX | CHAIR OF THE BOARD | 1 | $0 | $0 | $0 | $0 | 2 |
| THOMAS C BARRY | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| DAVID R CABOT | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| KATHLEEN A CORBET | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| LOUIS J D'AMBROSIO | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| TIMOTHY D DATTELS | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| DAVID D ELLIMAN | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| ANTHONY B EVNIN PHD | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 5 |
| RICHARD S GURIN | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| LEO A HOLT | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| RICHARD S LANNAMANN | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| SAM R LITTLE | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| NEAL B MILCH JD | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| DENNIS PAUSTENBACH PHD | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| CHARLES M RICE PHD | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 2 |
| JANET ROSSANT PHD | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| EDWARD RUBIN MD PHD | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| JOAN A STEITZ PHD | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 2 |
| BRIAN F WRUBLE | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
2014 · 39 people listed · 16 paid, $7.0M · 1,992 employees · 52 volunteers
| Name | Title | Hrs/wk | From org | From related | Other | Total | Orgs |
|---|---|---|---|---|---|---|---|
| EDISON T LIU MD | CHIEF EXECUTIVE OFFICER | 40 | $867,017 | $0 | $127,921 | $994,938 | 5 |
| CHARLES E HEWETT PHD | EXECUTIVE VICE PRESIDENT | 40 | $661,131 | $0 | $296,443 | $957,574 | 2 |
| BRIAN R LESLIE | GENERAL COUNSEL | 40 | $412,654 | $0 | $44,808 | $457,462 | 1 |
| AUROBINDO NAIR PHD | GM SCIENTIFIC RESEARCH SVCS | 40 | $397,510 | $0 | $56,682 | $454,192 | 1 |
| JACQUES F BANCHEREAU PHD | PROFESSOR | 40 | $373,518 | $0 | $48,644 | $422,162 | 1 |
| KRISTEN B ROZANSKY | VP DEVELOPMENT & COMMUNICATION | 40 | $359,489 | $0 | $51,113 | $410,602 | 1 |
| CHARLES LEE MD | SCIENTIFIC DIRECTOR, JAX GM | 40 | $351,329 | $0 | $54,368 | $405,697 | 1 |
| LINDA A JENSEN MS | CHIEF FINANCIAL OFFICER | 40 | $347,980 | $0 | $52,160 | $400,140 | 1 |
| ETZARD STOLTE PHD | CHIEF INFOMRATION OFFICER | 40 | $324,805 | $0 | $70,359 | $395,164 | 1 |
| ROBERT E BRAUN PHD | VICE PRESIDENT RESEARCH | 40 | $354,471 | $0 | $36,612 | $391,083 | 1 |
| MICHAEL HYDE | VP EXTERNAL AFFAIRS | 40 | $312,830 | $0 | $75,904 | $388,734 | 1 |
| KATHY L VANDEGRIFT | ASSOCIATE GENERAL MANAGER | 40 | $300,045 | $0 | $47,124 | $347,169 | 1 |
| JOHN FITZPATRICK | SENIOR DIRECTOR, FACILITIES | 40 | $268,668 | $0 | $71,201 | $339,869 | 1 |
| YIJUN RUAN PHD | DIRECTOR, JAX GM | 40 | $251,660 | $0 | $48,708 | $300,368 | 1 |
| LEAH RAE B DONAHUE PHD | DIR GENETIC RESOURCE SCIENCE | 40 | $161,353 | $0 | $33,693 | $195,046 | 1 |
| JAY VETELINO | ASSISTANT TREASURER | 40 | $114,525 | $0 | $35,883 | $150,408 | 1 |
| DAVID BALTIMORE PHD | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| DAVID R CABOT | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| KATHLEEN A CORBET | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| LOUIS J D'AMBROSIO | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| DAVID D ELLIMAN | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| ANTHONY B EVNIN PHD | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 5 |
| JAMES J GALLOGLY | TREASURER | 1 | $0 | $0 | $0 | $0 | 1 |
| PETER F GERRITY | SECRETARY | 1 | $0 | $0 | $0 | $0 | 1 |
| RICHARD S GURIN | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| LEO A HOLT | CHAIR OF BOARD | 1 | $0 | $0 | $0 | $0 | 1 |
| WESLIE R JANEWAY | VICE CHAIR OF BOARD | 1 | $0 | $0 | $0 | $0 | 3 |
| RICHARD S LANNAMANN | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| SAM R LITTLE | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| NEAL B MILCH JD | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| DENNIS PAUSTENBACH PHD | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| CHARLES M RICE PHD | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 2 |
| JANET ROSSANT PHD | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| DAVID J ROUX | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 2 |
| EDWARD RUBIN MD PHD | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| JOAN A STEITZ PHD | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 2 |
| DAVID VALLE MD | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| THOMAS S VOLPE | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| BRIAN F WRUBLE | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
2013 · 39 people listed · 17 paid, $6.3M · 1,725 employees · 55 volunteers
| Name | Title | Hrs/wk | From org | From related | Other | Total | Orgs |
|---|---|---|---|---|---|---|---|
| EDISON T LIU MD | CHIEF EXECUTIVE OFFICER | 40 | $817,268 | $0 | $129,951 | $947,219 | 5 |
| CHARLES E HEWETT PHD | EXECUTIVE VICE PRESIDENT | 40 | $623,521 | $0 | $293,267 | $916,788 | 2 |
| MICHAEL HYDE | VP EXTERNAL AFFAIRS | 40 | $327,208 | $0 | $83,195 | $410,403 | 1 |
| AUROBINDO NAIR PHD | GM SCIENTIFIC RESEARCH SVCS | 40 | $345,682 | $0 | $56,789 | $402,471 | 1 |
| ROBERT E BRAUN PHD | VICE PRESIDENT RESEARCH | 40 | $353,963 | $0 | $36,618 | $390,581 | 1 |
| LINDA A JENSEN MS | CHIEF FINANCIAL OFFICER | 40 | $335,519 | $0 | $54,059 | $389,578 | 1 |
| YIJUN RUAN PHD | DIRECTOR, JAX GM | 40 | $324,324 | $0 | $45,564 | $369,888 | 1 |
| KATHY L VANDEGRIFT | ASSOCIATE GENERAL MANAGER | 40 | $304,982 | $0 | $45,759 | $350,741 | 1 |
| BRIAN R LESLIE | GENERAL COUNSEL | 40 | $306,419 | $0 | $26,602 | $333,021 | 1 |
| LEAH RAE B DONAHUE PHD | DIR GENETIC RESOURCE SCIENCE | 40 | $241,062 | $0 | $49,460 | $290,522 | 1 |
| MICHAEL WATERS | SR DIR OPPORTUNITY DEVELOPMENT | 40 | $241,443 | $0 | $43,992 | $285,435 | 1 |
| JANAN T EPPIG PHD | PROFESSOR | 40 | $236,828 | $0 | $43,953 | $280,781 | 1 |
| LINDA WATERMAN DVM | SR DIR LAB ANIMAL HEALTH | 40 | $245,566 | $0 | $25,908 | $271,474 | 1 |
| KRISTEN B ROZANSKY | VP DEVELOPMENT & COMMUNICATION | 40 | $240,204 | $0 | $14,664 | $254,868 | 1 |
| CHARLES LEE MD | SCIENTIFIC DIRECTOR, JAX GM | 37 | $186,938 | $0 | $8,798 | $195,736 | 1 |
| JAY VETELINO | ASSISTANT TREASURER | 40 | $112,036 | $0 | $35,593 | $147,629 | 1 |
| JANA ROBINSON | ASSISTANT SECRETARY | 40 | $70,942 | $0 | $25,627 | $96,569 | 1 |
| DAVID BALTIMORE PhD | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| DAVID R CABOT | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| KATHLEEN A CORBET | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| LOUIS J D'AMBROSIO | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| JEFFREY DUNN | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| DAVID D ELLIMAN | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| ANTHONY B EVNIN PhD | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 5 |
| JAMES J GALLOGLY | TREASURER | 1 | $0 | $0 | $0 | $0 | 1 |
| PETER F GERRITY | SECRETARY | 1 | $0 | $0 | $0 | $0 | 1 |
| RICHARD S GURIN | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| LEO A HOLT | CHAIR OF BOARD | 1 | $0 | $0 | $0 | $0 | 1 |
| WESLIE R JANEWAY | VICE CHAIR OF BOARD | 1 | $0 | $0 | $0 | $0 | 3 |
| RICHARD S LANNAMANN | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| SAM R LITTLE | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| TOM MANIATIS | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 2 |
| NEAL B MILCH JD | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| DENNIS PAUSTENBACH PhD | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| CHARLES M RICE PhD | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 2 |
| DAVID J ROUX | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 2 |
| EDWARD RUBIN MD PhD | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| DAVID VALLE MD | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| THOMAS S VOLPE | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
2012 · 39 people listed · 15 paid, $5.5M · 1,661 employees · 156 volunteers
| Name | Title | Hrs/wk | From org | From related | Other | Total | Orgs |
|---|---|---|---|---|---|---|---|
| EDISON T LIU MD | CHIEF EXECUTIVE OFFICER | 40 | $786,307 | $0 | $122,116 | $908,423 | 5 |
| CHARLES E HEWETT PHD | Executive VP & COO | 40 | $655,809 | $0 | $250,209 | $906,018 | 2 |
| MICHAEL HYDE | VP EXT AFFAIRS & STRAT PSHIPS | 40 | $313,339 | $0 | $62,513 | $375,852 | 1 |
| ROBERT BRAUN PHD | VP RESEARCH | 40 | $334,531 | $0 | $36,110 | $370,641 | 1 |
| LINDA A JENSEN MS | CHIEF FINANCIAL OFFICER | 40 | $312,181 | $0 | $57,280 | $369,461 | 1 |
| AUROBINDO NAIR PHD | GM SCIENTIFIC RESEARCH SVCS | 40 | $312,870 | $0 | $55,288 | $368,158 | 1 |
| JOANNE RUH | CHIEF INFORMATION OFFICER | 40 | $321,034 | $0 | $25,704 | $346,738 | 1 |
| KATHY L VANDEGRIFT | ASSOC GEN MGR JMS | 40 | $267,166 | $0 | $45,172 | $312,338 | 1 |
| JANAN T EPPIG PHD | PROFESSOR | 40 | $226,593 | $0 | $41,490 | $268,083 | 1 |
| LEAH RAE B DONAHUE PHD | DIR GENETIC RESOURCE SCIENCE | 40 | $218,305 | $0 | $47,352 | $265,657 | 1 |
| LINDA WATERMAN DVM | SR DIR LAB ANIMAL HEALTH | 40 | $236,243 | $0 | $25,763 | $262,006 | 1 |
| MICHAEL WATERS | SR DIR OPPORTUNITY DVLPMT | 40 | $212,115 | $0 | $49,493 | $261,608 | 1 |
| GARY A CHURCHILL PHD | PROFESSOR | 40 | $210,903 | $0 | $50,535 | $261,438 | 1 |
| JOSEPH VETELINO | ASSISTANT TREASURER | 40 | $104,861 | $0 | $34,862 | $139,723 | 1 |
| JANA ROBINSON | ASSISTANT SECRETARY | 40 | $50,224 | $0 | $29,800 | $80,024 | 1 |
| DAVID R CABOT | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| KATHLEEN A CORBET | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| LOUIS J D'AMBROSIO | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| ROSS E DWORMAN | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| DAVID D ELLIMAN | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| JAMES J GALLOGLY | TREASURER | 1 | $0 | $0 | $0 | $0 | 1 |
| RICHARD S GURIN | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| LEO A HOLT | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| WESLIE R JANEWAY | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 3 |
| RICHARD S LANNAMANN | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| SAM R LITTLE | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| DAVID J ROUX | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 2 |
| TOM S VOLPE | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| PETER GERRITY | SECRETARY | 1 | $0 | $0 | $0 | $0 | 1 |
| EDWARD L SAMEK | TREASURER | 1 | $0 | $0 | $0 | $0 | 1 |
| DAVID BALTIMORE PHD | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| JEFFREY M DUNN MD | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| ANTHONY B EVNIN PHD | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 5 |
| WILLIAM S HARWOOD ESQ | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| TOM P MANIATIS PHD | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 2 |
| NEAL B MILCH JD | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| CHARLES M RICE PHD | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 2 |
| SHIRLEY M TILGHMAN PHD | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| DAVID VALLE | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
2010 · 39 people listed · 16 paid, $4.6M · 1,516 employees · 241 volunteers
| Name | Title | Hrs/wk | From org | From related | Other | Total | Orgs |
|---|---|---|---|---|---|---|---|
| CHARLES E HEWETT PHD | EXECUTIVE VICE PRESIDENT | 40 | $465,611 | $0 | $134,383 | $599,994 | 2 |
| RICHARD P WOYCHIK PHD | PRESIDENT & CEO | 40 | $434,322 | $0 | $107,413 | $541,735 | 1 |
| MICHAEL HYDE | VICE PRESIDENT FOR ADVANCEMENT | 40 | $292,048 | $0 | $56,986 | $349,034 | 1 |
| AUROBINDO NAIR PHD | ASSOC GEN MANAGER JMS | 40 | $295,306 | $0 | $43,944 | $339,250 | 1 |
| LINDA JENSEN | CHIEF FINANCIAL OFFICER | 40 | $289,482 | $0 | $43,965 | $333,447 | 1 |
| ROBERT BRAUN PHD | ASSOC DIR & CHAIR OF RESEARCH | 40 | $306,413 | $0 | $25,868 | $332,281 | 1 |
| KATHY L VANDEGRIFT | ASSOC GEN MGR JMS | 40 | $272,527 | $0 | $40,206 | $312,733 | 1 |
| MICHAEL WATERS | SENIOR DIR OF OPP DEVELOPMENT | 40 | $215,520 | $0 | $41,058 | $256,578 | 1 |
| JANAN T EPPIG PHD | PROFESSOR | 40 | $225,504 | $0 | $30,408 | $255,912 | 1 |
| GARY A CHURCHILL PHD | PROFESSOR | 40 | $208,709 | $0 | $40,686 | $249,395 | 1 |
| SUSAN D AIRHART | SR. DIR STRATEGIC OPPORTUNITY | 40 | $218,609 | $0 | $29,084 | $247,693 | 1 |
| LEAH RAE DONAHUE PHD | DIR GENETIC RESOURCE SCIENCE | 40 | $197,747 | $0 | $33,066 | $230,813 | 1 |
| KENNETH PAIGEN PHD | PROFESSOR | 40 | $211,804 | $0 | $0 | $211,804 | 1 |
| RONALD SUCY | ASSISTANT TREASURER | 40 | $120,724 | $0 | $19,882 | $140,606 | 1 |
| JOSEPH VETELINO | ASSISTANT TREASURER | 40 | $96,454 | $0 | $28,982 | $125,436 | 1 |
| JANA ROBINSON | ASSISTANT SECRETARY | 40 | $46,472 | $0 | $23,910 | $70,382 | 1 |
| DAVID BALTIMORE PHD | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| ROBERT C BECK | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| DAVID R CABOT | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| KATHLEEN A CORBET | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| LOUIS J D'AMBROSIO | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| ROSS E DWORMAN | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| DAVID D ELLIMAN | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| ANTHONY B EVNIN PHD | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 5 |
| JAMES J GALLOGLY | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| RICHARD S GURIN | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| WILLIAM S HARWOOD ESQ | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| LEO A HOLT | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| WESLIE R JANEWAY | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 3 |
| RICHARD S LANNAMANN | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| SAM R LITTLE | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| TERRY R MAGNUSON PHD | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| TOM P MANIATIS PHD | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 2 |
| SHIRLEY M TILGHMAN PHD | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| DAVID VALLE PHD | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| TOM S VOLPE | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| BRIAN WRUBLE | CHAIRMAN | 1 | $0 | $0 | $0 | $0 | 1 |
| PETER GERRITY | SECRETARY | 1 | $0 | $0 | $0 | $0 | 1 |
| EDWARD L SAMEK | TREASURER | 1 | $0 | $0 | $0 | $0 | 1 |
2009 · 36 people listed · 12 paid, $3.6M · 1,553 employees · 173 volunteers
| Name | Title | Hrs/wk | From org | From related | Other | Total | Orgs |
|---|---|---|---|---|---|---|---|
| RICHARD P WOYCHIK PHD | PRESIDENT & CEO | 40 | $415,896 | $0 | $123,904 | $539,800 | 1 |
| CHARLES E HEWETT PHD | VICE PRESIDENT & COO | 40 | $413,621 | $0 | $117,862 | $531,483 | 2 |
| AUROBINDO NAIR PHD | GENERAL MANAGER JMS MARKETING | 40 | $280,786 | $0 | $56,185 | $336,971 | 1 |
| LINDA JENSEN | CHIEF FINANCIAL OFFICER | 40 | $273,565 | $0 | $61,007 | $334,572 | 1 |
| ROBERT BRAUN PHD | ASSOC. DIR/CHAIR OF RESEARCH | 40 | $291,273 | $0 | $25,868 | $317,141 | 1 |
| MICHAEL HYDE | VICE PRESIDENT FOR ADANCEMENT | 40 | $274,656 | $0 | $42,348 | $317,004 | 1 |
| KATHY L VANDEGRIFT | GENERAL MANAGER JMS OPERATIONS | 40 | $248,117 | $0 | $48,742 | $296,859 | 1 |
| JANAN T EPPIG PHD | SCIENTIST, FACULTY | 40 | $213,370 | $0 | $28,690 | $242,060 | 1 |
| MICHAEL WATERS | SENIOR DIR OF OPP DEVELOPMENT | 40 | $189,986 | $0 | $36,827 | $226,813 | 1 |
| GARY A CHURCHILL PHD | SCIENTIST, FACULTY | 40 | $186,130 | $0 | $37,394 | $223,524 | 1 |
| RONALD SUCY | ASSISTANT TREASURER | 40 | $113,311 | $0 | $18,714 | $132,025 | 1 |
| JANA ROBINSON | ASSISTANT SECRETARY | 40 | $44,716 | $0 | $22,396 | $67,112 | 1 |
| DAVID BALTIMORE PHD | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| ROBERT C BECK | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| DAVID R CABOT | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| KATHLEEN A CORBET | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| LOUIS J D'AMBROSIO | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| ROSS E DWORMAN | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| DAVID D ELLIMAN | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| ANTHONY B EVNIN PHD | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 5 |
| JAMES J GALLOGLY | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| RICHARD S GURIN | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| WILLIAM S HARWOOD ESQ | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| STEWART J HEN | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 2 |
| LEO A HOLT | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| WESLIE R JANEWAY | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 3 |
| MARIE J LANGLOIS | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| RICHARD S LANNAMANN | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| SAM R LITTLE | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| TERRY R MAGNUSON PHD | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| TOM P MANIATIS PHD | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 2 |
| SHIRLEY M TILGHMAN PHD | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| TOM S VOLPE | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| BRIAN WRUBLE | CHAIRMAN | 1 | $0 | $0 | $0 | $0 | 1 |
| PETER GERRITY | SECRETARY | 1 | $0 | $0 | $0 | $0 | 1 |
| EDWARD L SAMEK | TREASURER | 1 | $0 | $0 | $0 | $0 | 1 |
Highest-paid independent contractors
2024 · 5 contractors · $31.0M
| Name | Location | Service | Paid |
|---|---|---|---|
| BIOTRANS LLC | MORRISTOWN, NJ | Transportation | $11,461,767 |
| TLR VENTURES INC | BELMONT, CA | Consulting Services | $9,709,848 |
| WHITING TURNER CONTRACTING | BALTIMORE, MD | Construction Management | $4,140,541 |
| LILY TRANSPORTATION CORPORATION | NEEDHAM, MA | Construction Management | $2,885,484 |
| SHI INTERNATIONAL CORP | DALLAS, TX | IT SERVICES AND SUPPORT | $2,815,406 |
2023 · 5 contractors · $52.3M
| Name | Location | Service | Paid |
|---|---|---|---|
| WHITING TURNER CONTRACTING | BALTIMORE, MD | Construction Management | $20,007,622 |
| BIOTRANS LLC | MORRISTOWN, NJ | Transportation | $11,029,584 |
| TLR VENTURES INC | BELMONT, CA | Consulting Services | $9,924,282 |
| MARKETONE BUILDERS INC | SACRAMENTO, CA | Construction Management | $6,119,731 |
| LANDRYFRENCH CONSTRUCTION CO | SCARBOROUGH, ME | Construction Management | $5,251,545 |
2022 · 5 contractors · $50.5M
| Name | Location | Service | Paid |
|---|---|---|---|
| WHITING TURNER CONTRACTING | BALTIMORE, MD | CONSTRUCTION MGMT | $19,326,058 |
| BIOTRANS LLC | MORRISTOWN, NJ | TRANSPORTATION | $9,663,447 |
| TLR VENTURES INC | BELMONT, CA | CONSULTING SERVICES | $8,306,681 |
| LANDRYFRENCH CONSTRUCTION CO | SCARBOROUGH, ME | CONSTRUCTION MGMT | $7,938,576 |
| MARKETONE BUILDERS INC | SACRAMENTO, CA | CONSTRUCTION MGMT | $5,272,466 |
2021 · 5 contractors · $21.9M
| Name | Location | Service | Paid |
|---|---|---|---|
| BIOTRANS LLC | MORRISTOWN, NJ | TRANSPORTATION | $8,725,873 |
| ROPES & GRAY | BOSTON, MA | LEGAL SERVICES | $3,603,570 |
| E L SHEA | ELLSWORTH, ME | CONSTRUCTION MGMT | $3,366,411 |
| WHITING TURNER CONTRACTING | BALTIMORE, MD | CONSTRUCTION MGMT | $3,125,175 |
| WRIGHT-RYAN CONSTRUCTION INC | PORTLAND, ME | CONSTRUCTION MGMT | $3,030,297 |
2020 · 5 contractors · $29.9M
| Name | Location | Service | Paid |
|---|---|---|---|
| WHITING TURNER CONTRACTING | BALTIMORE, MD | CONSTRUCTION MGMT | $15,359,247 |
| BIOTRANS LLC | MORRISTOWN, NJ | TRANSPORTATION | $7,509,427 |
| MARKETONE BUILDERS INC | SACRAMENTO, CA | CONSTRUCTION MGMT | $2,504,374 |
| NICKERSON & O'DAY INCORPORATED | BANGOR, ME | CONSTRUCTION MGMT | $2,308,394 |
| LILY TRANSPORTATION CORPORATION | NEEDHAM, MA | TRANSPORTATION | $2,189,267 |
2019 · 5 contractors · $51.0M
| Name | Location | Service | Paid |
|---|---|---|---|
| THE WHITING TURNER CONTRACTING | BALTIMORE, MD | CONSTRUCTION MGMT | $33,008,370 |
| PC CONSTRUCTION COMPANY | SOUTH BURLINGTON, VT | CONSTRUCTION MGMT | $7,368,242 |
| BIOTRANS LLC | MORRISONTOWN, NJ | TRANSPORTATION | $6,775,569 |
| JOHNSON CONTROLS INC | CHICAGO, IL | CONSTRUCTION MGMT | $2,399,004 |
| EYP INC | ALBANY, NY | CONSULTING & DESIGN | $1,454,677 |
2018 · 5 contractors · $11.4M
| Name | Location | Service | Paid |
|---|---|---|---|
| BIOTRANS LLC | MORRISTOWN, NJ | TRANSPORTATION | $6,131,644 |
| EYP INC | ALBANY, NY | CONSULTING & DESIGN | $2,139,887 |
| FRAMES ANIMAL TRANSPORT INC | RIDLEY PARK, PA | TRANSPORTATION | $1,244,033 |
| ROPES GRAY | BOSTON, MA | LEGAL FEES | $1,243,201 |
| WOLF GREENFIELD SACKS PC | BOSTON, MA | LEGAL FEES | $664,835 |
2017 · 5 contractors · $10.9M
| Name | Location | Service | Paid |
|---|---|---|---|
| BIOTRANS LLC | MORRISTOWN, NJ | TRANSPORTATION | $5,857,740 |
| MERIT SOLUTIONS INC | WHEATON, IL | IT CONSULTING | $1,684,464 |
| LILY TRANSPORTATION CORPORATION | NEEDHAM, MA | TRANSPORTATION | $1,436,988 |
| FRAMES ANIMAL TRANSPORT INC | RIDLEY PARK, PA | TRANSPORTATION | $1,122,353 |
| ROPES GRAY | BOSTON, MA | LEGAL FEES | $751,999 |
2016 · 5 contractors · $11.5M
| Name | Location | Service | Paid |
|---|---|---|---|
| BIOTRANS LLC | MORRISTOWN, NJ | TRANSPORTATION | $5,226,848 |
| EYP INC | ALBANY, NY | ARCHITECTURE | $2,011,074 |
| MERIT SOLUTIONS INC | WHEATON, IL | IT CONSULTING | $1,523,481 |
| LILY TRANSPORTATION CORPORATION | NEEDHAM, MA | TRANSPORTATION | $1,502,775 |
| AEROTEK INC | CHICAGO, IL | TEMP EMPLOYEES SRVCS | $1,256,455 |
2015 · 5 contractors · $3.6M
| Name | Location | Service | Paid |
|---|---|---|---|
| COLUMBUS IT PARTNER USA INC | STAMFORD, CT | IT CONSULTING | $1,075,145 |
| STARLIMS CORPORATION | HOLLYWOOD, FL | IT CONSULTING | $928,139 |
| NAVIGATION ARTS LLC | MCLEAN, VA | PRODUCT DEV. CONSULT | $621,192 |
| OPTIV SECURITY INC | DENVER, CO | IT CYBER SECURITY | $554,441 |
| HDR ARCHITECTURE INC | OMAHA, NE | ARCHITECT | $436,332 |
2014 · 5 contractors · $3.6M
| Name | Location | Service | Paid |
|---|---|---|---|
| FUSION CONSULTING INC | IRVING, TX | IT CONSULTING | $955,036 |
| STARLIMS CORPORATION | HOLLYWOOD, FL | IT CONSULTING | $907,812 |
| GILBANE BUILDING COMPANY | PROVIDENCE, RI | CONSTRUCTION MGMT | $716,742 |
| CENTERBROOK ARCHITECT | CENTERBROOK, CT | ARCHITECT | $605,845 |
| DIGITAL CONSULTING AND SOFTWARE SVC | SUGAR LAND, TX | SOFTWARE CONSULTING | $446,771 |
2013 · 5 contractors · $5.7M
| Name | Location | Service | Paid |
|---|---|---|---|
| CENTERBROOK ARCHITECT AND PLANNERS | ARCHITECT | $1,930,589 | |
| COLUMBUS IT PARTNER USA | IT CONSULTING | $1,475,647 | |
| GILBANE BUILDING COMPANY | CONSTRUCTION MGMT | $862,770 | |
| DIGITAL CONSULTING SOFTWARE | IT CONSULTING | $843,243 | |
| FUSION CONSULTING INC | IT CONSULTING | $551,513 |
2012 · 5 contractors · $8.6M
| Name | Location | Service | Paid |
|---|---|---|---|
| CENTERBROOK ARCH AND PLANNERS LLP | CENTERBROOK, CT | ARCH/CONTR MGMT | $3,960,962 |
| BVH INTEGRATED SERVICES INC | S BLOOMFIELD, CT | ARCH ENGINEERING | $1,590,259 |
| COLUMBUS IT PARTNERS | STAMFORD, CT | IT CONSULTING | $1,419,445 |
| HURON CONSULTING | CHICAGO, IL | IT CONSULTING | $928,983 |
| VELOCITY TECHNOLOGY SOLUTIONS INC | NEW YORK, NY | IT CONSULTING | $655,781 |
2010 · 5 contractors · $2.3M
| Name | Location | Service | Paid |
|---|---|---|---|
| COLUMBUS IT PARTNERS | STAMFORD, CT | IT CONSULTING | $953,960 |
| VELOCITY TECHNOLOGY SOLUTIONS | NEW YORK, NY | IT CONSULTING | $428,635 |
| RMW ARCHITECTS | SACRAMENTO, CA | ARCHITECTURAL | $316,847 |
| KPMG LLP | BOSTON, MA | AUDITING | $299,930 |
| HOGAN LOVELLS US LLP | MIAMI, FL | LEGAL | $259,010 |
2009 · 5 contractors · $1.2M
| Name | Location | Service | Paid |
|---|---|---|---|
| COLUMBUS IT PARTNERS | STAMFORD, CT | IT CONSULTING | $494,114 |
| WBRC ARCHITECTS ENGINEERS | BANGOR, ME | Architect-Consulting | $223,852 |
| GRANT THORNTON LLP | BOSTON, MA | IT CONSULTING | $219,448 |
| KPMG LLP | BOSTON, MA | AUDITING | $149,500 |
| WOLF GREENFIELD SACKS PC | BOSTON, MA | LEGAL | $103,879 |
Paid as a vendor by
Other organizations that listed this one among their highest-paid independent contractors. Contractor lists give no EIN, so these are matched on name and address; check the filing.
| Year | Paid by | Service | Paid | Filing |
|---|---|---|---|---|
| 2023 | JOSLIN DIABETES CENTER INC | RESEARCH | $524,480 | view vendor page |
Who the money went to
Grants this organization reported paying: Schedule I Part II of the Form 990, or the grants-paid list on the 990-PF. Open a year for every recipient. Recipients link to their own page when the grant names an EIN we have (990-PF grants list no EIN, so those link only on an exact, unique name and state). Grants to individuals are counted; their names are not shown.
2024 · 6 grants to organizations · $222K
Listed grants add up to $222,295; the return's “grants paid” expense line says $3,015,996. Returns can differ here (grants paid vs. accrued, items listed elsewhere); check the filing.
2023 · 7 grants to organizations · $230K
Listed grants add up to $229,943; the return's “grants paid” expense line says $2,940,710. Returns can differ here (grants paid vs. accrued, items listed elsewhere); check the filing.
2022 · 13 grants to organizations · $300K
Listed grants add up to $299,710; the return's “grants paid” expense line says $2,773,594. Returns can differ here (grants paid vs. accrued, items listed elsewhere); check the filing.
2021 · 7 grants to organizations · $222K
Listed grants add up to $221,787; the return's “grants paid” expense line says $2,892,537. Returns can differ here (grants paid vs. accrued, items listed elsewhere); check the filing.
2020 · 8 grants to organizations · $239K
Listed grants add up to $239,135; the return's “grants paid” expense line says $2,340,034. Returns can differ here (grants paid vs. accrued, items listed elsewhere); check the filing.
2019 · 6 grants to organizations · $188K
Listed grants add up to $187,500; the return's “grants paid” expense line says $2,442,757. Returns can differ here (grants paid vs. accrued, items listed elsewhere); check the filing.
2018 · 3 grants to organizations · $127K
Listed grants add up to $127,400; the return's “grants paid” expense line says $2,265,145. Returns can differ here (grants paid vs. accrued, items listed elsewhere); check the filing.
2017 · 3 grants to organizations · $108K
Listed grants add up to $108,165; the return's “grants paid” expense line says $2,254,850. Returns can differ here (grants paid vs. accrued, items listed elsewhere); check the filing.
2016 · 3 grants to organizations · $116K
Listed grants add up to $116,010; the return's “grants paid” expense line says $1,595,400. Returns can differ here (grants paid vs. accrued, items listed elsewhere); check the filing.
2015 · 3 grants to organizations · $106K
Listed grants add up to $106,000; the return's “grants paid” expense line says $1,113,816. Returns can differ here (grants paid vs. accrued, items listed elsewhere); check the filing.
2014 · 3 grants to organizations · $2.5M
2013 · 1 grant to organizations · $12K
Listed grants add up to $12,500; the return's “grants paid” expense line says $17,500. Returns can differ here (grants paid vs. accrued, items listed elsewhere); check the filing.
Negative amounts are returned or refunded grants; they are listed last and left out of the totals of grants paid.
Who gave
Contributor names are not public for this form type.
Public charities filing Form 990 or 990-EZ report large donors on Schedule B, but the IRS withholds their names and addresses from public copies. Private foundations (990-PF) are different: their contributors are public.
Finances
Newest first. Each filing: its name on one row, its figures on the row beneath. Greyed filings are superseded by a later return for the same period and are left out everywhere else on this page.
| Revenue | Expenses | Assets | Net assets | Contributions | Program revenue | Officer pay | Employees | Volunteers |
|---|---|---|---|---|---|---|---|---|
| 2024 · Form 990 | ||||||||
| $652,542,607 | $617,013,316 | $1,555,458,481 | $1,052,670,426 | $119,383,426 | $475,588,793 | $9,777,290 | 3,203 | 26 |
| 2023 · Form 990 | ||||||||
| $572,803,655 | $577,381,862 | $1,467,831,204 | $996,925,622 | $116,852,173 | $439,470,117 | $7,303,808 | 3,303 | 29 |
| 2022 · Form 990 | ||||||||
| $553,515,570 | $532,815,716 | $1,394,651,570 | $951,870,931 | $119,479,687 | $416,727,477 | $6,353,401 | 3,166 | 27 |
| 2021 · Form 990 | ||||||||
| $572,874,395 | $509,495,255 | $1,458,479,631 | $1,010,382,226 | $120,757,756 | $415,233,744 | $7,121,017 | 2,983 | 26 |
| 2020 · Form 990 | ||||||||
| $527,504,036 | $463,558,933 | $1,211,767,628 | $918,518,618 | $122,912,211 | $362,474,943 | $6,009,839 | 2,904 | 29 |
| 2019 · Form 990 | ||||||||
| $460,123,417 | $408,212,868 | $1,111,690,544 | $835,322,733 | $131,073,861 | $318,712,842 | $5,312,573 | 3,150 | 27 |
| 2018 · Form 990 | ||||||||
| $432,451,999 | $367,129,153 | $1,024,759,952 | $739,944,148 | $111,234,633 | $285,848,068 | $5,673,275 | 2,557 | 27 |
| 2017 · Form 990 | ||||||||
| $375,965,824 | $335,594,164 | $890,104,660 | $712,914,348 | $100,092,912 | $257,779,916 | $6,497,749 | 2,401 | 39 |
| 2016 · Form 990 | ||||||||
| $331,079,449 | $300,563,654 | $795,674,359 | $632,988,468 | $88,095,298 | $231,591,680 | $5,034,649 | 2,114 | 35 |
| 2015 · Form 990 | ||||||||
| $304,318,753 | $281,509,812 | $754,989,281 | $586,626,719 | $89,944,366 | $210,424,017 | $5,194,216 | 2,080 | 30 |
| 2014 · Form 990 | ||||||||
| $291,589,484 | $250,569,154 | $736,361,322 | $492,985,953 | $91,256,682 | $181,040,415 | $4,753,707 | 1,992 | 52 |
| 2013 · Form 990 | ||||||||
| $257,132,786 | $216,129,370 | $612,525,781 | $416,778,004 | $74,310,661 | $161,752,623 | $6,048,265 | 1,725 | 55 |
| 2012 · Form 990 | ||||||||
| $231,079,981 | $202,952,186 | $527,038,278 | $351,020,518 | $67,271,113 | $159,830,571 | $4,464,193 | 1,661 | 156 |
| 2010 · Form 990 | ||||||||
| $231,514,645 | $182,182,332 | $429,077,589 | $305,692,936 | $73,823,292 | $145,476,881 | $3,375,714 | 1,516 | 241 |
| 2009 · Form 990 | ||||||||
| $200,282,021 | $170,507,361 | $378,980,549 | $256,091,203 | $69,040,663 | $127,618,036 | $4,155,718 | 1,553 | 173 |
Connected to
Organizations that list some of the same people on their returns (officers, directors, key employees on this organization’s latest return), and related organizations it lists on Schedule R.
- BOWDOIN COLLEGE Brunswick, ME · 3 people in common (Bertrand Garcia-Moreno, John A Gibbons Jr, S CATHERINE Longley)
- ROCKEFELLER UNIVERSITY New York, NY · 2 people in common (Dinakar Singh, Stewart J Hen)
- THE NEW YORK PUBLIC LIBRARY ASTOR LENOX AND TILDEN FOUNDATIONS New York, NY · 1 person in common (Dinakar Singh)
- COLD SPRING HARBOR LABORATORY Cold Spg Hbr, NY · 1 person in common (Dinakar Singh)
- AMERICAN CANCER SOCIETY INC Atlanta, GA · 1 person in common (Edison T Liu Md)
- AMERICAN ASSOCIATION FOR CANCER RESEARCH Philadelphia, PA · 1 person in common (Edison T Liu Md)
- NEW YORK GENOME CENTER INC New York, NY · 1 person in common (Edison T Liu Md)
- ASSOCIATION OF AMERICAN CANCER INSTITUTES Pittsburgh, PA · 1 person in common (Edison T Liu Md)
Funders of this organization
175 grantors reported grants to this organization, $116,557,604 in all, tax years 2009 to 2025; the 25 largest shown (all 175). Exact: the grantor wrote this organization's EIN. Fuzzy: the grantor wrote only a name (foundations' 990-PF has no EIN field), matched to the same or a near-identical name in the same state; the name as filed is shown. From the latest return for each grantor and year, so amended returns aren't counted twice. CSV
| Grantor | Type | Match | Years given | Grants | Total | Latest year | Latest year's amount | Grants |
|---|---|---|---|---|---|---|---|---|
| MAINE TECHNOLOGY INSTITUTE | Public charity | Exact | 2011-2013, 2015-2019, 2023 | 9 | $13,636,065 | 2023 | $10,000 | show |
| MICHAEL J FOX FOUNDATION FOR PARKINSONS RESEARCH | Public charity | Exact | 2010-2016, 2019, 2021, 2023-2025 | 34 | $6,645,120 | 2025 | $3,081,467 | show |
| HOWARD HUGHES MEDICAL INSTITUTE | Public charity | Exact | 2010, 2014, 2017, 2019, 2022 | 5 | $5,692,000 | 2022 | $900,000 | show |
| THE MARK FOUNDATION FOR CANCER RESEARCH US LTD | Public charity | Exact | 2019, 2021-2024 | 5 | $5,575,972 | 2024 | $332,133 | show |
| UNIVERSITY OF PITTSBURGH | Public charity | Exact | 2009-2014, 2016-2024 | 15 | $4,963,691 | 2024 | $1,358,991 | show |
| SILICON VALLEY COMMUNITY FOUNDATION | DAF sponsor | Exact | 2013, 2018, 2021-2024 | 6 | $4,292,834 | 2024 | $60,000 | show |
| BROAD INSTITUTE INC | Public charity | Exact | 2017-2024 | 8 | $4,020,806 | 2024 | $271,488 | show |
| EMORY UNIVERSITY | Public charity | Exact | 2017-2024 | 8 | $4,007,152 | 2024 | $852,423 | show |
| FIDELITY INVESTMENTS CHARITABLE GIFT FUND | DAF sponsor | Exact | 2017-2024 | 8 | $3,959,080 | 2024 | $771,891 | show |
| CORNELL UNIVERSITY | Public charity | Exact | 2018-2024 | 7 | $3,904,699 | 2024 | $151,602 | show |
| GATES FOUNDATION | Private foundation | Fuzzy filed as “JACKSON LABORATORY” | 2021, 2023-2024 | 3 | $3,396,524 | 2024 | $1,374,297 | show |
| ALZHEIMERS DISEASE AND RELATED DISORDERS ASSOCIATION INC | Public charity | Exact | 2017, 2020-2023 | 6 | $3,038,716 | 2023 | $250,000 | show |
| COLD SPRING HARBOR LABORATORY | Public charity | Exact | 2013, 2015-2023 | 10 | $2,799,930 | 2023 | $205,468 | show |
| PEW CHARITABLE TRUSTS | DAF sponsor | Exact | 2011-2012, 2014 | 3 | $2,500,000 | 2014 | $500,000 | show |
| THE MEDICAL COLLEGE OF WISCONSIN INC | Public charity | Exact | 2014-2023 | 10 | $2,220,653 | 2023 | $53,501 | show |
| TRUSTEES OF COLUMBIA UNIVERSITY | DAF sponsor | Exact | 2015-2018, 2020-2024 | 9 | $2,160,938 | 2024 | $478,181 | show |
| YALE UNIVERSITY | DAF sponsor | Exact | 2014-2015, 2018-2024 | 9 | $2,047,486 | 2024 | $66,830 | show |
| TRUSTEES OF BOSTON UNIVERSITY | Public charity | Exact | 2020-2024 | 5 | $1,956,323 | 2024 | $800,066 | show |
| BRIGHTFOCUS FOUNDATION | Public charity | Exact | 2016, 2019-2022 | 8 | $1,875,000 | 2022 | $200,000 | show |
| AMERICAN CANCER SOCIETY INC | Public charity | Exact | 2009, 2014, 2016-2017 | 4 | $1,839,000 | 2017 | $163,500 | show |
| BREAKTHROUGH T1D | Public charity | Exact | 2009-2010, 2013-2018 | 8 | $1,812,038 | 2018 | $314,398 | show |
| VANDERBILT UNIVERSITY | Public charity | Exact | 2009-2015 | 7 | $1,781,959 | 2015 | $7,050 | show |
| FIDELITY NON-PROFIT MANAGEMENT FOUNDATION | Public charity | Exact | 2022-2023 | 2 | $1,610,000 | 2023 | $805,000 | show |
| UNIVERSITY OF SOUTHERN CALIFORNIA | DAF sponsor | Exact | 2023-2024 | 2 | $1,561,841 | 2024 | $607,421 | show |
| MAYO CLINIC GROUP RETURN | Public charity | Exact | 2017-2018, 2020-2021 | 4 | $1,468,250 | 2021 | $316,750 | show |
Similar organizations
Ranked without any AI: same NTEE code first, then the same NTEE group; then revenue within 2x, 5x or 10x; then the same state; then similar name and mission text. Same state only · More (100)
| Organization | State | NTEE | Latest revenue | Latest expenses | Top-paid title | Top pay | Why similar |
|---|---|---|---|---|---|---|---|
| SCRIPPS RESEARCH INSTITUTE | CA | H92 | $698,624,318 | $537,453,981 | PRESIDENT/CEO | $1,859,240 | Same NTEE code H92, revenue within 2x |
| HOWARD HUGHES MEDICAL INSTITUTE | MD | H92 | $2,004,784,057 | $1,178,202,544 | VP & CHIEF INVESTMENT OFFICER | $2,004,966 | Same NTEE code H92, revenue within 5x |
| WHITEHEAD INSTITUTE FOR BIOMEDICAL RESEARCH | MA | H92 | $222,267,487 | $174,270,117 | DIRECTOR/PRESIDENT | $1,081,921 | Same NTEE code H92, revenue within 5x |
| OKLAHOMA MEDICAL RESEARCH FOUNDATION | OK | H92 | $136,776,829 | $126,476,987 | EVP and Chief Medical Officer | $1,016,574 | Same NTEE code H92, revenue within 5x |
| SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE | CA | H92 | $114,401,821 | $116,107,616 | CEO & PRESIDENT | $1,345,526 | Same NTEE code H92, revenue within 10x |
| LOVELACE BIOMEDICAL RESEARCH INSTITUTE | NM | H92 | $83,397,041 | $87,744,696 | PRESIDENT AND CHAIRMAN OF THE BOARD | $1,387,128 | Same NTEE code H92, revenue within 10x |
| STOWERS INSTITUTE FOR MEDICAL RESEARCH | MO | H92 | $102,011,512 | $104,688,153 | DIRECTOR/CHAIR DECEASED 3/27/25 | $3,206,337 | Same NTEE code H92, revenue within 10x |
| BENAROYA RESEARCH INSTITUTE AT VIRGINIA MASON | WA | H92 | $81,277,408 | $80,732,627 | CHIEF EXECUTIVE OFFICER VMFH | $5,754,859 | Same NTEE code H92, revenue within 10x |
| FOUNDATION FOR THE NATIONAL INSTITUTE OF HEALTH INC | MD | H92 | $78,507,209 | $76,818,918 | Chief Executive Officer | $689,835 | Same NTEE code H92, revenue within 10x |
| MASONIC MEDICAL RESEARCH LABORATORY | NY | H92 | $10,134,010 | $11,033,378 | EXECUTIVE DIRECTOR | $659,772 | Same NTEE code H92, revenue differs more than 10x |
| TECHNOLOGY ACCELERATOR COMPANY | SC | H92 | $175,617 | $6,304 | CHAIR / DIRECTOR | $0 | Same NTEE code H92, revenue differs more than 10x, similar mission |
| OPEN HUMANS FOUNDATION | NC | H92 | $58,742 | $55,150 | EXECUTIVE DIRECTOR AND PRESIDENT | $0 | Same NTEE code H92, revenue differs more than 10x |
| SONA GLOBAL LIMITED | MA | H92 | $101,394 | $47,032 | President | $0 | Same NTEE code H92, revenue differs more than 10x |
| FOUNDATION FOR BIOMEDICAL RESEARCH | DC | H92 | $1,931,597 | $1,205,880 | PRESIDENT | $199,375 | Same NTEE code H92, revenue differs more than 10x |
| NEBRASKA EDUCATIONAL BIOMEDICAL RESEARCH ASSOCIATION | NE | H92 | $1,151,613 | $843,457 | DIRECTOR | $0 | Same NTEE code H92, revenue differs more than 10x |
| PENNINGTON BIOMEDICAL RESEARCH FOUNDATION | LA | H92 | $4,483,977 | $4,163,749 | CHIEF DEVELOPMENT OFFICER | $256,778 | Same NTEE code H92, revenue differs more than 10x |
| CINCINNATI EDUCATION AND RESEARCH FOR VETERANS FOUNDATION | OH | H92 | $1,256,582 | $1,689,441 | BOARD MEMBER | $453,478 | Same NTEE code H92, revenue differs more than 10x |
| HFII CORPORATION | MI | H92 | $2,898 | $3,628 | TRUSTEE -CHAIR | $7,081,174 | Same NTEE code H92, revenue differs more than 10x |
| GARY AND MARY WEST HEALTH INSTITUTE | CA | H92 | $44,564,569 | $42,453,440 | CMO & EVP CLINICAL RESEARCH | $958,995 | Same NTEE code H92, revenue differs more than 10x |
| GLOBAL GENOMICS AND BIOINFORMATICS RESEARCH INSTITUTE | VA | H92 | $494 | $0 | PRESIDENT | $0 | Same NTEE code H92, revenue differs more than 10x |
| WISCONSIN CORPORATION FOR BIOMEDICAL RESEARCH | WI | H92 | $776,831 | $490,153 | BOARD MEMBER | $352,262 | Same NTEE code H92, revenue differs more than 10x |
| FOGARTY INSTITUTE FOR INNOVATION | CA | H92 | $2,887,855 | $7,841,457 | CHIEF STRATEGY OFFICER | $377,860 | Same NTEE code H92, revenue differs more than 10x |
| SOUTHERN CALIFORNIA INSTITUTE FOR RESEARCH AND EDUCATION | CA | H92 | $2,941,163 | $2,335,904 | Chair | $419,756 | Same NTEE code H92, revenue differs more than 10x |
| PINEHURST BIOMEDICAL FOUNDATION | CA | H92 | $8 | $60,229 | CEO | $0 | Same NTEE code H92, revenue differs more than 10x |
| APEIRON RESEARCH CENTER | CO | H92 | $4,811,542 | $1,506,305 | President/Principal Investigator | $352,916 | Same NTEE code H92, revenue differs more than 10x |
Who funds organizations like this
Grantors that funded the 100 most similar organizations. Ranked by total given to them. Foundations (990-PF) and donor-advised fund sponsors only. Same matching as Funders above (by EIN, or by name for foundations).
The full list · all similar organizations
Where the money went
Every expense line on each return, biggest first: Form 990 Part IX (with its program, management and fundraising columns), 990-EZ Part I, or 990-PF Part I. Event marks lines the organization itself describes as events. “Events” in each summary adds those lines, conferences and meetings, and the direct costs of fundraising events. Unusual is not the same as improper. Many of these patterns have ordinary explanations. Check the filing.
2024 · Form 990 · $617,013,316 spent · pay $345,822,365 · grants $3,015,996 · events $216,677
| Line | As described | Total | Program | Management | Fundraising | Share |
|---|---|---|---|---|---|---|
| Other salaries and wages | $252,501,524 | $212,208,099 | $37,726,271 | $2,567,154 | 40.9% | |
| Other (as described) | Supplies | $86,926,162 | $83,160,851 | $3,578,396 | $186,915 | 14.1% |
| Depreciation and depletion | $60,411,066 | $57,169,699 | $3,241,367 | - | 9.8% | |
| Other employee benefits | $44,559,154 | $35,231,566 | $8,944,588 | $383,000 | 7.2% | |
| Fees: other services | $32,664,796 | $25,065,907 | $7,544,793 | $54,096 | 5.3% | |
| Pension plan contributions | $20,991,526 | $17,968,010 | $2,802,500 | $221,016 | 3.4% | |
| Information technology | $20,503,267 | $16,031,816 | $4,315,488 | $155,963 | 3.3% | |
| Occupancy | $19,544,799 | $17,909,454 | $1,635,345 | - | 3.2% | |
| Payroll taxes | $17,992,871 | $15,121,624 | $2,688,316 | $182,931 | 2.9% | |
| Interest | $11,351,264 | $11,318,431 | $32,833 | - | 1.8% | |
| Pay: officers, directors, trustees, key employees | $9,777,290 | $4,124,765 | $5,652,525 | $0 | 1.6% | |
| Travel | $8,311,311 | $6,531,047 | $1,424,568 | $355,696 | 1.3% | |
| Other (as described) | Service fees/credit card, bank etc | $6,016,677 | $3,918,525 | $2,088,280 | $9,872 | 1.0% |
| Other (as described) | Other expense | $4,737,081 | $495,427 | $4,241,654 | $0 | 0.8% |
| Insurance | $3,971,673 | $3,842,851 | $128,822 | - | 0.6% | |
| Royalties | $3,563,544 | $3,563,544 | - | - | 0.6% | |
| Fees: legal | $3,210,574 | - | $3,210,574 | - | 0.5% | |
| Grants to US individuals | $2,656,654 | $2,656,654 | - | - | 0.4% | |
| Other (as described) | Equipment rental | $2,051,438 | $1,966,873 | $79,684 | $4,881 | 0.3% |
| Office expenses | $1,424,552 | $878,690 | $465,946 | $79,916 | 0.2% | |
| Advertising and promotion | $1,314,065 | $1,178,175 | $135,870 | $20 | 0.2% | |
| All other expenses | $1,267,434 | $1,267,434 | $0 | $0 | 0.2% | |
| Fees: accounting | $380,750 | - | $380,750 | - | 0.1% | |
| Grants to US organizations and governments | $359,342 | $359,342 | - | - | 0.1% | |
| Fees: investment management | $307,825 | - | $307,825 | - | 0.0% | |
| Conferences, conventions and meetings | $216,677 | $190,066 | $26,527 | $84 | 0.0% | |
| Total | $617,013,316 | 100% |
2023 · Form 990 · $577,381,862 spent · pay $324,314,275 · grants $2,940,710 · events $400,638
| Line | As described | Total | Program | Management | Fundraising | Share |
|---|---|---|---|---|---|---|
| Other salaries and wages | $236,364,005 | $198,627,010 | $35,215,937 | $2,521,058 | 40.9% | |
| Other (as described) | Supplies | $85,299,039 | $81,586,854 | $3,620,157 | $92,028 | 14.8% |
| Depreciation and depletion | $54,336,709 | $51,623,791 | $2,712,918 | - | 9.4% | |
| Other employee benefits | $45,288,780 | $34,970,140 | $9,894,222 | $424,418 | 7.8% | |
| Fees: other services | $31,173,936 | $24,535,464 | $6,548,936 | $89,536 | 5.4% | |
| Pension plan contributions | $18,119,599 | $15,555,240 | $2,365,253 | $199,106 | 3.1% | |
| Information technology | $18,104,402 | $11,862,333 | $6,111,065 | $131,004 | 3.1% | |
| Occupancy | $18,020,073 | $16,821,346 | $1,198,723 | $4 | 3.1% | |
| Payroll taxes | $17,238,083 | $14,485,915 | $2,568,307 | $183,861 | 3.0% | |
| Interest | $9,167,101 | $8,847,851 | $319,250 | - | 1.6% | |
| Travel | $8,443,524 | $6,347,264 | $1,863,085 | $233,175 | 1.5% | |
| Pay: officers, directors, trustees, key employees | $7,303,808 | $1,979,101 | $5,324,707 | - | 1.3% | |
| Other (as described) | Service fees/credit card, bank etc | $5,803,717 | $3,839,038 | $1,959,375 | $5,304 | 1.0% |
| Insurance | $4,099,024 | $3,979,741 | $119,283 | - | 0.7% | |
| Other (as described) | Interco service fees | $3,207,008 | $3,207,008 | - | - | 0.6% |
| Fees: legal | $2,898,061 | $47,449 | $2,850,612 | - | 0.5% | |
| Grants to US individuals | $2,606,711 | $2,606,711 | - | - | 0.5% | |
| Royalties | $2,269,606 | $2,269,606 | - | - | 0.4% | |
| All other expenses | $1,853,019 | $1,917,609 | -$64,590 | $0 | 0.3% | |
| Advertising and promotion | $1,602,899 | $1,289,802 | $313,097 | - | 0.3% | |
| Office expenses | $1,381,167 | $849,633 | $489,083 | $42,451 | 0.2% | |
| Other (as described) | Equipment rental | $1,324,008 | $1,228,044 | $87,901 | $8,063 | 0.2% |
| Conferences, conventions and meetings | $400,638 | $357,167 | $43,246 | $225 | 0.1% | |
| Fees: accounting | $383,500 | - | $383,500 | - | 0.1% | |
| Grants to US organizations and governments | $333,999 | $333,999 | - | - | 0.1% | |
| Fees: investment management | $296,446 | - | $296,446 | - | 0.1% | |
| Fees: lobbying | $63,000 | - | $63,000 | - | 0.0% | |
| Total | $577,381,862 | 100% |
2022 · Form 990 · $532,815,716 spent · pay $291,592,343 · grants $2,773,594 · events $123,899
| Line | As described | Total | Program | Management | Fundraising | Share |
|---|---|---|---|---|---|---|
| Other salaries and wages | $214,903,818 | $183,640,082 | $28,792,738 | $2,470,998 | 40.3% | |
| Other (as described) | SUPPLIES | $81,429,453 | $78,476,015 | $2,832,076 | $121,362 | 15.3% |
| Depreciation and depletion | $52,261,314 | $49,366,026 | $2,895,288 | - | 9.8% | |
| Other employee benefits | $36,955,741 | $29,480,635 | $7,083,700 | $391,406 | 6.9% | |
| Fees: other services | $29,953,169 | $23,418,142 | $6,379,425 | $155,602 | 5.6% | |
| Information technology | $20,711,985 | $16,024,421 | $4,542,990 | $144,574 | 3.9% | |
| Pension plan contributions | $18,100,553 | $15,766,729 | $2,122,905 | $210,919 | 3.4% | |
| Occupancy | $17,445,803 | $16,247,536 | $1,198,267 | - | 3.3% | |
| Payroll taxes | $15,278,830 | $13,056,100 | $2,047,052 | $175,678 | 2.9% | |
| Interest | $7,683,570 | $7,414,542 | $269,028 | - | 1.4% | |
| Travel | $6,916,206 | $4,824,283 | $1,888,294 | $203,629 | 1.3% | |
| Pay: officers, directors, trustees, key employees | $6,353,401 | $2,012,609 | $4,340,792 | - | 1.2% | |
| Other (as described) | OTHER SERVICES | $4,957,265 | $3,453,814 | $1,499,120 | $4,331 | 0.9% |
| Insurance | $3,221,609 | $3,123,732 | $97,877 | - | 0.6% | |
| Royalties | $3,203,161 | $3,203,161 | - | - | 0.6% | |
| Fees: legal | $3,092,293 | - | $3,092,293 | - | 0.6% | |
| Grants to US individuals | $2,475,529 | $2,475,529 | - | - | 0.5% | |
| Advertising and promotion | $1,855,716 | $1,579,702 | $275,014 | $1,000 | 0.3% | |
| Other (as described) | INTERCO SERVICE FEE | $1,854,092 | $1,854,092 | - | - | 0.3% |
| Office expenses | $1,335,716 | $839,260 | $472,462 | $23,994 | 0.3% | |
| Other (as described) | EQUIPMENT RENTAL | $1,253,733 | $1,169,378 | $77,339 | $7,016 | 0.2% |
| Fees: accounting | $425,770 | - | $425,770 | - | 0.1% | |
| Fees: investment management | $365,320 | - | $365,320 | - | 0.1% | |
| All other expenses | $359,705 | $534,376 | -$174,671 | - | 0.1% | |
| Grants to US organizations and governments | $298,065 | $298,065 | - | - | 0.1% | |
| Conferences, conventions and meetings | $123,899 | $103,631 | $20,057 | $211 | 0.0% | |
| Total | $532,815,716 | 100% |
2021 · Form 990 · $509,495,255 spent · pay $266,577,106 · grants $2,892,537 · events $5,166
| Line | As described | Total | Program | Management | Fundraising | Share |
|---|---|---|---|---|---|---|
| Other salaries and wages | $193,270,136 | $163,713,321 | $26,957,106 | $2,599,709 | 37.9% | |
| Other (as described) | SUPPLIES | $95,960,187 | $91,921,927 | $3,932,579 | $105,681 | 18.8% |
| Depreciation and depletion | $50,968,126 | $47,385,148 | $3,143,841 | $439,137 | 10.0% | |
| Other employee benefits | $35,843,084 | $28,308,755 | $7,092,056 | $442,273 | 7.0% | |
| Fees: other services | $22,435,699 | $13,471,002 | $8,752,356 | $212,341 | 4.4% | |
| Information technology | $17,812,117 | $13,427,914 | $4,281,748 | $102,455 | 3.5% | |
| Occupancy | $16,491,203 | $15,087,639 | $1,345,221 | $58,343 | 3.2% | |
| Pension plan contributions | $16,471,753 | $14,378,249 | $1,862,914 | $230,590 | 3.2% | |
| Payroll taxes | $13,871,116 | $11,749,805 | $1,934,728 | $186,583 | 2.7% | |
| Interest | $7,852,500 | $7,489,256 | $353,977 | $9,267 | 1.5% | |
| Pay: officers, directors, trustees, key employees | $7,121,017 | $2,718,747 | $4,402,270 | - | 1.4% | |
| Other (as described) | OTHER SERVICES | $5,037,945 | $3,363,730 | $1,669,261 | $4,954 | 1.0% |
| Fees: legal | $4,497,832 | - | $4,497,832 | - | 0.9% | |
| Other (as described) | INTERCO SERVICE FEE | $4,304,564 | $4,304,564 | - | - | 0.8% |
| Insurance | $3,231,834 | $3,097,781 | $117,398 | $16,655 | 0.6% | |
| Grants to US individuals | $2,588,685 | $2,588,685 | - | - | 0.5% | |
| Royalties | $2,193,776 | $2,193,776 | - | - | 0.4% | |
| Travel | $2,082,661 | $1,078,906 | $933,794 | $69,961 | 0.4% | |
| Other (as described) | SETTLEMENTS | $1,900,000 | - | $1,900,000 | - | 0.4% |
| All other expenses | $1,658,553 | $1,345,792 | $304,189 | $8,572 | 0.3% | |
| Advertising and promotion | $1,557,337 | $1,233,813 | $316,277 | $7,247 | 0.3% | |
| Office expenses | $1,278,428 | $735,755 | $492,406 | $50,267 | 0.3% | |
| Fees: investment management | $399,879 | - | $399,879 | - | 0.1% | |
| Fees: accounting | $357,805 | - | $357,805 | - | 0.1% | |
| Grants to US organizations and governments | $303,852 | $303,852 | - | - | 0.1% | |
| Conferences, conventions and meetings | $5,166 | -$16,660 | $21,684 | $142 | 0.0% | |
| Total | $509,495,255 | 100% |
2020 · Form 990 · $463,558,933 spent · pay $245,058,305 · grants $2,340,034 · events -$25,961
| Line | As described | Total | Program | Management | Fundraising | Share |
|---|---|---|---|---|---|---|
| Other salaries and wages | $177,564,239 | $150,860,949 | $24,403,097 | $2,300,193 | 38.3% | |
| Other (as described) | SUPPLIES | $95,695,374 | $90,240,891 | $5,324,077 | $130,406 | 20.6% |
| Depreciation and depletion | $47,661,064 | $44,179,772 | $3,030,165 | $451,127 | 10.3% | |
| Other employee benefits | $32,609,882 | $25,399,447 | $6,821,516 | $388,919 | 7.0% | |
| Occupancy | $15,963,926 | $14,170,373 | $1,728,624 | $64,929 | 3.4% | |
| Pension plan contributions | $15,865,068 | $13,722,665 | $1,931,211 | $211,192 | 3.4% | |
| Fees: other services | $14,991,518 | $11,689,892 | $3,054,163 | $247,463 | 3.2% | |
| Payroll taxes | $13,009,277 | $11,052,856 | $1,787,897 | $168,524 | 2.8% | |
| Information technology | $12,874,549 | $9,686,299 | $3,124,937 | $63,313 | 2.8% | |
| Fees: legal | $6,456,350 | - | $6,456,350 | - | 1.4% | |
| Interest | $6,305,113 | $6,013,448 | $284,224 | $7,441 | 1.4% | |
| Pay: officers, directors, trustees, key employees | $6,009,839 | $2,176,051 | $3,833,788 | - | 1.3% | |
| Other (as described) | OTHER SERVICES | $3,713,078 | $2,489,348 | $1,219,238 | $4,492 | 0.8% |
| Other (as described) | INTERCO MGMT FEE | $3,046,560 | $3,046,560 | $0 | $0 | 0.7% |
| Insurance | $2,699,580 | $2,539,438 | $145,030 | $15,112 | 0.6% | |
| Grants to US individuals | $2,045,374 | $2,045,374 | - | - | 0.4% | |
| Office expenses | $1,612,004 | $932,320 | $585,652 | $94,032 | 0.3% | |
| Advertising and promotion | $1,321,659 | $1,020,606 | $296,278 | $4,775 | 0.3% | |
| Other (as described) | EQUIPMENT RENTAL | $1,210,595 | $539,821 | $658,032 | $12,742 | 0.3% |
| Royalties | $1,092,716 | $1,092,716 | - | - | 0.2% | |
| Travel | $1,033,331 | $703,483 | $292,658 | $37,190 | 0.2% | |
| Fees: investment management | $356,863 | - | $356,863 | - | 0.1% | |
| Fees: accounting | $315,680 | - | $315,680 | - | 0.1% | |
| Grants to US organizations and governments | $294,660 | $294,660 | - | - | 0.1% | |
| Conferences, conventions and meetings | -$25,961 | -$37,208 | $10,999 | $248 | -0.0% | |
| All other expenses | -$163,405 | $251,396 | -$414,847 | $46 | -0.0% | |
| Total | $463,558,933 | 100% |
2019 · Form 990 · $408,212,868 spent · pay $225,564,526 · grants $2,442,757 · events $428,394
| Line | As described | Total | Program | Management | Fundraising | Share |
|---|---|---|---|---|---|---|
| Other salaries and wages | $163,595,129 | $139,325,428 | $21,824,148 | $2,445,553 | 40.1% | |
| Other (as described) | SUPPLIES | $62,621,655 | $61,272,740 | $1,189,756 | $159,159 | 15.3% |
| Depreciation and depletion | $41,924,263 | $39,051,211 | $2,519,729 | $353,323 | 10.3% | |
| Other employee benefits | $31,242,237 | $24,274,296 | $6,562,108 | $405,833 | 7.7% | |
| Occupancy | $16,211,391 | $14,811,282 | $1,338,104 | $62,005 | 4.0% | |
| Fees: other services | $13,816,642 | $10,235,336 | $2,961,765 | $619,541 | 3.4% | |
| Pension plan contributions | $13,416,141 | $11,643,763 | $1,565,940 | $206,438 | 3.3% | |
| Payroll taxes | $11,998,446 | $10,218,450 | $1,600,634 | $179,362 | 2.9% | |
| Travel | $9,755,451 | $7,280,707 | $2,216,693 | $258,051 | 2.4% | |
| Information technology | $9,625,921 | $6,894,246 | $2,682,577 | $49,098 | 2.4% | |
| Interest | $5,892,549 | $5,619,705 | $265,814 | $7,030 | 1.4% | |
| Pay: officers, directors, trustees, key employees | $5,312,573 | $2,072,708 | $3,239,865 | - | 1.3% | |
| Fees: legal | $3,698,077 | - | $3,698,077 | - | 0.9% | |
| Other (as described) | OTHER SERVICES | $3,181,761 | $2,746,438 | $427,709 | $7,614 | 0.8% |
| Office expenses | $2,725,078 | $1,922,663 | $428,854 | $373,561 | 0.7% | |
| Other (as described) | INTER-COMPANY MANAGEMENT FEE | $2,491,950 | $2,491,950 | $0 | $0 | 0.6% |
| Grants to US individuals | $2,221,988 | $2,221,988 | - | - | 0.5% | |
| Insurance | $2,047,063 | $1,930,914 | $105,686 | $10,463 | 0.5% | |
| Advertising and promotion | $1,859,732 | $1,350,914 | $478,920 | $29,898 | 0.5% | |
| All other expenses | $1,425,413 | $114,795 | $1,310,604 | $14 | 0.3% | |
| Royalties | $1,218,798 | $1,218,798 | - | - | 0.3% | |
| Other (as described) | EQUIPMENT RENTAL | $702,706 | $593,582 | $82,968 | $26,156 | 0.2% |
| Conferences, conventions and meetings | $428,394 | $390,420 | $37,296 | $678 | 0.1% | |
| Fees: accounting | $311,831 | - | $311,831 | - | 0.1% | |
| Fees: investment management | $266,910 | - | $266,910 | - | 0.1% | |
| Grants to US organizations and governments | $220,769 | $220,769 | - | - | 0.1% | |
| Total | $408,212,868 | 100% |
2018 · Form 990 · $367,129,153 spent · pay $205,976,997 · grants $2,265,145 · events $258,467
| Line | As described | Total | Program | Management | Fundraising | Share |
|---|---|---|---|---|---|---|
| Other salaries and wages | $152,005,451 | $129,487,853 | $20,269,974 | $2,247,624 | 41.4% | |
| Other (as described) | SUPPLIES | $57,764,320 | $56,324,090 | $1,198,097 | $242,133 | 15.7% |
| Depreciation and depletion | $35,759,188 | $32,709,780 | $2,461,666 | $587,742 | 9.7% | |
| Other employee benefits | $25,627,044 | $19,903,265 | $5,400,735 | $323,044 | 7.0% | |
| Occupancy | $15,427,504 | $13,890,058 | $1,417,660 | $119,786 | 4.2% | |
| Pension plan contributions | $11,783,142 | $10,597,650 | $993,865 | $191,627 | 3.2% | |
| Fees: other services | $11,366,282 | $8,556,159 | $2,431,390 | $378,733 | 3.1% | |
| Payroll taxes | $10,888,085 | $9,275,160 | $1,451,929 | $160,996 | 3.0% | |
| Information technology | $9,261,118 | $7,112,778 | $2,057,677 | $90,663 | 2.5% | |
| Travel | $8,727,810 | $6,284,897 | $2,096,489 | $346,424 | 2.4% | |
| Pay: officers, directors, trustees, key employees | $5,673,275 | $2,104,909 | $3,568,366 | - | 1.5% | |
| Interest | $4,948,994 | $4,577,336 | $320,034 | $51,624 | 1.3% | |
| Fees: legal | $3,961,224 | $3,096 | $3,958,119 | $9 | 1.1% | |
| Other (as described) | OTHER SERVICES | $3,134,222 | $2,702,546 | $425,696 | $5,980 | 0.9% |
| Office expenses | $3,101,064 | $2,284,555 | $516,233 | $300,276 | 0.8% | |
| Grants to US individuals | $2,100,324 | $2,100,324 | - | - | 0.6% | |
| Insurance | $1,694,443 | $1,576,112 | $102,991 | $15,340 | 0.5% | |
| Advertising and promotion | $1,406,851 | $1,163,985 | $227,099 | $15,767 | 0.4% | |
| Royalties | $749,403 | $749,403 | - | - | 0.2% | |
| Other (as described) | EQUIPMENT RENTAL | $465,315 | $383,690 | $55,510 | $26,115 | 0.1% |
| Fees: accounting | $388,715 | - | $388,715 | - | 0.1% | |
| Other (as described) | OTHER EXPENSE | $278,534 | $108,551 | $169,686 | $297 | 0.1% |
| Conferences, conventions and meetings | $258,467 | $221,114 | $34,415 | $2,938 | 0.1% | |
| Fees: investment management | $185,999 | - | $185,999 | - | 0.1% | |
| Grants to US organizations and governments | $164,821 | $164,821 | - | - | 0.0% | |
| Fees: lobbying | $7,500 | - | $7,500 | - | 0.0% | |
| All other expenses | $58 | - | $58 | - | 0.0% | |
| Total | $367,129,153 | 100% |
2017 · Form 990 · $335,594,164 spent · pay $185,441,730 · grants $2,254,850 · events $336,845
| Line | As described | Total | Program | Management | Fundraising | Share |
|---|---|---|---|---|---|---|
| Other salaries and wages | $133,932,439 | $109,412,920 | $23,127,936 | $1,391,583 | 39.9% | |
| Other (as described) | SUPPLIES | $50,945,235 | $49,933,881 | $931,903 | $79,451 | 15.2% |
| Depreciation and depletion | $35,059,682 | $32,307,406 | $2,471,679 | $280,597 | 10.4% | |
| Other employee benefits | $25,115,189 | $17,762,486 | $7,130,356 | $222,347 | 7.5% | |
| Fees: other services | $14,721,747 | $10,908,120 | $3,587,686 | $225,941 | 4.4% | |
| Occupancy | $14,160,572 | $12,841,752 | $1,245,280 | $73,540 | 4.2% | |
| Pension plan contributions | $10,070,150 | $8,779,193 | $1,174,467 | $116,490 | 3.0% | |
| Payroll taxes | $9,826,203 | $8,027,283 | $1,696,824 | $102,096 | 2.9% | |
| Information technology | $8,522,535 | $6,711,528 | $1,733,586 | $77,421 | 2.5% | |
| Travel | $7,159,057 | $5,373,728 | $1,533,813 | $251,516 | 2.1% | |
| Pay: officers, directors, trustees, key employees | $6,497,749 | $1,860,138 | $4,637,611 | - | 1.9% | |
| Interest | $5,269,370 | $4,841,608 | $381,984 | $45,778 | 1.6% | |
| Office expenses | $2,698,060 | $2,039,304 | $491,120 | $167,636 | 0.8% | |
| Other (as described) | OTHER SERVICES | $2,496,675 | $2,149,788 | $341,723 | $5,164 | 0.7% |
| Grants to US individuals | $2,119,435 | $2,119,435 | - | - | 0.6% | |
| Royalties | $1,843,527 | $232,930 | $1,610,597 | - | 0.5% | |
| Insurance | $1,459,959 | $1,362,789 | $89,537 | $7,633 | 0.4% | |
| Advertising and promotion | $1,413,251 | $1,196,874 | $211,135 | $5,242 | 0.4% | |
| Fees: legal | $871,083 | - | $871,083 | - | 0.3% | |
| Other (as described) | EQUIPMENT RENTAL | $349,560 | $284,426 | $63,842 | $1,292 | 0.1% |
| Conferences, conventions and meetings | $336,845 | $287,776 | $48,444 | $625 | 0.1% | |
| Fees: investment management | $271,713 | - | $271,713 | - | 0.1% | |
| Fees: accounting | $247,159 | $22,917 | $224,242 | - | 0.1% | |
| Grants to US organizations and governments | $135,415 | $135,415 | - | - | 0.0% | |
| Other (as described) | OTHER EXPENSE | $61,554 | $163,882 | -$102,788 | $460 | 0.0% |
| Fees: lobbying | $10,000 | - | $10,000 | - | 0.0% | |
| Total | $335,594,164 | 100% |
2016 · Form 990 · $300,563,654 spent · pay $157,463,695 · grants $1,595,400 · events $376,888
| Line | As described | Total | Program | Management | Fundraising | Share |
|---|---|---|---|---|---|---|
| Other salaries and wages | $113,101,613 | $91,082,299 | $20,737,745 | $1,281,569 | 37.6% | |
| Other (as described) | SUPPLIES | $46,741,103 | $45,858,007 | $809,527 | $73,569 | 15.6% |
| Depreciation and depletion | $35,465,452 | $33,047,906 | $2,099,248 | $318,298 | 11.8% | |
| Other employee benefits | $22,566,956 | $15,238,453 | $7,084,974 | $243,529 | 7.5% | |
| Fees: other services | $15,715,533 | $13,306,743 | $2,215,390 | $193,400 | 5.2% | |
| Occupancy | $14,405,146 | $13,205,179 | $1,110,411 | $89,556 | 4.8% | |
| Pension plan contributions | $8,595,362 | $7,368,332 | $1,119,011 | $108,019 | 2.9% | |
| Payroll taxes | $8,165,115 | $6,558,951 | $1,513,877 | $92,287 | 2.7% | |
| Information technology | $6,740,544 | $5,334,988 | $1,335,836 | $69,720 | 2.2% | |
| Travel | $6,506,641 | $4,861,463 | $1,471,262 | $173,916 | 2.2% | |
| Interest | $5,356,344 | $5,066,413 | $245,236 | $44,695 | 1.8% | |
| Pay: officers, directors, trustees, key employees | $5,034,649 | $1,718,175 | $3,316,474 | - | 1.7% | |
| Office expenses | $2,501,449 | $1,866,284 | $487,158 | $148,007 | 0.8% | |
| Other (as described) | OTHER SERVICES | $1,881,632 | $1,733,473 | $142,656 | $5,503 | 0.6% |
| Fees: legal | $1,777,150 | $914 | $1,776,224 | $12 | 0.6% | |
| Insurance | $1,606,692 | $1,502,437 | $94,937 | $9,318 | 0.5% | |
| Grants to US individuals | $1,453,480 | $1,453,480 | - | - | 0.5% | |
| Advertising and promotion | $969,744 | $592,702 | $376,943 | $99 | 0.3% | |
| Other (as described) | EQUIPMENT RENTAL | $618,940 | $499,495 | $91,083 | $28,362 | 0.2% |
| Fees: accounting | $436,577 | $25,000 | $411,577 | - | 0.1% | |
| Fees: investment management | $344,852 | - | $344,852 | - | 0.1% | |
| Conferences, conventions and meetings | $215,001 | $164,643 | $45,349 | $5,009 | 0.1% | |
| Grants to US organizations and governments | $141,920 | $141,920 | - | - | 0.0% | |
| Other (as described) | OTHER EXPENSE | $99,264 | $99,009 | - | $255 | 0.0% |
| Fees: professional fundraisers | $67,546 | - | - | $67,546 | 0.0% | |
| Royalties | $54,949 | $54,949 | - | - | 0.0% | |
| Fundraising events Event | direct expenses; gross income $3,400 | $161,887 | reported apart | |||
| Total | $300,563,654 | 100% |
2015 · Form 990 · $281,509,812 spent · pay $150,912,017 · grants $1,113,816 · events $529,315
| Line | As described | Total | Program | Management | Fundraising | Share |
|---|---|---|---|---|---|---|
| Other salaries and wages | $110,216,741 | $89,648,074 | $19,129,584 | $1,439,083 | 39.2% | |
| Other (as described) | SUPPLIES | $41,516,287 | $40,701,712 | $527,256 | $287,319 | 14.7% |
| Depreciation and depletion | $33,654,197 | $31,412,382 | $1,888,199 | $353,616 | 12.0% | |
| Other employee benefits | $18,939,474 | $12,730,307 | $5,984,951 | $224,216 | 6.7% | |
| Occupancy | $14,094,009 | $12,992,152 | $1,014,978 | $86,879 | 5.0% | |
| Fees: other services | $13,247,479 | $11,634,507 | $1,533,052 | $79,920 | 4.7% | |
| Pension plan contributions | $8,485,929 | $7,124,070 | $1,245,876 | $115,983 | 3.0% | |
| Payroll taxes | $8,075,657 | $6,568,576 | $1,401,638 | $105,443 | 2.9% | |
| Information technology | $7,095,950 | $5,631,383 | $1,368,468 | $96,099 | 2.5% | |
| Travel | $6,090,813 | $4,574,920 | $1,184,129 | $331,764 | 2.2% | |
| Interest | $5,308,427 | $5,112,557 | $148,204 | $47,666 | 1.9% | |
| Pay: officers, directors, trustees, key employees | $5,194,216 | $1,139,614 | $4,054,602 | - | 1.8% | |
| Office expenses | $2,204,508 | $1,512,991 | $526,445 | $165,072 | 0.8% | |
| Other (as described) | OTHER SERVICES | $1,882,687 | $1,652,754 | $222,745 | $7,188 | 0.7% |
| Insurance | $1,618,622 | $1,514,906 | $90,712 | $13,004 | 0.6% | |
| Grants to US individuals | $984,466 | $984,466 | - | - | 0.3% | |
| Advertising and promotion | $915,367 | $846,945 | $68,416 | $6 | 0.3% | |
| Fees: legal | $825,129 | $31,234 | $793,830 | $65 | 0.3% | |
| Fees: accounting | $372,590 | $25,000 | $347,590 | - | 0.1% | |
| Fees: investment management | $328,453 | - | $328,453 | - | 0.1% | |
| Conferences, conventions and meetings | $297,080 | $243,314 | $51,836 | $1,930 | 0.1% | |
| Other (as described) | EQUIPMENT RENTAL | $175,952 | $139,029 | $23,269 | $13,654 | 0.1% |
| Fees: professional fundraisers | $175,252 | - | - | $175,252 | 0.1% | |
| Grants to US organizations and governments | $129,350 | $129,350 | - | - | 0.0% | |
| Fees: lobbying | $100,751 | - | $100,751 | - | 0.0% | |
| Royalties | $33,118 | $33,118 | - | - | 0.0% | |
| Other (as described) | AP DISC, SETTLEMENTS, OTHER | -$452,692 | -$304,608 | -$149,054 | $970 | -0.2% |
| Fundraising events Event | direct expenses; gross income $2,925 | $232,235 | reported apart | |||
| Total | $281,509,812 | 100% |
2014 · Form 990 · $250,569,154 spent · pay $129,338,203 · grants $2,526,000 · events $432,013
| Line | As described | Total | Program | Management | Fundraising | Share |
|---|---|---|---|---|---|---|
| Other salaries and wages | $92,487,219 | $76,082,499 | $15,433,940 | $970,780 | 36.9% | |
| Other (as described) | SUPPLIES | $40,373,731 | $39,569,398 | $676,608 | $127,725 | 16.1% |
| Depreciation and depletion | $27,510,673 | $24,711,203 | $2,341,473 | $457,997 | 11.0% | |
| Other employee benefits | $18,295,275 | $12,783,793 | $5,314,595 | $196,887 | 7.3% | |
| Fees: other services | $12,755,125 | $10,186,473 | $1,992,154 | $576,498 | 5.1% | |
| Occupancy | $12,272,561 | $11,080,720 | $1,097,524 | $94,317 | 4.9% | |
| Pension plan contributions | $6,975,345 | $6,188,666 | $707,443 | $79,236 | 2.8% | |
| Payroll taxes | $6,826,657 | $5,615,794 | $1,139,208 | $71,655 | 2.7% | |
| Information technology | $5,784,690 | $4,786,563 | $930,042 | $68,085 | 2.3% | |
| Travel | $5,370,946 | $4,028,087 | $1,019,938 | $322,921 | 2.1% | |
| Pay: officers, directors, trustees, key employees | $4,753,707 | $338,827 | $4,414,880 | - | 1.9% | |
| Interest | $3,988,732 | $3,769,128 | $186,727 | $32,877 | 1.6% | |
| Grants to US organizations and governments | $2,526,000 | $2,526,000 | - | - | 1.0% | |
| Office expenses | $2,278,152 | $1,399,913 | $704,908 | $173,331 | 0.9% | |
| Other (as described) | OTHER SERVICES | $1,796,799 | $1,573,785 | $216,928 | $6,086 | 0.7% |
| Insurance | $1,572,623 | $1,465,260 | $94,999 | $12,364 | 0.6% | |
| Advertising and promotion | $986,454 | $913,997 | $71,235 | $1,222 | 0.4% | |
| Fees: legal | $919,064 | $86,637 | $831,469 | $958 | 0.4% | |
| Other (as described) | STIPENDS | $777,423 | $774,923 | - | $2,500 | 0.3% |
| Other (as described) | EQUIPMENT RENTAL | $516,220 | $345,475 | $136,142 | $34,603 | 0.2% |
| Fees: lobbying | $447,156 | - | $447,156 | - | 0.2% | |
| Conferences, conventions and meetings | $353,404 | $296,020 | $56,505 | $879 | 0.1% | |
| Fees: investment management | $292,990 | - | $292,990 | - | 0.1% | |
| Fees: professional fundraisers | $241,427 | - | - | $241,427 | 0.1% | |
| Fees: accounting | $204,165 | $25,000 | $179,165 | - | 0.1% | |
| Royalties | $161,786 | $161,786 | - | - | 0.1% | |
| All other expenses | $100,830 | $88,338 | $10,302 | $2,190 | 0.0% | |
| Fundraising events Event | direct expenses; gross income $2,175 | $78,609 | reported apart | |||
| Total | $250,569,154 | 100% |
2013 · Form 990 · $216,129,370 spent · pay $114,591,517 · grants $17,500 · events $538,174
| Line | As described | Total | Program | Management | Fundraising | Share |
|---|---|---|---|---|---|---|
| Other salaries and wages | $80,317,401 | $65,988,417 | $13,129,653 | $1,199,331 | 37.2% | |
| Other (as described) | SUPPLIES | $34,073,089 | $32,958,764 | $1,024,607 | $89,718 | 15.8% |
| Depreciation and depletion | $23,069,093 | $21,702,269 | $1,263,239 | $103,585 | 10.7% | |
| Other employee benefits | $15,643,025 | $10,737,308 | $4,734,570 | $171,147 | 7.2% | |
| Occupancy | $11,694,686 | $10,653,304 | $977,719 | $63,663 | 5.4% | |
| Fees: other services | $10,169,166 | $9,022,128 | $990,390 | $156,648 | 4.7% | |
| Pension plan contributions | $6,383,225 | $5,676,740 | $601,908 | $104,577 | 3.0% | |
| Payroll taxes | $6,199,601 | $5,093,564 | $1,013,462 | $92,575 | 2.9% | |
| Pay: officers, directors, trustees, key employees | $6,048,265 | $1,264,455 | $4,783,810 | - | 2.8% | |
| Information technology | $5,745,062 | $4,652,210 | $1,022,513 | $70,339 | 2.7% | |
| Travel | $4,617,309 | $3,476,697 | $869,675 | $270,937 | 2.1% | |
| Interest | $3,251,277 | $3,133,034 | $107,383 | $10,860 | 1.5% | |
| Office expenses | $2,006,977 | $1,170,368 | $761,788 | $74,821 | 0.9% | |
| Other (as described) | OTHER SERVICES | $1,502,876 | $1,286,940 | $210,293 | $5,643 | 0.7% |
| Insurance | $1,460,359 | $1,402,810 | $52,483 | $5,066 | 0.7% | |
| Other (as described) | STIPENDS | $777,476 | $777,476 | - | - | 0.4% |
| Advertising and promotion | $607,491 | $553,598 | $53,893 | - | 0.3% | |
| Fees: legal | $595,361 | $7,507 | $587,854 | - | 0.3% | |
| Other (as described) | EQUIPMENT RENTAL | $464,764 | $338,978 | $124,700 | $1,086 | 0.2% |
| Conferences, conventions and meetings | $443,322 | $370,739 | $67,893 | $4,690 | 0.2% | |
| Fees: accounting | $344,000 | $25,000 | $319,000 | - | 0.2% | |
| Fees: investment management | $238,384 | - | $238,384 | - | 0.1% | |
| All other expenses | $182,574 | $159,541 | $12,024 | $11,009 | 0.1% | |
| Fees: professional fundraisers | $130,573 | - | - | $130,573 | 0.1% | |
| Royalties | $91,918 | $91,918 | - | - | 0.0% | |
| Fees: lobbying | $54,596 | - | $54,596 | - | 0.0% | |
| Grants to US organizations and governments | $17,500 | $17,500 | - | - | 0.0% | |
| Fundraising events Event | direct expenses; gross income $5,625 | $94,852 | reported apart | |||
| Total | $216,129,370 | 100% |
2012 · Form 990 · $202,952,186 spent · pay $111,935,295 · grants $0 · events $532,457
| Line | As described | Total | Program | Management | Fundraising | Share |
|---|---|---|---|---|---|---|
| Other salaries and wages | $80,595,983 | $67,585,995 | $11,841,782 | $1,168,206 | 39.7% | |
| Other (as described) | SUPPLIES | $31,580,509 | $30,140,328 | $1,401,979 | $38,202 | 15.6% |
| Depreciation and depletion | $19,335,692 | $17,485,490 | $1,770,315 | $79,887 | 9.5% | |
| Other employee benefits | $14,460,966 | $12,823,631 | $1,411,728 | $225,607 | 7.1% | |
| Occupancy | $10,795,207 | $9,471,700 | $1,291,266 | $32,241 | 5.3% | |
| Pension plan contributions | $6,387,713 | $5,811,292 | $475,444 | $100,977 | 3.1% | |
| Payroll taxes | $6,026,440 | $5,070,120 | $868,684 | $87,636 | 3.0% | |
| Fees: other services | $5,123,310 | $2,837,244 | $2,038,293 | $247,773 | 2.5% | |
| All other expenses | $4,791,318 | $4,728,459 | $61,919 | $940 | 2.4% | |
| Pay: officers, directors, trustees, key employees | $4,464,193 | $445,606 | $4,018,587 | - | 2.2% | |
| Travel | $4,264,883 | $3,421,932 | $579,434 | $263,517 | 2.1% | |
| Interest | $3,361,259 | $3,342,313 | $18,946 | - | 1.7% | |
| Information technology | $3,060,618 | $2,520,973 | $497,323 | $42,322 | 1.5% | |
| Office expenses | $2,163,817 | $1,725,776 | $343,496 | $94,545 | 1.1% | |
| Insurance | $1,347,178 | $1,226,634 | $115,339 | $5,205 | 0.7% | |
| Other (as described) | OTHER SERVICES | $1,327,369 | $1,144,375 | $179,109 | $3,885 | 0.7% |
| Fees: legal | $1,274,979 | $743,755 | $530,713 | $511 | 0.6% | |
| Advertising and promotion | $696,848 | $639,774 | $57,074 | - | 0.3% | |
| Other (as described) | STIPENDS | $518,010 | $517,610 | $400 | - | 0.3% |
| Conferences, conventions and meetings | $406,379 | $332,801 | $69,534 | $4,044 | 0.2% | |
| Fees: accounting | $343,044 | $70,000 | $273,044 | - | 0.2% | |
| Other (as described) | EQUIPMENT RENTAL | $274,664 | $208,594 | $58,615 | $7,455 | 0.1% |
| Fees: investment management | $200,000 | - | $200,000 | - | 0.1% | |
| Royalties | $95,642 | $85,642 | $10,000 | - | 0.0% | |
| Fees: lobbying | $56,165 | - | $56,165 | - | 0.0% | |
| Fundraising events Event | direct expenses; gross income - | $126,078 | reported apart | |||
| Total | $202,952,186 | 100% |
2010 · Form 990 · $182,182,332 spent · pay $101,918,122 · grants $0 · events $860,691
| Line | As described | Total | Program | Management | Fundraising | Share |
|---|---|---|---|---|---|---|
| Other salaries and wages | $72,738,902 | $61,814,706 | $9,823,522 | $1,100,674 | 39.9% | |
| Other (as described) | SUPPLIES | $24,826,714 | $24,282,648 | $456,234 | $87,832 | 13.6% |
| Depreciation and depletion | $17,628,798 | $15,307,067 | $2,210,521 | $111,210 | 9.7% | |
| Other employee benefits | $14,765,798 | $13,198,497 | $1,335,640 | $231,661 | 8.1% | |
| Occupancy | $11,907,011 | $10,703,492 | $1,164,372 | $39,147 | 6.5% | |
| Pension plan contributions | $5,624,204 | $5,073,249 | $460,080 | $90,875 | 3.1% | |
| Payroll taxes | $5,413,504 | $4,599,267 | $732,342 | $81,895 | 3.0% | |
| Other (as described) | OTHER EXPENSES | $5,214,500 | $5,189,905 | $23,425 | $1,170 | 2.9% |
| Interest | $3,519,314 | $3,487,934 | $29,891 | $1,489 | 1.9% | |
| Travel | $3,429,977 | $2,699,605 | $659,960 | $70,412 | 1.9% | |
| Fees: other services | $3,407,611 | $1,998,965 | $1,397,937 | $10,709 | 1.9% | |
| Pay: officers, directors, trustees, key employees | $3,375,714 | $394,166 | $2,981,548 | - | 1.9% | |
| Information technology | $2,670,229 | $2,318,557 | $335,597 | $16,075 | 1.5% | |
| Office expenses | $1,720,694 | $1,259,253 | $438,606 | $22,835 | 0.9% | |
| Fees: legal | $1,357,000 | $27,604 | $1,329,396 | - | 0.7% | |
| Insurance | $1,194,779 | $1,050,381 | $137,798 | $6,600 | 0.7% | |
| Other (as described) | OTHER SERVICES | $992,890 | $915,836 | $73,297 | $3,757 | 0.5% |
| Conferences, conventions and meetings | $738,973 | $495,500 | $231,824 | $11,649 | 0.4% | |
| Other (as described) | STIPENDS | $622,018 | $622,018 | - | - | 0.3% |
| Advertising and promotion | $424,033 | $323,004 | $97,843 | $3,186 | 0.2% | |
| Fees: investment management | $200,000 | - | $200,000 | - | 0.1% | |
| Fees: accounting | $183,156 | - | $183,156 | - | 0.1% | |
| Other (as described) | EQUIPMENT RENTAL | $159,712 | $110,584 | $46,792 | $2,336 | 0.1% |
| Fees: lobbying | $66,801 | - | $66,801 | - | 0.0% | |
| Fundraising events Event | direct expenses; gross income - | $121,718 | reported apart | |||
| Total | $182,182,332 | 100% |
2009 · Form 990 · $170,507,361 spent · pay $96,734,994 · grants $0 · events $701,825
| Line | As described | Total | Program | Management | Fundraising | Share |
|---|---|---|---|---|---|---|
| Other salaries and wages | $67,955,012 | $57,841,759 | $9,143,129 | $970,124 | 39.9% | |
| Other (as described) | SUPPLIES | $22,765,970 | $21,236,423 | $1,529,547 | - | 13.4% |
| Depreciation and depletion | $18,758,068 | $16,889,471 | $1,754,662 | $113,935 | 11.0% | |
| Other employee benefits | $13,519,887 | $10,734,995 | $2,602,011 | $182,881 | 7.9% | |
| Occupancy | $9,924,287 | $9,313,216 | $565,565 | $45,506 | 5.8% | |
| Pension plan contributions | $5,756,887 | $5,189,652 | $478,635 | $88,600 | 3.4% | |
| Payroll taxes | $5,347,490 | $4,551,648 | $719,500 | $76,342 | 3.1% | |
| Other (as described) | OTHER EXPENSES | $5,088,763 | $4,877,093 | $211,529 | $141 | 3.0% |
| Pay: officers, directors, trustees, key employees | $4,155,718 | $1,105,938 | $3,049,780 | - | 2.4% | |
| Interest | $3,669,632 | $3,659,611 | $10,021 | - | 2.2% | |
| Travel | $2,910,142 | $2,454,820 | $294,402 | $160,920 | 1.7% | |
| Fees: other services | $2,396,271 | $2,146,933 | $245,665 | $3,673 | 1.4% | |
| Information technology | $2,166,991 | $1,884,100 | $269,728 | $13,163 | 1.3% | |
| Advertising and promotion | $1,203,024 | $923,742 | $269,641 | $9,641 | 0.7% | |
| Insurance | $1,148,688 | $1,006,873 | $135,216 | $6,599 | 0.7% | |
| Other (as described) | OTHER SERVICES | $796,075 | $705,361 | $90,714 | - | 0.5% |
| Office expenses | $688,863 | $497,545 | $182,995 | $8,323 | 0.4% | |
| Other (as described) | STIPENDS | $673,158 | $673,158 | - | - | 0.4% |
| Conferences, conventions and meetings | $531,365 | $392,263 | $138,842 | $260 | 0.3% | |
| Other (as described) | EQUIPMENT RENTAL | $443,364 | $346,599 | $94,951 | $1,814 | 0.3% |
| Fees: legal | $283,387 | $9,242 | $274,119 | $26 | 0.2% | |
| Fees: accounting | $280,156 | - | $280,156 | - | 0.2% | |
| Fees: lobbying | $44,163 | - | $44,163 | - | 0.0% | |
| Fundraising events Event | direct expenses; gross income - | $170,460 | reported apart | |||
| Total | $170,507,361 | 100% |
Federal lobbying
Lobbying Disclosure Act reports naming a client or registrant with this organization's name and state. Spent: what lobbying for it cost (firm income plus its own reported expenses). Earned: income it reported as a lobbying firm.
| Year | Spent | Earned | Reports |
|---|---|---|---|
| 2026 | $180,000 | 6 | |
| 2025 | $170,000 | 7 | |
| 2024 | $120,000 | 4 | |
| 2023 | $157,500 | 9 | |
| 2022 | $120,000 | 4 | |
| 2021 | $120,000 | 4 | |
| 2020 | $120,000 | 4 | |
| 2019 | $120,000 | 4 | |
| 2018 | $160,000 | 4 | |
| 2017 | $40,000 | 2 | |
| 2014 | $50,000 | 3 | |
| 2011 | $40,000 | 2 | |
| 2010 | $40,000 | 4 | |
| 2009 | $90,000 | 4 | |
| 2008 | $60,000 | 4 | |
| 2007 | $40,000 | 2 | |
| 2006 | $80,000 | 2 | |
| 2005 | $60,000 | 2 | |
| 2004 | $40,000 | 2 | |
| 2002 | $80,000 | 1 | |
| 2001 | 2 |
Issues: Health Issues, Medical/Disease Research/Clinical Labs, Budget/Appropriations, Agriculture, Animals, Defense, Transportation, Immigration, Energy/Nuclear, Law Enforcement/Crime/Criminal Justice, Aviation/Airlines/Airports
Firms hired: THE JACKSON LABORATORY, K&L GATES, LLP, TWENTY-FIRST CENTURY GROUP, INC., THE PETRIZZO GROUP, INC., DONOVAN STRATEGIES LLC
Federal grants and contracts
Awards from USAspending.gov to a recipient with this organization's name and zip code. Obligations by federal fiscal year (October to September); each award links to its page on usaspending.gov.
| Fiscal year | Grants and other assistance | Contracts | Awards |
|---|---|---|---|
| 2026 | $83,644,524 | $2,623,029 | 162 |
| 2025 | $106,477,016 | $1,392,406 | 163 |
| 2024 | $89,955,079 | $6,354,690 | 181 |
| 2023 | $78,426,865 | $4,916,698 | 168 |
| 2022 | $78,368,606 | $5,461,363 | 199 |
| 2021 | $73,518,378 | $5,192,666 | 181 |
| 2020 | $74,761,903 | $5,702,686 | 174 |
| 2019 | $80,240,776 | $3,027,916 | 154 |
| 2018 | $74,321,553 | $1,901,081 | 225 |
| 2017 | $65,610,324 | $2,606,612 | 243 |
| 2016 | $54,247,929 | $2,813,110 | 203 |
| 2015 | $60,501,607 | $2,553,313 | 218 |
| 2014 | $52,230,718 | $1,482,601 | 111 |
| 2013 | $50,523,523 | $1,641,686 | 128 |
| 2012 | $52,612,122 | $1,956,402 | 134 |
| 2011 | $51,741,228 | $2,649,077 | 153 |
| 2010 | $51,347,516 | -$6,924,762 | 148 |
| 2009 | $53,482,114 | $3,041,665 | 143 |
| 2008 | $35,635,665 | $2,674,463 | 808 |
| 2007 | $20,526,396 | $7,776,766 | 689 |
Largest awards · 200 shown
| Year | Agency | Kind | Program | Description | Obligated |
|---|---|---|---|---|---|
| 2026 | National Institutes of Health | Grant or other assistance | HUMAN GENOME RESEARCH 93.172 | MOUSE GENOME DATABASE (MGD): A CORE KNOWLEDGE RESOURCE FOR FUNCTIONAL CHARACTERIZATION OF THE HUMAN GENOME - PROJECT SUMMARY AS THE COST OF GENOME-SCALE SEQUENC | $6,720,141 |
| 2026 | National Institutes of Health | Grant or other assistance | TRANS-NIH RESEARCH SUPPORT 93.310 | PRECLINICAL GENOME EDITING FOR RARE NEUROLOGICAL DISEASES - PROJECT SUMMARY OVERALL WHILE THE DEVELOPMENT OF HIGH-THROUGHPUT SEQUENCING TECHNOLOGY AND ITS APPLI | $5,934,549 |
| 2026 | Health Resources and Services Administration | Grant or other assistance | CONGRESSIONAL DIRECTIVES 93.493 | JAX NYSCF CENTER FOR PRECISION MEDICINE AND STEM CELL AUTOMATION - THE JACKSON LABORATORY NEW YORK STEM CELL FOUNDATION (JAX-NYSCF) MANHATTAN CAMPUS IS HOME TO | $5,000,000 |
| 2026 | National Institutes of Health | Grant or other assistance | HUMAN GENOME RESEARCH 93.172 | THE HUMAN PHENOTYPE ONTOLOGY: ACCELERATING COMPUTATIONAL INTEGRATION OF CLINICAL DATA FOR GENOMICS - PROJECT SUMMARY/ABSTRACT TO IMPROVE DIAGNOSTIC YIELD FOR RA | $2,922,568 |
| 2026 | Health Resources and Services Administration | Grant or other assistance | CONGRESSIONAL DIRECTIVES 93.493 | THE JACKSON LABORATORY MAJOR RESEARCH INSTRUMENTATION FOR BIOMEDICAL IMAGING AND MICROSCOPY - THE JACKSON LABORATORY MAJOR RESEARCH EQUIPMENT FOR BIOMEDICAL IMA | $2,679,000 |
| 2026 | National Institutes of Health | Grant or other assistance | ALLERGY AND INFECTIOUS DISEASES RESEARCH 93.855 | MODULATION OF LUNG IMMUNE RESPONSES TO VIRAL INFECTION | $2,637,774 |
| 2026 | National Institutes of Health | Grant or other assistance | DRUG USE AND ADDICTION RESEARCH PROGRAMS 93.279 | CENTER FOR SYSTEMS NEUROGENETICS OF ADDICTION | $2,419,183 |
| 2026 | National Institutes of Health | Grant or other assistance | ORAL DISEASES AND DISORDERS RESEARCH 93.121 | THE JACKSON LABORATORY KNOCKOUT MOUSE PRODUCTION AND PHENOTYPING PROJECT (JAX KOMP2) | $2,392,254 |
| 2026 | National Institutes of Health | Grant or other assistance | CHILD HEALTH AND HUMAN DEVELOPMENT EXTRAMURAL RESEARCH 93.865 | GENE EXPRESSION DATABASE FOR MOUSE DEVELOPMENT | $2,234,043 |
| 2026 | National Institutes of Health | Grant or other assistance | CANCER CENTERS SUPPORT GRANTS 93.397 | CANCER CENTER SUPPORT (CORE) GRANT | $2,230,200 |
| 2026 | National Institutes of Health | Grant or other assistance | RESEARCH INFRASTRUCTURE PROGRAMS 93.351 | THE JACKSON LABORATORY CENTER FOR PRECISION GENETICS | $2,188,748 |
| 2026 | National Institutes of Health | Grant or other assistance | ADVANCED RESEARCH PROJECTS AGENCY FOR HEALTH (ARPA-H) 93.384 | CARDIOVERSE: COMPREHENSIVE ASSESSMENT OF CARDIAC RISK THROUGH DATA-DRIVEN IN-SILICO VIRTUAL ECOSYSTEMS FOR SAFETY EVALUATION | $1,974,082 |
| 2026 | National Institutes of Health | Grant or other assistance | HUMAN GENOME RESEARCH 93.172 | JAX MORPHIC DATA PRODUCTION CENTER - PROJECT SUMMARY THIS PROPOSAL WILL ESTABLISH A MOLECULAR PHENOTYPES OF NULL ALLELES IN CELLS (MORPHIC) PHASE 1: DATA PRODUC | $1,874,508 |
| 2026 | National Institutes of Health | Grant or other assistance | AGING RESEARCH 93.866 | INTERVENTIONS THAT RETARD MAMMALIAN AGING | $1,770,000 |
| 2026 | National Institutes of Health | Contract | RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY) 541714 | VALIDATION AND OPTIMIZATION OF ONE-STEP TAGGING IN HUMAN INDUCED PLURIPOTENT STEM CELLS | $1,673,413 |
| 2026 | National Institutes of Health | Grant or other assistance | HUMAN GENOME RESEARCH 93.172 | GENOME TECHNOLOGIES COORDINATING CENTER - PROJECT SUMMARY THE GENOME TECHNOLOGY PORTFOLIO AT NHGRI ENCOMPASSES A SUBSTANTIAL DIVERSITY OF SCIENTIFIC APPROACHES | $1,499,962 |
| 2026 | National Institutes of Health | Grant or other assistance | AGING RESEARCH 93.866 | SHOCK CENTER FOR AGING RESEARCH AT THE JACKSON LABORATORY | $1,459,793 |
| 2026 | National Institutes of Health | Grant or other assistance | RESEARCH INFRASTRUCTURE PROGRAMS 93.351 | ESTABLISHING A MUTANT MOUSE REGIONAL RESOURCE CENTER AT THE JACKSON LABORATORY | $1,296,980 |
| 2026 | National Institutes of Health | Grant or other assistance | RESEARCH INFRASTRUCTURE PROGRAMS 93.351 | SPECIAL MOUSE STRAINS RESOURCE | $1,150,663 |
| 2026 | National Institutes of Health | Grant or other assistance | DRUG USE AND ADDICTION RESEARCH PROGRAMS 93.279 | MOUSE PHENOME PROJECT | $1,061,993 |
| 2026 | National Institutes of Health | Grant or other assistance | EXTRAMURAL RESEARCH PROGRAMS IN THE NEUROSCIENCES AND NEUROLOGICAL DISORDERS 93.853 | THE GENETICS OF THE NEUROMUSCULAR JUNCTION: MECHANISMS AND DISEASE MODELS | $1,032,326 |
| 2026 | National Institutes of Health | Grant or other assistance | ALLERGY AND INFECTIOUS DISEASES RESEARCH 93.855 | TRAINED IMMUNITY SIGNATURES OF REDUCED VACCINE RESPONSES IN OLDER ADULTS - PROJECT SUMMARY AGING LEADS TO WIDESPREAD CHANGES IN THE IMMUNE SYSTEM, INCLUDING INC | $932,993 |
| 2026 | National Institutes of Health | Grant or other assistance | ALLERGY AND INFECTIOUS DISEASES RESEARCH 93.855 | A DEEP LONGITUDINAL ANALYSIS OF NEXT GENERATION INFLUENZA VACCINES IN OLDER ADULTS - PROJECT SUMMARY THE WHO ESTIMATES THAT ANNUAL EPIDEMICS OF INFLUENZA RESULT | $919,804 |
| 2026 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | GENETIC PROGRAMMING OF HUMAN ISLET METABOLIC AND ENDOPLASMIC RETICULUM (ER) STRESS RESPONSES IN DIABETES - PROJECT SUMMARY TYPE 2 DIABETES (T2D) RESULTS FROM FA | $891,736 |
| 2026 | National Institutes of Health | Grant or other assistance | HUMAN GENOME RESEARCH 93.172 | GENERATIVE AI APPROACH TO ENCODE CELL-TYPE-SPECIFIC CHROMATIN ACCESSIBILITY AND GENE EXPRESSION - PROJECT SUMMARY UNDERSTANDING AND CONTROLLING GENE REGULATION | $888,829 |
| 2026 | National Institutes of Health | Grant or other assistance | RESEARCH INFRASTRUCTURE PROGRAMS 93.351 | A NOVEL WILD-DERIVED DIVERSITY MOUSE POPULATION FOR PRECISION MAPPING AND SYSTEMS GENETICS - PROJECT SUMMARY INBRED MOUSE STRAINS ARE INTEGRAL TOOLS FOR BOTH PR | $885,913 |
| 2026 | National Institutes of Health | Grant or other assistance | CARDIOVASCULAR DISEASES RESEARCH 93.837 | TYPE I INTERFERON RESPONSES IN THE PATHOBIOLOGY OF ANTHRACYCLINE-INDUCED CARDIOTOXICITY | $882,234 |
| 2026 | National Institutes of Health | Grant or other assistance | AGING RESEARCH 93.866 | BUILDING A SPATIAL TRANSCRIPTOMICS INFRASTRUCTURE FOR ISOFORM PROFILING IN AGING PRE-NEOPLASTIC TISSUES - PROJECT SUMMARY/ABSTRACT AGING IS THE GREATEST RISK FA | $834,699 |
| 2026 | National Institutes of Health | Grant or other assistance | DRUG USE AND ADDICTION RESEARCH PROGRAMS 93.279 | GENETIC AND MICROBIOME CONTROL OF ADDICTION-LIKE BEHAVIORS IN MICE - PROJECT SUMMARY THE RESEARCH PROPOSAL ADDRESSES THE URGENT NEED FOR PREDICTIVE BIOMARKERS | $805,077 |
| 2026 | National Institutes of Health | Grant or other assistance | AGING RESEARCH 93.866 | DECONSTRUCTION OF A HYPOTHALAMIC EXERCISE-RESPONSIVE CIRCUIT FOR NEUROPROTECTION - PROJECT SUMMARY EXERCISE SLOWS THE COGNITIVE DECLINES ASSOCIATED WITH AGING A | $803,594 |
| 2026 | National Institutes of Health | Grant or other assistance | ORAL DISEASES AND DISORDERS RESEARCH 93.121 | DEVELOPMENTAL SYSTEMS GENOMICS OF MORPHOGENETIC TIMING AND FACIAL SHAPE VARIATION - PROJECT SUMMARY THE OBJECTIVE OF THIS PROPOSAL IS TO ELUCIDATE THE COMPLEX G | $795,730 |
| 2026 | National Institutes of Health | Grant or other assistance | ORAL DISEASES AND DISORDERS RESEARCH 93.121 | PREDICTING TISSUE SPECIFIC GLI3 REGULATORY ACTIVITY USING HAND2 - PROJECT SUMMARY THE HEDGEHOG (HH) SIGNALING PATHWAY IS ESSENTIAL FOR NORMAL EMBRYONIC DEVELOPM | $757,088 |
| 2026 | National Institutes of Health | Grant or other assistance | CHILD HEALTH AND HUMAN DEVELOPMENT EXTRAMURAL RESEARCH 93.865 | INCREASING THE YIELD AND UTILITY OF PEDIATRIC GENOMIC MEDICINE WITH EXOMISER - PROJECT SUMMARY AS MUCH AS 10% OF THE POPULATION SUFFERS FROM A RARE DISEASE (RD) | $751,739 |
| 2026 | National Institutes of Health | Contract | RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY) 541714 | THE SCOPE OF THIS CONTRACT WILL BE TO PRODUCE, MAINTAIN, AND DISTRIBUTE ANEUPLOID MICE WITH A PRIMARY EMPHASIS ON MODELS OF HUMAN TRISOMY FOR CHROMOSOME 21. SEV | $749,999 |
| 2026 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | TYPE 2 DIABETES RISK VARIANT EFFECTS ON MITOCHONDRIAL (PATHO)PHYSIOLOGY - PROJECT SUMMARY / ABSTRACT TYPE 2 DIABETES (T2D) RESULTS WHEN PANCREATIC ISLET SS-CELL | $740,706 |
| 2026 | National Institutes of Health | Grant or other assistance | CHILD HEALTH AND HUMAN DEVELOPMENT EXTRAMURAL RESEARCH 93.865 | FUNCTIONAL VALIDATION OF NOVEL VARIANTS ASSOCIATED WITH CONGENITAL DIAPHRAGMATIC HERNIA - PROJECT SUMMARY/ABSTRACT CONGENITAL DIAPHRAGMATIC HERNIA (CDH) IS A CO | $737,356 |
| 2026 | National Institutes of Health | Grant or other assistance | CANCER BIOLOGY RESEARCH 93.396 | DISCOVERY OF HOST GENETIC ELEMENTS AFFECTING RESPONSE TO IMMUNE CHECKPOINT INHIBITORS - PROJECT SUMMARY ABROGATING IMMUNE CHECKPOINT CONTROL HAS PROVEN TO BE A | $735,877 |
| 2026 | National Institutes of Health | Grant or other assistance | VISION RESEARCH 93.867 | ROLE OF ARMS2 MUTATIONS IN AGE-RELATED MACULAR DEGENERATION - PROJECT SUMMARY/ABSTRACT GENOME-WIDE ASSOCIATION (GWA) AND LINKAGE STUDIES HAVE IDENTIFIED >50 GEN | $733,431 |
| 2026 | National Institutes of Health | Grant or other assistance | EXTRAMURAL RESEARCH PROGRAMS IN THE NEUROSCIENCES AND NEUROLOGICAL DISORDERS 93.853 | CAT-TAILS: A NOVEL TYPE OF PROTEIN MODIFICATION IMPLICATED IN NEURODEGENERATION | $732,471 |
| 2026 | National Institutes of Health | Grant or other assistance | TRANS-NIH RESEARCH SUPPORT 93.310 | SHORT COURSE ON METHODS FOR MULTIOMICS DATA ANALYSIS - PROJECT SUMMARY / ABSTRACT LARGE-SCALE MOLECULAR DATASETS HAVE GREAT POTENTIAL TO YIELD NEW BIOLOGICAL DI | $728,495 |
| 2026 | National Institutes of Health | Grant or other assistance | AGING RESEARCH 93.866 | GENETIC DISSECTION OF MICROGLIA FUNCTIONS IN COMPLEMENT-MEDIATED SYNAPSE LOSS IN ALZHEIMER S DISEASE - PROJECT SUMMARY MICROGLIA ARE THE MACROPHAGES OF THE BRAI | $716,579 |
| 2026 | National Institutes of Health | Grant or other assistance | CANCER TREATMENT RESEARCH 93.395 | DATA COORDINATION CENTER FOR PDX NET | $712,216 |
| 2026 | National Institutes of Health | Grant or other assistance | CANCER BIOLOGY RESEARCH 93.396 | PRE-LEUKEMIC HEMATOPOIETIC STEM CELL CLONAL SELECTION BY THE ADAPTIVE IMMUNE SYSTEM - PROJECT SUMMARY/ABSTRACT A LACK OF PROVEN INTERVENTIONS TO PREVENT LEUKEMI | $704,636 |
| 2026 | National Institutes of Health | Grant or other assistance | VISION RESEARCH 93.867 | RETINAL DISEASE: MOLECULAR BASIS AND PATHOPHYSIOLOGY | $699,455 |
| 2026 | National Institutes of Health | Grant or other assistance | AGING RESEARCH 93.866 | MACHINE LEARNING BASED FRAILTY INDEX FOR THE GENETICALLY DIVERSE MICE - PROJECT SUMMARY AGING IS A TERMINAL PROCESS THAT AFFECTS ALL BIOLOGICAL SYSTEMS. BIOLOGI | $667,286 |
| 2026 | National Institutes of Health | Grant or other assistance | CANCER BIOLOGY RESEARCH 93.396 | SITE-SPECIFIC INTEGRATION OF LARGE (10-100 KB) DNA CONSTRUCTS INTO THE MOUSE GENOME AND HUMAN INDUCED PLURIPOTENT STEM CELLS USING THE CAS9-BXB1 INTEGRASE TOOLB | $660,883 |
| 2026 | National Institutes of Health | Grant or other assistance | VISION RESEARCH 93.867 | IDENTIFYING MECHANISTIC PATHWAYS UNDERLYING RPE PATHOGENESIS IN MODELS OF PATTERN DYSTROPHY - PROJECT SUMMARY/ABSTRACT THE RETINAL PIGMENT EPITHELIUM (RPE) PLAY | $658,790 |
| 2026 | National Institutes of Health | Grant or other assistance | EXTRAMURAL RESEARCH PROGRAMS IN THE NEUROSCIENCES AND NEUROLOGICAL DISORDERS 93.853 | FUNCTIONAL ALLOCATION IN CIRCUIT REPAIR AFTER STROKE - PROJECT SUMMARY / ABSTRACT STROKE CAUSES LONG-TERM DEFICITS IN MOTOR FUNCTION, MAKING IT THE LEADING CAUS | $653,098 |
| 2026 | National Institutes of Health | Grant or other assistance | RESEARCH RELATED TO DEAFNESS AND COMMUNICATION DISORDERS 93.173 | HAIR CELL POLARIZATION AND SENSORY BUNDLE DEVELOPMENT | $640,063 |
| 2026 | National Institutes of Health | Grant or other assistance | VISION RESEARCH 93.867 | GENETIC MODIFIERS OF RETINAL DISEASE | $616,564 |
| 2026 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | DEVELOPING EFFECTIVE APPROACHES TO EXTEND HEMATOPOIETIC HEALTHSPAN BY TARGETING CELL-EXTRINSIC AND CELL-INTRINSIC ALTERATIONS AT MIDDLE AGE | $608,811 |
| 2026 | National Institutes of Health | Grant or other assistance | CANCER BIOLOGY RESEARCH 93.396 | LUNG RESIDENT MESENCHYMAL CELLS IN THE PRE-METASTATIC NICHE FORMATION - PROJECT SUMMARY/ABSTRACT METASTATIC DISEASE REMAINS THE MAJOR CAUSE OF CANCER-RELATED DE | $572,036 |
| 2026 | National Institutes of Health | Grant or other assistance | HUMAN GENOME RESEARCH 93.172 | MULTI-OMIC PHENOTYPING OF HUMAN TRANSCRIPTIONAL REGULATORS - PROJECT SUMMARY THE MOLECULAR PHENOTYPES OF NULL ALLELES IN CELLS (MORPHIC) PROGRAM IS USING MULTIP | $545,877 |
| 2026 | National Institutes of Health | Grant or other assistance | CANCER BIOLOGY RESEARCH 93.396 | INVESTIGATING THE ROLE OF ZBTB7A IN AML DIFFERENTIATION - THE PROPOSED ANIMAL STUDIES ARE ESSENTIAL TO EVALUATE THE IN VIVO EFFECTS OF AML ENGRAFTMENT, DISEASE | $543,984 |
| 2026 | National Institutes of Health | Grant or other assistance | BIOMEDICAL RESEARCH AND RESEARCH TRAINING 93.859 | EMPOWERING FACULTY TO CREATE COURSE-BASED UNDERGRADUATE TRANSLATIONAL 'OMICS RESEARCH EXPERIENCES - PROJECT SUMMARY/ABSTRACT THE EMPOWERING FACULTY TO CREATE CO | $514,561 |
| 2026 | National Institutes of Health | Grant or other assistance | BIOMEDICAL RESEARCH AND RESEARCH TRAINING 93.859 | EVOLUTIONARY GENOMICS OF FUNCTIONAL CHROMATIN DOMAINS | $506,220 |
| 2026 | National Institutes of Health | Grant or other assistance | BIOMEDICAL RESEARCH AND RESEARCH TRAINING 93.859 | CELLULAR SYSTEMS GENETIC APPROACHES TO UNDERSTANDING REGULATORY VARIATION | $506,220 |
| 2026 | National Institutes of Health | Grant or other assistance | AGING RESEARCH 93.866 | AGE-STRATIFIED HUMAN GUT-ON-A-CHIP MODEL TO STUDY MICROBIOME-MEDIATED EPITHELIAL AGING - PROJECT SUMMARY/ABSTRACT AGING OF THE HUMAN GUT IS ACCOMPANIED BY IMPAI | $506,000 |
| 2026 | National Institutes of Health | Grant or other assistance | BIOMEDICAL RESEARCH AND RESEARCH TRAINING 93.859 | DECODING THE INTERPLAY BETWEEN QKI AND M7G METHYLATION ON 3'UTR - PROJECT SUMMARY POST-TRANSCRIPTIONAL REGULATION IS A CRITICAL MECHANISM CONTROLLING CELLULAR D | $506,000 |
| 2026 | National Institutes of Health | Grant or other assistance | AGING RESEARCH 93.866 | ENGINEERING A HUMAN GLIAL-NEURONAL MICROPHYSIOLOGICAL SYSTEM TO STUDY MYELINATION AND AXONAL-SYNAPTIC PATHOLOGY IN ALZHEIMER'S DISEASE - PROJECT SUMMARY AXONOPA | $486,750 |
| 2026 | National Institutes of Health | Grant or other assistance | RESEARCH INFRASTRUCTURE PROGRAMS 93.351 | DEVELOPING IMPROVED REPORTER MOUSE MODELS FOR IN VIVO GENE EDITING - PROJECT SUMMARY CRISPR-CAS9 TECHNOLOGIES HAVE REVOLUTIONIZED GENETIC ENGINEERING AND HAVE L | $486,750 |
| 2026 | National Institutes of Health | Grant or other assistance | BIOMEDICAL RESEARCH AND RESEARCH TRAINING 93.859 | DEVELOPING A MULTI-ORGAN MULTI-OMICS COMPUTATIONAL FRAMEWORK FOR STUDYINGMAMMALIAN IRON SYSTEMS BIOLOGY - PROJECT SUMMARY/ABSTRACT IRON DISORDERS ARE CAUSED BY | $486,750 |
| 2026 | National Science Foundation | Grant or other assistance | BIOLOGICAL SCIENCES 47.074 | REU SITE RENEWAL: FUNCTIONAL GENOMICS RESEARCH FOR UNDERGRADUATES -THIS REU SITE AWARD TO THE JACKSON LABORATORY (JAX), LOCATED IN BAR HARBOR, ME, WILL SUPPORT | $465,000 |
| 2026 | National Institutes of Health | Grant or other assistance | CANCER BIOLOGY RESEARCH 93.396 | ADVANCING AND VALIDATING SINGLE-CELL LONG-READ SEQUENCING FOR BROAD ADOPTION IN CANCER MOLECULAR PROFILING - PROJECT SUMMARY/ABSTRACT THE FUTURE OF PERSONALIZED | $452,458 |
| 2026 | National Institutes of Health | Grant or other assistance | CHILD HEALTH AND HUMAN DEVELOPMENT EXTRAMURAL RESEARCH 93.865 | DISARMING THE IMMUNOLOGICAL BARRIERS TO REGENERATION IN MAMMALS - PROJECT SUMMARY/ABSTRACT THE LONG-TERM GOAL OF THIS WORK IS TO FACILITATE THE FAITHFUL REGENER | $447,042 |
| 2026 | National Institutes of Health | Grant or other assistance | EXTRAMURAL RESEARCH PROGRAMS IN THE NEUROSCIENCES AND NEUROLOGICAL DISORDERS 93.853 | INTERROGATION OF NEUROLOGICAL PATHOLOGIES ASSOCIATED WITH MUTATIONS IN KIF1A - PROJECT SUMMARY KAND (KIF1A-ASSOCIATED NEUROLOGICAL DISORDER) IS CAUSED BY MUTATI | $433,867 |
| 2026 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | CELLULAR AND GENETIC MECHANISMS OF AUTOIMMUNE DIABETES ASSOCIATED NEURITIS - PROJECT SUMMARY TYPE 1 DIABETES (T1D) IS OFTEN ACCOMPANIED BY OTHER AUTOIMMUNE DISO | $424,704 |
| 2026 | National Institutes of Health | Grant or other assistance | CANCER TREATMENT RESEARCH 93.395 | PEDIATRIC ONCOLOGY IN VIVO TESTING PROGRAM COORDINATING CENTER - PROJECT SUMMARY THE OVERARCHING GOAL OF NCI'S PEDIATRIC IN VIVO TESTING PROGRAM (PED-IN VIVO-TP | $403,496 |
| 2026 | National Institute of Standards and Technology | Grant or other assistance | CONGRESSIONALLY-IDENTIFIED PROJECTS 11.617 | PURPOSE: THE PURPOSE OF THIS PROJECT IS TO ACQUIRE A STATE-OF-THE-ART DESKTOP IN VIVO MICRO-COMPUTED TOMOGRAPHY (MICRO-CT) IMAGING SYSTEM TO SUPPORT TRANSLATION | $401,898 |
| 2026 | National Institutes of Health | Grant or other assistance | CANCER TREATMENT RESEARCH 93.395 | THE ROLE OF LUNG RESIDENT MESENCHYMAL STEM CELLS IN POST-CHEMOTHERAPY LUNG METASTASES OF BREAST CANCER | $390,969 |
| 2026 | National Institutes of Health | Contract | ALL OTHER PROFESSIONAL, SCIENTIFIC, AND TECHNICAL SERVICES 541990 | IPSC GENERATION AND BETA CELL DIFFERENTIATION | $361,950 |
| 2026 | National Institutes of Health | Grant or other assistance | AGING RESEARCH 93.866 | MOUSE PHENOME DATABASE: NIA INTERVENTIONS TESTING PROGRAM DATA COORDINATING CENTER | $354,000 |
| 2026 | National Institutes of Health | Grant or other assistance | AGING RESEARCH 93.866 | DISCOVERY OF DISEASE-ASSOCIATED EQTLS WITH A SCALABLE HUMAN IN VITRO MODEL OF MICROGLIA-ASTROCYTE INTERACTIONS - PROJECT SUMMARY DEMENTIAS ARE PROJECTED TO BECO | $354,000 |
| 2026 | National Institutes of Health | Contract | ALL OTHER ANIMAL PRODUCTION 112990 | PROVISIONS FOR BARRIER REARED AND MAINTAINED, RATS, MICE, HAMSTERS, GERBILS, AND SPECIALIZED ANIMAL SERVICES | $290,000 |
| 2026 | National Institutes of Health | Grant or other assistance | AGING RESEARCH 93.866 | TRAINING PROGRAM IN PRECISION GENETICS OF AGING, ALZHEIMER'S DISEASE AND RELATED DEMENTIAS | $269,738 |
| 2026 | National Institutes of Health | Contract | ALL OTHER ANIMAL PRODUCTION 112990 | THIS FUNDING SHALL BE USED TO ACQUIRE THE FOLLOWING AS SPECIFIED IN THE SUBMITTED CATALOG AND/OR PRICE LIST: VARIOUS STRAINS AND STOCKS OF BARRIER REARED RODENT | $265,000 |
| 2026 | National Institutes of Health | Contract | BIOLOGICAL PRODUCT (EXCEPT DIAGNOSTIC) MANUFACTURING 325414 | THE INDI PROJECT IS A LARGE-SCALE GENOME ENGINEERING EFFORT EMBEDDED WITHIN CARD TO GENERATE DISEASE-RELEVANT IPSC MODELS FOR NEURODEGENERATIVE DISEASE RESEARCH | $248,905 |
| 2026 | National Institutes of Health | Grant or other assistance | MENTAL HEALTH RESEARCH GRANTS 93.242 | THE SHORT COURSE ON THE APPLICATION OF MACHINE LEARNING FOR AUTOMATED QUANTIFICATION OF BEHAVIOR - PROJECT SUMMARY/ABSTRACT ELUCIDATING THE MECHANISM AND FUNCTI | $208,945 |
| 2026 | National Institutes of Health | Grant or other assistance | CANCER RESEARCH MANPOWER 93.398 | SHORT COURSE ON EXPERIMENTAL MODELS OF HUMAN CANCER | $207,174 |
| 2026 | Department of Veterans Affairs | Contract | ALL OTHER ANIMAL PRODUCTION 112990 | LABORATORY ANIMALS (GENETIC SPECIFIC STRAINS) | $175,000 |
| 2026 | National Institutes of Health | Grant or other assistance | CHILD HEALTH AND HUMAN DEVELOPMENT EXTRAMURAL RESEARCH 93.865 | SHORT COURSE ON MEDICAL AND EXPERIMENTAL MAMMALIAN GENETICS | $155,987 |
| 2026 | National Institutes of Health | Grant or other assistance | HUMAN GENOME RESEARCH 93.172 | THE SHORT COURSE ON SPATIAL TRANSCRIPTOMICS - SPATIAL TRANSCRIPTOMICS (ST) IS A RAPIDLY EVOLVING FIELD WITH GREAT POTENTIAL TO SHAPE OUR UNDERSTANDING OF CELLS | $155,269 |
| 2026 | National Institutes of Health | Grant or other assistance | VISION RESEARCH 93.867 | INTERROGATING MICROGLIA-DRIVEN RETINAL GANGLION CELL AND VASCULAR DYSFUNCTION IN METABOLIC SYNDROME ASSOCIATED RETINOPATHY - PROJECT SUMMARY RETINAL VASCULAR DI | $140,388 |
| 2026 | National Institutes of Health | Grant or other assistance | CANCER RESEARCH MANPOWER 93.398 | DEFINING THE ROLES OF ZBTB7 PARALOGS IN LEUKEMOGENESIS - PROJECT SUMMARY/ABSTRACT DEFECTS IN CELLULAR PROLIFERATION CAN LEAD TO A VARIETY OF DEVELOPMENTAL DISO | $136,687 |
| 2026 | National Institutes of Health | Grant or other assistance | HUMAN GENOME RESEARCH 93.172 | GENOMICS IN ACTION - PROJECT SUMMARY/ABSTRACT THE GOAL OF THIS PROJECT IS TO PROVIDE TRAINING AND EDUCATION IN HUMAN GENOMICS-RELATED TOPICS TO THE ENTRY-LEVEL | $111,707 |
| 2026 | National Institutes of Health | Grant or other assistance | EXTRAMURAL RESEARCH PROGRAMS IN THE NEUROSCIENCES AND NEUROLOGICAL DISORDERS 93.853 | SUMMER RESEARCH EXPERIENCE IN NEUROBIOLOGY | $98,494 |
| 2026 | National Institutes of Health | Grant or other assistance | CANCER RESEARCH MANPOWER 93.398 | SUMMER UNDERGRADUATE RESEARCH FELLOWSHIP IN THE MOLECULAR BIOLOGY AND GENOMICS OF HUMAN CANCER | $98,056 |
| 2026 | National Institutes of Health | Grant or other assistance | RESEARCH RELATED TO DEAFNESS AND COMMUNICATION DISORDERS 93.173 | THE ROLE OF ACO2 IN PROGRESSIVE HEARING LOSS - PROJECT SUMMARY/ABSTRACT DEAFNESS IS A SIGNIFICANT HEALTH CONCERN THAT AFFECTS MORE THAN 450 MILLION PEOPLE WORLD | $79,348 |
| 2026 | National Institutes of Health | Grant or other assistance | RESEARCH RELATED TO DEAFNESS AND COMMUNICATION DISORDERS 93.173 | MODELING HEARING AND BALANCE DISORDERS IN MICE: THE HEAR@JAX WORKSHOP - PROJECT SUMMARY THIS APPLICATION SEEKS PARTIAL SUPPORT FOR “MODELING HEARING AND BALANCE | $59,623 |
| 2026 | National Institutes of Health | Grant or other assistance | AGING RESEARCH 93.866 | COMPUTATIONAL TECHNIQUES AND RESOURCES FOR EFFECTIVE TRANSLATIONAL RESEARCH IN ALZHEIMER'S DISEASE - PROJECT SUMMARY / ABSTRACT ALZHEIMER’S DISEASE (AD) IS A CO | $50,000 |
| 2026 | National Institutes of Health | Contract | TESTING LABORATORIES AND SERVICES 541380 | NIDDK: SERVICE: IN VIVO PHARMACOKINETIC STUDY: NON-SEVERABLE | $38,803 |
| 2026 | National Institutes of Health | Contract | ALL OTHER ANIMAL PRODUCTION 112990 | [26-001981] NHLBI REQUIRES CRYO STORAGE RENEWAL FOR REDERIVATION (MICE CLEANING) PROJECTS IN ORDER TO MAINTAIN FROZEN MOUSE LINES FOR NHLBI INVESTIGATORS FOR US | $34,500 |
| 2026 | National Institutes of Health | Grant or other assistance | AGING RESEARCH 93.866 | ESSENTIAL SKILLS DEVELOPMENT IN THE USE OF THE LABORATORY MOUSE AS A MODEL OF AGING-RELATED DISEASES - PROJECT SUMMARY ADVANCING OUR UNDERSTANDING OF AGING AND | $30,000 |
| 2026 | National Institutes of Health | Contract | ALL OTHER ANIMAL PRODUCTION 112990 | DELIVERY ORDER FOR BARRIER-REARED ANIMALS IN ACCORDANCE WITH THE BASE CONTRACT AND SOW. | $30,000 |
| 2026 | Department of Veterans Affairs | Contract | ALL OTHER ANIMAL PRODUCTION 112990 | SOLE SOURCE AWARD TO UNIVERSITY OF CALIFORNIA IRVINE FOR ANIMAL HUSBANDRY SERVICES FOR THE RESEARCH DEPARTMENT AT THE VA LONG BEACH. | $21,282 |
| 2026 | National Institutes of Health | Grant or other assistance | DRUG USE AND ADDICTION RESEARCH PROGRAMS 93.279 | GROWING THE GENETICS OF ADDICTION WORKFORCE WITH URM FACULTY-STUDENT RESEARCH EXPERIENCES - PROJECT SUMMARY THE JACKSON LABORATORY (JAX) WILL PROVIDE A UNIQUE R | $1 |
| 2026 | National Institutes of Health | Grant or other assistance | BIOMEDICAL RESEARCH AND RESEARCH TRAINING 93.859 | MECHANISMS OF POST-TRANSCRIPTIONAL REGULATION OF SPLICING FACTORS | $0 |
| 2026 | National Institutes of Health | Grant or other assistance | ALLERGY AND INFECTIOUS DISEASES RESEARCH 93.855 | HOW ANTIGEN EXPOSURE SHAPES THE SUBSEQUENT NK CELL RESPONSE TO HIV - THE GOAL OF THIS PROPOSAL IS TO DETERMINE HOW ANTIGEN EXPOSURE SHAPES SUBSEQUENT NATURAL KI | $0 |
| 2026 | National Institutes of Health | Grant or other assistance | AGING RESEARCH 93.866 | ALZHEIMER'S DISEASE-RELATED DEMENTIA MODELS BY PRECISION EDITING AND RELEVANT GENETIC X ENVIRONMENTAL EXPOSURES - PROJECT SUMMARY ALZHEIMER’S DISEASE IS THE MOS | $0 |
| 2026 | National Institutes of Health | Grant or other assistance | ALLERGY AND INFECTIOUS DISEASES RESEARCH 93.855 | TBD | $0 |
| 2026 | National Institutes of Health | Grant or other assistance | CANCER RESEARCH MANPOWER 93.398 | WORKSHOP ON TECHNIQUES IN MODELING HUMAN CANCER IN MICE | $0 |
| 2026 | National Institutes of Health | Grant or other assistance | BIOMEDICAL RESEARCH AND RESEARCH TRAINING 93.859 | CURRICULUM IN EXPERIMENTAL DESIGN AND STATISTICS FOR BIOMEDICAL RESEARCHERS - PROJECT SUMMARY FOR MANY DECADES BIOMEDICAL RESEARCH HAS BENEFITTED FROM EXPERIMEN | $0 |
| 2026 | National Institutes of Health | Grant or other assistance | DRUG USE AND ADDICTION RESEARCH PROGRAMS 93.279 | GENETIC VARIATION IN OPIOID INDUCED RESPIRATORY DEPRESSION IN MICE | $0 |
| 2026 | National Institutes of Health | Grant or other assistance | RESEARCH RELATED TO DEAFNESS AND COMMUNICATION DISORDERS 93.173 | MECHANISM AND FUNCTIONAL SIGNIFICANCE OF POLARITY REVERSAL IN MECHANOSENSORY ORGANS | -$4 |
| 2026 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | B-LYMPHOCYTE TARGETING THERAPIES FOR AUTOIMMUNE DIABETES | -$6 |
| 2026 | National Institutes of Health | Contract | RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY) 541715 | TITLE: REPOSITORY OF MOUSE MODELS FOR CYTOGENETIC RESEARCH | -$7 |
| 2026 | National Institutes of Health | Grant or other assistance | ALLERGY AND INFECTIOUS DISEASES RESEARCH 93.855 | HIGH-RESOLUTION SINGLE CELL PROFILING OF VACCINE RESPONSIVENESS IN THE ELDERLY | -$11 |
| 2026 | National Institutes of Health | Contract | TESTING LABORATORIES AND SERVICES 541380 | LABORATORY AND TESTING SERVICES | -$38 |
| 2026 | National Institutes of Health | Grant or other assistance | TRANS-NIH RESEARCH SUPPORT 93.310 | GENETIC VARIATION OF ULTRA-POTENT SYNTHETIC OPIOID SENSITIVITY IN MICE - PROJECT SUMMARY/ABSTRACT THE WEAPONIZATION OF ULTRAPOTENT SYNTHETIC OPIOIDS (UPS) HAS M | -$81 |
| 2026 | National Institutes of Health | Grant or other assistance | BIOMEDICAL RESEARCH AND RESEARCH TRAINING 93.859 | THE WHOLE SCIENTIST PROGRAM | -$105 |
| 2026 | National Institutes of Health | Grant or other assistance | AGING RESEARCH 93.866 | DLGAP2 AS A REGULATOR OF ALZHEIMER'S DISEASE RELATED COGNITIVE DECLINES VIA SYNAPTIC MODIFICATIONS - PROJECT SUMMARY TO DATE, THERE IS A SIGNIFICANT KNOWLEDGE G | -$297 |
| 2026 | National Institutes of Health | Contract | RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY) 541714 | SERVICE FOR GENERATING 3 MUTANT MOUSE LINES | -$387 |
| 2026 | National Institutes of Health | Contract | ALL OTHER ANIMAL PRODUCTION 112990 | TRANSGENIC MICE | -$586 |
| 2026 | National Institutes of Health | Contract | ALL OTHER ANIMAL PRODUCTION 112990 | JACKSON LAB (AMBIS #2091228) MICE QTY 20 AND SHIPPING CONTAINERS QTY 4 | -$1,008 |
| 2026 | National Institutes of Health | Contract | ALL OTHER PROFESSIONAL, SCIENTIFIC, AND TECHNICAL SERVICES 541990 | SPERM CRYOPRESERVATION | -$1,192 |
| 2026 | National Institutes of Health | Contract | TESTING LABORATORIES AND SERVICES 541380 | PROJECT: STUDY/TESTING: HISTAMINE CHALLENGING IN 12 COLLABORATIVE MICE CROSS STRAINS, HISTAMINE-INDUCED, & DATA RESULTS | -$1,647 |
| 2026 | National Institutes of Health | Grant or other assistance | DRUG USE AND ADDICTION RESEARCH PROGRAMS 93.279 | SHORT COURSE ON THE GENETICS OF ADDICTION | -$2,542 |
| 2026 | National Institutes of Health | Contract | ALL OTHER ANIMAL PRODUCTION 112990 | PROVISIONS FOR BARRIER REARED AND MAINTAINED, RATS, MICE, HAMSTERS, GERBILS AND SPECIALIZED ANIMAL SERVICES. | -$7,601 |
| 2026 | Department of Veterans Affairs | Contract | TESTING LABORATORIES AND SERVICES 541380 | LABORATORY ANIMAL(MICE) | -$7,860 |
| 2026 | National Institutes of Health | Contract | ALL OTHER PROFESSIONAL, SCIENTIFIC, AND TECHNICAL SERVICES 541990 | EMBRYO CRYOPRESERVATION SERVICES | -$7,998 |
| 2026 | National Institutes of Health | Contract | ALL OTHER ANIMAL PRODUCTION 112990 | EMBRYO CRYO AND RECOVERY OF CRYOPRESERVED MICE | -$14,256 |
| 2026 | National Institutes of Health | Grant or other assistance | HUMAN GENOME RESEARCH 93.172 | ETHICAL, LEGAL, SOCIAL, AND POLICY IMPLICATIONS OF WORKPLACE GENOMIC TESTING | -$15,015 |
| 2026 | Food and Drug Administration | Contract | ALL OTHER ANIMAL PRODUCTION 112990 | MICE FOR LABORATORY INVESTIGATIONS | -$15,609 |
| 2026 | National Institutes of Health | Contract | ALL OTHER ANIMAL PRODUCTION 112990 | PROVISIONS FOR BARRIER-REARED ANIMALS AND SPECIALIZED SERVICES POP: 12/16/2020-6/30/2021 | -$17,992 |
| 2026 | Department of Veterans Affairs | Contract | ALL OTHER ANIMAL PRODUCTION 112990 | LABORATORY ANIMAL(MICE) | -$20,506 |
| 2026 | Department of Veterans Affairs | Contract | RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY) 541714 | MICE | -$46,303 |
| 2026 | Department of Veterans Affairs | Contract | ALL OTHER ANIMAL PRODUCTION 112990 | RESEARCH:LAB ANIMALS_________ | -$97,989 |
| 2026 | National Institutes of Health | Grant or other assistance | HUMAN GENOME RESEARCH 93.172 | JAX DIVERSITY ACTION PLAN (DAP) POST-BACCALAUREATE PROGRAM IN GENOMICS (GDAP) - PROJECT SUMMARY/ABSTRACT THE GOAL OF THE JACKSON LABORATORY (JAX) DIVERSITY ACTI | -$302,327 |
| 2026 | National Institutes of Health | Contract | RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY) 541714 | JACKSON LABORATORY:1105789 [20-006752] INDI-PLUS (INDI+), ADDITIONAL ALLELES FOR THE IPSC NEURODEGENERATION INITIATIVE PROJECT | -$1,024,838 |
| 2025 | National Institutes of Health | Grant or other assistance | ADVANCED RESEARCH PROJECTS AGENCY FOR HEALTH (ARPA-H) 93.384 | CARDIOVERSE: COMPREHENSIVE ASSESSMENT OF CARDIAC RISK THROUGH DATA-DRIVEN IN-SILICO VIRTUAL ECOSYSTEMS FOR SAFETY EVALUATION | $23,169,820 |
| 2025 | National Institutes of Health | Grant or other assistance | TRANS-NIH RESEARCH SUPPORT 93.310 | PRECLINICAL GENOME EDITING FOR RARE NEUROLOGICAL DISEASES - PROJECT SUMMARY OVERALL WHILE THE DEVELOPMENT OF HIGH-THROUGHPUT SEQUENCING TECHNOLOGY AND ITS APPLI | $4,319,346 |
| 2025 | National Institutes of Health | Grant or other assistance | TRANS-NIH RESEARCH SUPPORT 93.310 | THE JACKSON LABORATORY SENESCENCE TISSUE MAPPING CENTER (JAX-SEN TMC) - PROJECT SUMMARY/ABSTRACT OVERALL THE JACKSON LABORATORY (JAX) CELLULAR SENESCENCE NETWOR | $2,959,985 |
| 2025 | National Institutes of Health | Grant or other assistance | ALLERGY AND INFECTIOUS DISEASES RESEARCH 93.855 | MODULATION OF LUNG IMMUNE RESPONSES TO VIRAL INFECTION | $2,637,774 |
| 2025 | National Institutes of Health | Grant or other assistance | HUMAN GENOME RESEARCH 93.172 | MOUSE GENOME DATABASE (MGD): A CORE KNOWLEDGE RESOURCE FOR FUNCTIONAL CHARACTERIZATION OF THE HUMAN GENOME - PROJECT SUMMARY AS THE COST OF GENOME-SCALE SEQUENC | $2,488,941 |
| 2025 | National Institutes of Health | Grant or other assistance | VISION RESEARCH 93.867 | THE JACKSON LABORATORY KNOCKOUT MOUSE PRODUCTION AND PHENOTYPING PROJECT (JAX KOMP2) | $2,392,254 |
| 2025 | National Institutes of Health | Grant or other assistance | DRUG USE AND ADDICTION RESEARCH PROGRAMS 93.279 | CENTER FOR SYSTEMS NEUROGENETICS OF ADDICTION | $2,365,171 |
| 2025 | Defense Health Agency | Grant or other assistance | MILITARY MEDICAL RESEARCH AND DEVELOPMENT 12.420 | MAPPING THE RNA SPLICING LANDSCAPE OF NF1 AND ITS IMPACT ON NEUROFIBROMIN FUNCTION ACROSS TISSUES | $2,268,386 |
| 2025 | National Institutes of Health | Grant or other assistance | CHILD HEALTH AND HUMAN DEVELOPMENT EXTRAMURAL RESEARCH 93.865 | GENE EXPRESSION DATABASE FOR MOUSE DEVELOPMENT | $2,234,990 |
| 2025 | National Institutes of Health | Grant or other assistance | CANCER CENTERS SUPPORT GRANTS 93.397 | CANCER CENTER SUPPORT (CORE) GRANT | $2,230,200 |
| 2025 | National Institutes of Health | Grant or other assistance | RESEARCH INFRASTRUCTURE PROGRAMS 93.351 | THE JACKSON LABORATORY CENTER FOR PRECISION GENETICS | $2,188,748 |
| 2025 | National Institutes of Health | Grant or other assistance | HUMAN GENOME RESEARCH 93.172 | IDENTIFYING AND CHARACTERIZING THE FULL SPECTRUM OF HAPLOTYPE-RESOLVED STRUCTURAL VARIATION IN HUMAN GENOMES | $2,126,598 |
| 2025 | Defense Health Agency | Grant or other assistance | MILITARY MEDICAL RESEARCH AND DEVELOPMENT 12.420 | REVEALING SPATIAL TRANSCRIPTOMIC AND PROTEOMIC SHIFTS IN TUMOR-INFILTRATING IMMUNOCYTES: CHARTING A PATH TO ENHANCED MELANOMA THERAPEUTICS | $1,893,376 |
| 2025 | National Institutes of Health | Grant or other assistance | AGING RESEARCH 93.866 | AN EXPLAINABLE UNIFIED AI STRATEGY FOR EFFICIENT AND ROBUST INTEGRATIVE ANALYSIS OF MULTI-OMICS DATA FROM HIGHLY HETEROGENEOUS MULTIPLE STUDIES - HEALTHY CENTEN | $1,892,433 |
| 2025 | National Institutes of Health | Grant or other assistance | HUMAN GENOME RESEARCH 93.172 | JAX MORPHIC DATA PRODUCTION CENTER - PROJECT SUMMARY THIS PROPOSAL WILL ESTABLISH A MOLECULAR PHENOTYPES OF NULL ALLELES IN CELLS (MORPHIC) PHASE 1: DATA PRODUC | $1,874,508 |
| 2025 | National Institutes of Health | Grant or other assistance | ALLERGY AND INFECTIOUS DISEASES RESEARCH 93.855 | A DEEP LONGITUDINAL ANALYSIS OF NEXT GENERATION INFLUENZA VACCINES IN OLDER ADULTS - PROJECT SUMMARY THE WHO ESTIMATES THAT ANNUAL EPIDEMICS OF INFLUENZA RESULT | $1,843,486 |
| 2025 | National Institutes of Health | Grant or other assistance | ALLERGY AND INFECTIOUS DISEASES RESEARCH 93.855 | NOVEL MECHANISMS REGULATING IMMUNITY TO RESPIRATORY VIRUS INFECTION - INFLUENZA VIRUSES ARE RAPIDLY MUTATING RNA VIRUSES AND ARE THE CAUSATIVE AGENT OF ABOUT ON | $1,742,128 |
| 2025 | National Institutes of Health | Grant or other assistance | AGING RESEARCH 93.866 | INTERVENTIONS THAT RETARD MAMMALIAN AGING | $1,734,603 |
| 2025 | National Institutes of Health | Grant or other assistance | AGING RESEARCH 93.866 | MODELING THE GENETIC INTERACTION BETWEEN KLOTHO AND APOE ALLELES IN ALZHEIMER'S DISEASE - PROJECT SUMMARY UNDERSTANDING HOW COMBINATIONS OF GENETIC RISK FACTORS | $1,664,858 |
| 2025 | National Institutes of Health | Contract | BIOLOGICAL PRODUCT (EXCEPT DIAGNOSTIC) MANUFACTURING 325414 | INDI ALFATAG CELL LINES FOR THE IPSC NEURODEGENETIVE DISEASE INITIATIVE (INDI) PROJECT | $1,530,320 |
| 2025 | National Institutes of Health | Grant or other assistance | HUMAN GENOME RESEARCH 93.172 | GENOME TECHNOLOGIES COORDINATING CENTER - PROJECT SUMMARY THE GENOME TECHNOLOGY PORTFOLIO AT NHGRI ENCOMPASSES A SUBSTANTIAL DIVERSITY OF SCIENTIFIC APPROACHES | $1,499,962 |
| 2025 | National Institutes of Health | Grant or other assistance | AGING RESEARCH 93.866 | SHOCK CENTER FOR AGING RESEARCH AT THE JACKSON LABORATORY | $1,459,793 |
| 2025 | National Institutes of Health | Grant or other assistance | RESEARCH INFRASTRUCTURE PROGRAMS 93.351 | ESTABLISHING A MUTANT MOUSE REGIONAL RESOURCE CENTER AT THE JACKSON LABORATORY | $1,296,980 |
| 2025 | National Institutes of Health | Grant or other assistance | RESEARCH INFRASTRUCTURE PROGRAMS 93.351 | SPECIAL MOUSE STRAINS RESOURCE | $1,104,638 |
| 2025 | Defense Health Agency | Grant or other assistance | MILITARY MEDICAL RESEARCH AND DEVELOPMENT 12.420 | UNCOVERING SPATIAL AND TEMPORAL ALTERATIONS OF METABOLISM IN THE KIDNEY, PAVING THE ROAD TO TREATMENT OF LUPUS NEPHRITIS | $1,000,000 |
| 2025 | National Institutes of Health | Grant or other assistance | EXTRAMURAL RESEARCH PROGRAMS IN THE NEUROSCIENCES AND NEUROLOGICAL DISORDERS 93.853 | THE GENETICS OF THE NEUROMUSCULAR JUNCTION: MECHANISMS AND DISEASE MODELS | $991,022 |
| 2025 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | GENETIC PROGRAMMING OF HUMAN ISLET METABOLIC AND ENDOPLASMIC RETICULUM (ER) STRESS RESPONSES IN DIABETES - PROJECT SUMMARY TYPE 2 DIABETES (T2D) RESULTS FROM FA | $923,710 |
| 2025 | National Institutes of Health | Grant or other assistance | CANCER TREATMENT RESEARCH 93.395 | DATA COORDINATION CENTER FOR PDX NET | $908,936 |
| 2025 | National Institutes of Health | Grant or other assistance | RESEARCH INFRASTRUCTURE PROGRAMS 93.351 | A NOVEL WILD-DERIVED DIVERSITY MOUSE POPULATION FOR PRECISION MAPPING AND SYSTEMS GENETICS - PROJECT SUMMARY INBRED MOUSE STRAINS ARE INTEGRAL TOOLS FOR BOTH PR | $898,002 |
| 2025 | National Institutes of Health | Grant or other assistance | DRUG USE AND ADDICTION RESEARCH PROGRAMS 93.279 | MOUSE PHENOME PROJECT | $884,995 |
| 2025 | National Institutes of Health | Grant or other assistance | CANCER TREATMENT RESEARCH 93.395 | PEDIATRIC ONCOLOGY IN VIVO TESTING PROGRAM COORDINATING CENTER - PROJECT SUMMARY THE OVERARCHING GOAL OF NCI'S PEDIATRIC IN VIVO TESTING PROGRAM (PED-IN VIVO-TP | $882,044 |
| 2025 | National Institutes of Health | Grant or other assistance | DRUG USE AND ADDICTION RESEARCH PROGRAMS 93.279 | ESTABLISHMENT AND CHARACTERIZATION OF NOVEL MUTANT MOUSE MODELS FOR THE ADDICTION RESEARCH COMMUNITY - PROJECT SUMMARY/ABSTRACT ADDICTION IS AN ENORMOUS ECONOMI | $877,994 |
| 2025 | National Institutes of Health | Grant or other assistance | CANCER BIOLOGY RESEARCH 93.396 | ELECTRONIC ACCESS TO MOUSE TUMOR DATA | $839,047 |
| 2025 | National Institutes of Health | Grant or other assistance | AGING RESEARCH 93.866 | BUILDING A SPATIAL TRANSCRIPTOMICS INFRASTRUCTURE FOR ISOFORM PROFILING IN AGING PRE-NEOPLASTIC TISSUES - PROJECT SUMMARY/ABSTRACT AGING IS THE GREATEST RISK FA | $816,112 |
| 2025 | National Institutes of Health | Grant or other assistance | HUMAN GENOME RESEARCH 93.172 | THE HUMAN PHENOTYPE ONTOLOGY: ACCELERATING COMPUTATIONAL INTEGRATION OF CLINICAL DATA FOR GENOMICS - PROJECT SUMMARY/ABSTRACT TO IMPROVE DIAGNOSTIC YIELD FOR RA | $811,824 |
| 2025 | National Institutes of Health | Grant or other assistance | AGING RESEARCH 93.866 | DECONSTRUCTION OF A HYPOTHALAMIC EXERCISE-RESPONSIVE CIRCUIT FOR NEUROPROTECTION - PROJECT SUMMARY EXERCISE SLOWS THE COGNITIVE DECLINES ASSOCIATED WITH AGING A | $783,186 |
| 2025 | National Institutes of Health | Grant or other assistance | ORAL DISEASES AND DISORDERS RESEARCH 93.121 | PREDICTING TISSUE SPECIFIC GLI3 REGULATORY ACTIVITY USING HAND2 - PROJECT SUMMARY THE HEDGEHOG (HH) SIGNALING PATHWAY IS ESSENTIAL FOR NORMAL EMBRYONIC DEVELOPM | $782,311 |
| 2025 | National Institutes of Health | Grant or other assistance | DRUG USE AND ADDICTION RESEARCH PROGRAMS 93.279 | DISCOVERY OF ADDICTION-RELATED GENES WITH ADVANCED MOUSE RESOURCES | $780,023 |
| 2025 | National Institutes of Health | Grant or other assistance | ALLERGY AND INFECTIOUS DISEASES RESEARCH 93.855 | HOW ANTIGEN EXPOSURE SHAPES THE SUBSEQUENT NK CELL RESPONSE TO HIV - THE GOAL OF THIS PROPOSAL IS TO DETERMINE HOW ANTIGEN EXPOSURE SHAPES SUBSEQUENT NATURAL KI | $774,994 |
| 2025 | National Institutes of Health | Grant or other assistance | CANCER BIOLOGY RESEARCH 93.396 | DISCOVERY OF HOST GENETIC ELEMENTS AFFECTING RESPONSE TO IMMUNE CHECKPOINT INHIBITORS - PROJECT SUMMARY ABROGATING IMMUNE CHECKPOINT CONTROL HAS PROVEN TO BE A | $754,511 |
| 2025 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | TYPE 2 DIABETES RISK VARIANT EFFECTS ON MITOCHONDRIAL (PATHO)PHYSIOLOGY - PROJECT SUMMARY / ABSTRACT TYPE 2 DIABETES (T2D) RESULTS WHEN PANCREATIC ISLET SS-CELL | $740,447 |
| 2025 | National Institutes of Health | Grant or other assistance | CHILD HEALTH AND HUMAN DEVELOPMENT EXTRAMURAL RESEARCH 93.865 | FUNCTIONAL VALIDATION OF NOVEL VARIANTS ASSOCIATED WITH CONGENITAL DIAPHRAGMATIC HERNIA - PROJECT SUMMARY/ABSTRACT CONGENITAL DIAPHRAGMATIC HERNIA (CDH) IS A CO | $736,062 |
| 2025 | National Institutes of Health | Grant or other assistance | EXTRAMURAL RESEARCH PROGRAMS IN THE NEUROSCIENCES AND NEUROLOGICAL DISORDERS 93.853 | CAT-TAILS: A NOVEL TYPE OF PROTEIN MODIFICATION IMPLICATED IN NEURODEGENERATION | $735,524 |
| 2025 | National Institutes of Health | Grant or other assistance | VISION RESEARCH 93.867 | ROLE OF ARMS2 MUTATIONS IN AGE-RELATED MACULAR DEGENERATION - PROJECT SUMMARY/ABSTRACT GENOME-WIDE ASSOCIATION (GWA) AND LINKAGE STUDIES HAVE IDENTIFIED >50 GEN | $728,017 |
| 2025 | National Institutes of Health | Grant or other assistance | CANCER CAUSE AND PREVENTION RESEARCH 93.393 | GENOMIC BIOLOGY OF THE TANDEM DUPLICATOR PHENOTYPE IN MOUSE AND HUMAN CANCERS - PROJECT SUMMARY WE HAVE IDENTIFIED A GROUP OF GENOME INSTABILITY CONFIGURATIONS | $703,993 |
| 2025 | National Institutes of Health | Grant or other assistance | CHILD HEALTH AND HUMAN DEVELOPMENT EXTRAMURAL RESEARCH 93.865 | INCREASING THE YIELD AND UTILITY OF PEDIATRIC GENOMIC MEDICINE WITH EXOMISER - PROJECT SUMMARY AS MUCH AS 10% OF THE POPULATION SUFFERS FROM A RARE DISEASE (RD) | $702,879 |
| 2025 | National Institutes of Health | Grant or other assistance | VISION RESEARCH 93.867 | RETINAL DISEASE: MOLECULAR BASIS AND PATHOPHYSIOLOGY | $700,655 |
| 2025 | National Institutes of Health | Grant or other assistance | CANCER BIOLOGY RESEARCH 93.396 | SITE-SPECIFIC INTEGRATION OF LARGE (10-100 KB) DNA CONSTRUCTS INTO THE MOUSE GENOME AND HUMAN INDUCED PLURIPOTENT STEM CELLS USING THE CAS9-BXB1 INTEGRASE TOOLB | $660,883 |
| 2025 | National Institutes of Health | Grant or other assistance | VISION RESEARCH 93.867 | IDENTIFYING MECHANISTIC PATHWAYS UNDERLYING RPE PATHOGENESIS IN MODELS OF PATTERN DYSTROPHY - PROJECT SUMMARY/ABSTRACT THE RETINAL PIGMENT EPITHELIUM (RPE) PLAY | $656,020 |
| 2025 | National Institutes of Health | Grant or other assistance | AGING RESEARCH 93.866 | MACHINE LEARNING BASED FRAILTY INDEX FOR THE GENETICALLY DIVERSE MICE - PROJECT SUMMARY AGING IS A TERMINAL PROCESS THAT AFFECTS ALL BIOLOGICAL SYSTEMS. BIOLOGI | $653,941 |
| 2025 | National Institutes of Health | Contract | RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY) 541714 | NICHD: R&D: TO PRODUCE, POTENTIALLY ACQUIRE, MAINTAIN, AND DISTRIBUTE MOUSE MODELS FOR CYTOGENETIC RESEARCH, SPECIFICALLY MODELS FOR DOWN SYNDROME (HUMAN TRISOM | $649,999 |
| 2025 | National Institutes of Health | Grant or other assistance | RESEARCH RELATED TO DEAFNESS AND COMMUNICATION DISORDERS 93.173 | HAIR CELL POLARIZATION AND SENSORY BUNDLE DEVELOPMENT | $640,063 |
| 2025 | National Institutes of Health | Grant or other assistance | ARTHRITIS, MUSCULOSKELETAL AND SKIN DISEASES RESEARCH 93.846 | MOLECULAR MECHANISMS OF STAPHYLOCOCCAL MODULATION OF SKIN HOMEOSTASIS - PROJECT SUMMARY / ABSTRACT STAPHYLOCOCCUS (S.) SP. ARE UBIQUITOUS COLONIZERS OF HUMAN SK | $627,515 |
| 2025 | National Institutes of Health | Grant or other assistance | VISION RESEARCH 93.867 | GENETIC MODIFIERS OF RETINAL DISEASE | $616,564 |
| 2025 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | DEVELOPING EFFECTIVE APPROACHES TO EXTEND HEMATOPOIETIC HEALTHSPAN BY TARGETING CELL-EXTRINSIC AND CELL-INTRINSIC ALTERATIONS AT MIDDLE AGE | $615,355 |
| 2025 | Defense Health Agency | Grant or other assistance | MILITARY MEDICAL RESEARCH AND DEVELOPMENT 12.420 | REVEALING SPATIAL TRANSCRIPTOMIC AND PROTEOMIC SHIFTS IN TUMOR-INFILTRATING IMMUNOCYTES: CHARTING A PATH TO ENHANCED MELANOMA THERAPEUTICS | $601,272 |
| 2025 | National Institutes of Health | Grant or other assistance | HUMAN GENOME RESEARCH 93.172 | MULTI-OMIC PHENOTYPING OF HUMAN TRANSCRIPTIONAL REGULATORS - PROJECT SUMMARY THE MOLECULAR PHENOTYPES OF NULL ALLELES IN CELLS (MORPHIC) PROGRAM IS USING MULTIP | $548,374 |
| 2025 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | B-LYMPHOCYTE TARGETING THERAPIES FOR AUTOIMMUNE DIABETES | $543,679 |
| 2025 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | CELLULAR AND GENETIC MECHANISMS OF AUTOIMMUNE DIABETES ASSOCIATED NEURITIS - PROJECT SUMMARY TYPE 1 DIABETES (T1D) IS OFTEN ACCOMPANIED BY OTHER AUTOIMMUNE DISO | $537,140 |
| 2025 | National Institutes of Health | Grant or other assistance | HUMAN GENOME RESEARCH 93.172 | FUNCTIONAL MAPPING OF ENHANCER CONSERVATION BETWEEN SPECIES TO ENABLE MECHANISTIC INSIGHTS INTO POLYGENIC DISEASE - PROJECT SUMMARY RECENT ADVANCES TO CHARACTER | $519,229 |
| 2025 | National Institutes of Health | Grant or other assistance | AGING RESEARCH 93.866 | SKIN IMMUNITY AS A FUNCTION OF FRAILTY, AGING, AND SKIN MICROBIOME COMPOSITION - PROJECT SUMMARY / ABSTRACT THE GOAL OF THIS PROPOSAL IS TO PROFILE SKIN IMMUNIT | $512,483 |
| 2025 | National Institutes of Health | Grant or other assistance | AGING RESEARCH 93.866 | ASSESSING THE INTERPLAY BETWEEN INFLAMMATORY SIGNALING AND EPIGENETIC DYSREGULATION IN AGE-ASSOCIATED CLONAL HEMATOPOIESIS AND LEUKEMIA INITIATION - PROJECT SUM | $509,734 |
| 2025 | National Institutes of Health | Grant or other assistance | BIOMEDICAL RESEARCH AND RESEARCH TRAINING 93.859 | EVOLUTIONARY GENOMICS OF FUNCTIONAL CHROMATIN DOMAINS | $506,220 |
| 2025 | National Institutes of Health | Grant or other assistance | BIOMEDICAL RESEARCH AND RESEARCH TRAINING 93.859 | CELLULAR SYSTEMS GENETIC APPROACHES TO UNDERSTANDING REGULATORY VARIATION | $505,193 |
| 2025 | National Institutes of Health | Grant or other assistance | CANCER BIOLOGY RESEARCH 93.396 | MYC-REGULATED RNA BINDING PROTEIN NETWORKS AND SPLICED ISOFORMS DRIVING CANCER - SUMMARY ALTERNATIVE RNA SPLICING IS A KEY STEP IN GENE EXPRESSION REGULATION AN | $502,751 |
| 2025 | National Institutes of Health | Grant or other assistance | ARTHRITIS, MUSCULOSKELETAL AND SKIN DISEASES RESEARCH 93.846 | MOLECULAR MECHANISMS OF STAPHYLOCOCCUS EPIDERMIDIS STRAIN DIVERSITY - PROJECT SUMMARY / ABSTRACT STAPHYLOCOCCUS EPIDERMIDIS IS A UBIQUITOUS MEMBER OF THE HUMAN | $486,882 |
| 2025 | National Institutes of Health | Grant or other assistance | AGING RESEARCH 93.866 | IMPACT OF AGE-RELATED CLONAL HEMATOPOIESIS ON ALZHEIMER'S DISEASE - PROJECT SUMMARY / ABSTRACT THE GOAL OF THIS PROPOSAL IS TO ESTABLISH WHETHER AGE-RELATED FUN | $486,750 |
| 2025 | National Institutes of Health | Grant or other assistance | BIOMEDICAL RESEARCH AND RESEARCH TRAINING 93.859 | DEVELOPING A MULTI-ORGAN MULTI-OMICS COMPUTATIONAL FRAMEWORK FOR STUDYINGMAMMALIAN IRON SYSTEMS BIOLOGY - PROJECT SUMMARY/ABSTRACT IRON DISORDERS ARE CAUSED BY | $486,750 |
| 2025 | National Institutes of Health | Grant or other assistance | RESEARCH RELATED TO DEAFNESS AND COMMUNICATION DISORDERS 93.173 | EXPLORING MORPHOLOGICAL CHANGES IN SUPPORTING CELL: NEW CELL POLARITY PERSPECTIVE AND APPROACHES - PROJECT SUMMARY CELL POLARITY MECHANISMS ARE ESSENTIAL FOR SH | $486,750 |
| 2025 | National Institutes of Health | Grant or other assistance | CHILD HEALTH AND HUMAN DEVELOPMENT EXTRAMURAL RESEARCH 93.865 | DISARMING THE IMMUNOLOGICAL BARRIERS TO REGENERATION IN MAMMALS - PROJECT SUMMARY/ABSTRACT THE LONG-TERM GOAL OF THIS WORK IS TO FACILITATE THE FAITHFUL REGENER | $485,286 |
| 2025 | National Institutes of Health | Grant or other assistance | CANCER BIOLOGY RESEARCH 93.396 | LUNG RESIDENT MESENCHYMAL CELLS IN THE PRE-METASTATIC NICHE FORMATION - PROJECT SUMMARY/ABSTRACT METASTATIC DISEASE REMAINS THE MAJOR CAUSE OF CANCER-RELATED DE | $484,308 |
State business registration
- THE JACKSON LABORATORY, INCORPORATED FL, Foreign nonprofit corporation (FORNP), Active, formed 2009-11-30
The same business name in the same state, from the state’s official registry data.
Patents
76 US patents filed in the last 20 years.
- The Jackson Laboratory 76 patents, 2010-08-10 to 2026-10-20 FUZZY medium confidence: same name (governing-board words and legal endings aside) and state
| Patent | Title | Granted | Source |
|---|---|---|---|
| US 12768831 | Model of functions and regulation of human natural killer cells | 2026-10-20 | PTBLXML, file of 2026-10-20 |
| US 12694716 | Action detection using machine learning models | 2026-07-28 | PTBLXML, file of 2026-07-28 |
| US 12612657 | Extrachromosomal DNA labeling | 2026-04-28 | PTBLXML, file of 2026-04-28 |
| US 12595490 | Non-HLA matched humanized NSG mouse model with patient-derived xenograft | 2026-04-07 | PTBLXML, file of 2026-04-07 |
| US 12577584 | Non-HLA matched humanized NSG mouse model with patient-derived xenograft | 2026-03-17 | PTBLXML, file of 2026-03-17 |
| US 12559789 | Method of targeting patient-specific oncogenes in extrachromosomal DNA to treat glioblastoma | 2026-02-24 | PTBLXML, file of 2026-02-24 |
| US 12551481 | Molecular targets for addiction | 2026-02-17 | PTBLXML, file of 2026-02-17 |
| US 12510548 | Method of determining toxicity of an immunomodulatory drug for use in humans | 2025-12-30 | PVGPATDIS, file of 2026-04-10 |
| US 12428638 | Three-component CRISPR/Cas complex system and uses thereof | 2025-09-30 | PVGPATDIS, file of 2026-04-10 |
| US 12409237 | Methods and models for assessing efficacy of immunotherapies | 2025-09-09 | PVGPATDIS, file of 2026-04-10 |
The newest patents of the PatentsView assignees above, matched to this record by name (and state).
Trademarks
66 US trademarks, 29 live.
- The Jackson Laboratory 66 marks, ME FUZZY medium confidence: same name (governing-board words and legal endings aside) and state
| Mark | Serial | Filed | Status | Source |
|---|---|---|---|---|
| JACKSON LABORATORIES | 99791596 | 2026-04-28 | Pending application | TRTDXFAP, file of 2026-10-07 |
| GEDI | 99789601 | 2026-04-27 | Pending application | TRTDXFAP, file of 2026-09-09 |
| JACKSON LABORATORY | 99748554 | 2026-04-13 | Pending application | TRTDXFAP, file of 2026-10-07 |
| HEALTHSENSE | 99649023 | 2026-02-12 | Pending application | TRTDXFAP, file of 2026-09-15 |
| ENDORISE | 99236378 | 2025-06-16 | Registered | TRTDXFAP, file of 2026-05-14 |
| ENDORISE | 99236371 | 2025-06-16 | Pending application | TRTDXFAP, file of 2026-09-09 |
| INTRES | 99147303 | 2025-04-21 | Pending application | TRTDXFAP, file of 2026-07-01 |
| ENVISION | 98923668 | 2024-12-26 | Registered | TRTDXFAP, file of 2026-07-08 |
| JAX ENVISION | 98923661 | 2024-12-26 | Registered | TRTDXFAP, file of 2026-07-08 |
| JAX SOMATICSEQ | 98828249 | 2024-10-30 | Registered | TRTDXFAP, file of 2026-07-15 |
The newest marks of the trademark owners above, matched to this record by name (and state).
Comments